var title_f2_1_2064="TEE mitral valve leaflet perforation";
var content_f2_1_2064=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/79920/teezmvp_conv.mp4?title=TEE+mitral+valve+leaflet+perforation+\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transesophageal echo (TEE) closeup view showing a perforated mitral valve leaflet",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 250px; height: 321px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The transesophageal echocardiogram with a close up of the mitral valve shows a perforation of the anterior leaflet.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Binder, MD. University of Vienna.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_1_2064=[""].join("\n");
var outline_f2_1_2064=null;
var title_f2_1_2065="Cutaneous continent reservoir PI";
var content_f2_1_2065=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F70318&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F70318&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 484px\">",
"   <div class=\"ttl\">",
"    Cutaneous continent reservoir (also called an Indiana pouch)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 464px; height: 652px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure depicts one option for people who have a cystectomy (bladder removal) for bladder treatment. A reservoir (like a pouch) may be created under the skin of the abdomen using tissue from the stomach or intestines. Urine collects in the pouch, and the patient uses a catheter (a thin tube) to empty the pouch periodically. It is not necessary to wear a drainage bag. This is called a continent cutaneous diversion (commonly referred to as an Indiana pouch).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_1_2065=[""].join("\n");
var outline_f2_1_2065=null;
var title_f2_1_2066="Pediatric olecranon fractures";
var content_f2_1_2066=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F63943&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F63943&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pediatric olecranon fractures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 278px; height: 590px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Type I: Apophysitis.",
"    <br>",
"     (B) Type II: Incomplete stress fracture.",
"     <br>",
"      (C) Type III: Complete fracture, apophyseal avulsion, apophyseal metaphyseal combination.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"       Reproduced with permission from: Pring ME, Wenger DR, Rang M. Elbow: Proximal radius and ulna. In: Rang's Children's Fractures, 3rd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2005. Copyright &copy; 2005 Lippincott Williams &amp; Wilkins.",
"      </div>",
"      <div class=\"contractual\">",
"       <br/>",
"       <a href=\"file://www.lww.com\">",
"        file://www.lww.com",
"       </a>",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_1_2066=[""].join("\n");
var outline_f2_1_2066=null;
var title_f2_1_2067="Neuropathology vanishing white matter disease";
var content_f2_1_2067=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F82200&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F82200&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Neuropathology of vanishing white matter disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 289px; height: 432px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGwASEDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6TooooAKKKWgBMUtFGKACil49R+JpdpxnHFADaKX68fXiigBKKXFGKAGOwQZOaGO2nFQeoBprqTjFACK244FOqNTtY5qTIxntQAUUAg9KMUAIGBOBS0YA7UUAFJS0UAJRS0UAJSUvSigBKKKKACiiigAooooAKKKKACiiigAooooAdRRQKAFFAyTgUVBf3UNjZzXN0xWCJdzsByATj+dADb28itI2eRhgLnqOtcvqXjSK3GA8ETbsHfICR6/0rJ+IGn+IdUtbS38NhLrT5HZp5d4jkjb0ZiRxjOcV5jdWHhTTVkk1rxHNqlwxIFppIyobP3WlIIH5dqAPQLrx7LJbsTqMPm4JQIVAxngYPeuXuviPeEm3Rr2aSIZkdZwo/wCA+1ctdPYXdmINM0aC1iJV2YymeY7emZCcAEdcCsLXruPTIwUtgPtBDbnfcVUAgBfTOeaAPZvBHifxbcXEdxNZXV5o7cGWWSOHr0ZGcgMB6c5r1EapYs8aC+tRLIMiPz0J/nzXx0sxuonjmm8wogKpOS3PYDPSlWziRd7KI2/iQcqf880AfaTBgo460ikFRz3x+NfFz+Jb3Tk2QaxeWuGyDHct124zkH8MV0WkfFPxZp0HljVXvoGWIRx3iLIAP4skANz25oA+rWzn5elBJJwpye+K4j4b+LLnxNok02oRWsF7BMI2WBiEdSMggEkg4z1PatW88TaJayolzq9vFJIxVVeXJbHBIGKAN4570/8Agx3xmuEvfiToltbuYLj7bMrbAkUTqDx/ebAqbSvH2j38xe4a7sHCAMlwB5eM9cgkUAdkCQMCnrnndVa2uobiFJYGE0b8iSM5X86tuSuKAGu3HB5oX7oJph55p4GUAoAPpzS0Ku0YoxQAUUUUAFJS0UAJRRRQAlFLSUAFFFFABRRRQAUUUUAFFFFADqUUlKKACsXxbfNZ6WfKUPK52gEA475wetbYrkfiwfs/gPVr+NR9otITJG2ORkgEfiDQB4Pf+MdfXxBPqMGszL5bbYlaUqjAnp5f3ccelM8S3Wha9pt5rFpbRaHrCxo9xp6unkXA3bSYsch+QSMciuKGyWaNWUgKdxbHf096V7eK6kd0J8iJvlMowWPuO3tQBiz61f2kyWmn6mYFdmkkEUhUlV6cj15GPSrD6jcatJFNM/myFsNluCPc16Jp3wwbUbJricrDPLGMKEHK44Ga4nXfCN74dmiE6brcsQkoUFc/3cfSgDd0nSrWaEznymVyysScBOQAc+5NYGvyQ2MzwRSs4Tp5cu7cfY9/TNTxNutAWbyo0GXYDDH6UyLRZbyaLyIwZJQWUsMKqk9AKAOZ03TXMr3N4jliGKR7zhSQcE+p5r0vwf4Lur8Q3M7ARSFdkOw5B9TxW94L+HkbpFPfRyO65ZI1I2nnv617IthDoejiV0Xds2DAAAQDPIHpQB5/rMsXhbTHhjlMNw5QSzRgAFecJ9K8k8QeKL27uZ1QNBC5+RM9fr6nnvXRfEi5a/1JooCJWwG3ZIyOTXl2pTzTyzJZbEjiQh+PmLeq/rQBfub6/wBoJuJWCnjY2cN1/Cp9O8T6jZ79kzuJMKdxyCe+KwPL1K3VZCUUbQyiQZznABP4Gr1vcQoI1mJdjIAGUdDu5498GgD1fwd4xuXu2ksZza3ZAAVWIWU553DoSP617loPi4zQgasscDltqSbgVYAdx25r5Rt1VwrWuUCsSdg4zzjJ9a3dE17UdNnTzESdRywKdu+P89qAPrm0m+0QI6yRyZA3FTwT6j2qbFeKeD/EDxxrfWU21JjmWPPysc9Nvb8K9c03VYby1iYZXcCxyOQc4IoAvU+PvTcg9CD9KUA84oAkpKHyF4oX7ooAKKDSEgdaAFopAwJ4paAEooooASilpKACiiigAooooAKKKKAHUtJS0AKK4j41TiD4X6+zgHKRqATjOZE4/nXbivLP2iLmVfBa2sOCrSCaXJ6KuAMj6n9KAPnPSZYvtcUUzMS4GABn5vQ1ueVHp7mS8hFxavLtYbiCGB46dfrXDt9ps5zdJLvjDcZ78gflXVtr1pPp0drMGJ3qSX+ZhxyFb9RQB6v4U8RTI9nZyxPLgB1Zifug8L78V3PjHw9a6vo7zxxoEmGQNu7yyR1Hp9a8E0nUI3hNsJJFnT54JdxBZvTj8vevcPAfiaO9tjBJhv8AlnIkiklJMfy65FAHzv4g0m8037RazRH7RGCrcEZUngjFangvVUsWtJxtuZEBgkjfLbAeA2Bzj9K918beC4b+G5YqFlkXKSmQ5P8A9avBte8H3WhznUIJVScN5ckUZI465BPUfhQB7fpXiS0tYFVVR3KAIVOQ49QOxzU2q6pJdWJM5jjibAkDuQ2O2PUV45pXidYrBnvNLDYyPPt32Hgd/Squr+M5pbVEs9Pbfj/WzzlsLjHIzz60AO8XLbafcuw/eX10uI1JChATtBx6dT71xaoyJJHbQRyTt/FGNxXPbPUVrabo+o6rcma7mEsoXmXcSSOyqDXofh/wddMxS0j+z27BCSfmL7l5z+X60AeRS+GNTdFluZkgjbGY05x7/Wnf8I5eWgQRMko35PzYyAT2r6PtPBGmmyNtNbB5Cg3lnP5Z9M1j6z8O7eYbrOZoWBw43lvpgUAeE2K31mznMoQuH2446d8V0NmbXUpPLmfZKT8jK3GAP0Oa6vUPBOpafukUR3duAWk2sA/5elchLpux2uLJCIoyfMRvU9/p/hQBveGbtrG9FlNthVmyGY4H19Otey6HrMtvFBLGVYbCrRyH5H5xu46d68FgnhQJDqQY26kiN19c8/XtXUxatPZ20MsEpurcg4iDFsEcZPoOlAHuekeIE8yVZiByAoxkd8gEdfyFdDa3IlTcozuGcCvBdI8Uwi46eS6sC4duCuB3+veuqsvErEtKZCTbzDztkhbjr26cfhQB6uGDYyRjqKeMY46Vzthq9vqcCfZ0khnbojc49sjg/nW8rlkUHaDjle4oAVic/L0oA3D5hTk+7S0AMwq5PAHvSqwZQykFSMgjuKd6+4xSGgApKWigBKKKKAEopaSgAooooAKKKKAHUtJS0ALXFfE7Qm1jSbhEieTzIQuE6ghuPy612tVNSvEtIcv345NAHzFD8LdUsdbVoLqF2Qh4i65Ix/s0g+GWqwyIBteEKRtJx+Q9a9ouvF+nwagYZZVV3baEJGQB6gdBWtFfWd4PugggfOuDk+vFAHzNe6DJpUrMrySpG43OV2FT/PFd94T8RLaia5FvAsir+98glkIzjdu7g/4123jTw3btby3kIhDqNzE5wy45yPpXj+maZZ6ZqN7AljcJs+drp2yjxk8JjPUEk5x3oA+ifDes2+sWDwORtf5VJPKDHANcp438GJdz+fHlZ4xiMsPkYeuPWszwhq9taO1ipxFxtbdkDj1/pXqmmzx6hYhZlLsQcAnuO9AHzL4i8OJbKwSd7VNu6Qbc7n9cUukaFFOkM8CxzM45iLneOB86jGMV71rmgW80ym7j3uoILHpjFY8WjaRoSpN5fk7yFByWJb0A7UAYeg+Egsq3MxebdjbAq4RSO/616FDp0dtGHu5lgjXAAJwfpWfLrcdlCy28XkqOssoGSvpj1rhPEni020nMkk0oGSM4AzyAcegoA9LurrTX/d+aMjHygMB9cipra3t7jJjYvEOWwf6V4UvjGQiO4uI8EsShLDkH0Ar03wZevNcWphkwrN86nkMCrcfng0AdLqelRNBI6BUHBx7V494o0+Kx1OK5tkCpMxVlJymf/rjNeqeJNQaKOVUcqqnDkdTXjHizU31DUgqEJbRn+7/EKAOS1iEQazJyqLKSQu3IUdeKrzzNamO5t5/KK54XgDp1FZviHUpbrVgq5YriNSpyBj07CkMN6LZN8QRcFi3Tcc5Gc85oA05L6K5MK3Noxy27KOVLe+O9WdP+0W4eeK4fZuLFA25T/d3fzrGtYbuOXzJY93lYOG5ySOD9K0bFCpNxbuI2ONynuewx6UAeoeGdYaeBJw6xSK4JjJwGxjoa9XstdtfsYMkqq4QFiScfgcc14rptxbvZRPaokNwoUeW7dW7mr91qt/p+/wAm0RllwQSAQrDksc9qAPbtNu4riM+XJG/POG6VdrwbR/Gh+1wAhrWRsbGRsqCexGe9exeH9ZTUVEUuFugoO3P3vcUAaxopxppoASilpKACkpaKAEFJSnpRQAlFFFABRRRQA6lpKWgBRzXB/FK/ubTSb1oDCY1tjw3DBieCDXeKcc1yXxC0pNU0ia1KpmaJoyWHr3z7YoA+ZrfWEtbrNxDHJEGG4yICJDjPzYwSD9a6LQPEVvASlvqAtW6Iu3Cg+3bH1riNVtJbW4a2uvNikjJD4Xr2GPanWFtNaknyzJCzKMeXvIbBweR60Ae2an4jlvNL+zXk0CGVdyeWctIOhBxnk/1ptroI1rSp1uYrlDeShCGwDbx5HKj1GM89aZ8OI9JubXdLDGbpceZuQKYzj09MivRGjFtcsw2ywTKDuUdCAMDHH6UAeOaZpt1b67dWMlwoj05j+9RdpliB+ViP7x6H0PtXq/hrVoZFQROqTbSHicnIHp/9esnxRo0Vxi68hZJiT+8ztO0ghlJHYg9DWC8V5pEUc9rGJIDzJsBLRj0C+g9c0AeqLd+Xb7Vlw3A3hdxDAYPBNcxrN9DpVl5hPzSuzDn5y3uTWJp2vNLAuXLSYKjI+b1JNY2t3Fwxj+3EtBjDNnIGc8+x3AUAZniHV7nUbkx28u1JCreUQMbwT3P8vesTUrV3tGDbpJVYtIcY2knjAHXj8Km1i+gt5YjbwkSSjeJA24sucYIHQ5XtWbHctPLGIN53/JI3YZ5I+me9AFNrcQLsWKRWAxtYbtvAySPzH417d8OoHt7BJHwscSFx0JIxgV57pFqt9JACkUkr5YsCxYc4AI4GMZxXs2l2K2fh10iQIZH29Oq/0oA4PxvqdzbTpDEgeK4fDMR935a4dXWSSco6O6uWRsdsdOeteg69pE2oXXnKxAUjaM4Ax3x9KxtN8JGRC8xWUSMTtPUfWgDjtJ0a5vrlP7OhSNjKN3y4AGD+tdt/wrxin+nEtLKpDhVzgZyOa67wj4f/ALLdRHCGjMgYg5OCPSuze1RrqNssCcttJznoOPxoA8O1nwM1pYFLKSY3BB2K2DkdcdPbv61yk1mBLG72yxSxkrKCwJLH+E/if0r6I1OwaQDzGRpGGVZQV+b+lefavpMkr3AWJBI58wfIOSOvOPpQB5xHE08yxzJIjjMgX7uDxgZ9gc1YK36XHkwXBcM5X94RjkfdwSPetkaH5llCl8RFeIrAyx5OBnjp1/HsKl0i3FxHcWl5HE1xCBueVB2+XP4kigDkYpTqELi4DJIMK2Bg4Xpj04rovCfiWS31KKyd5P3ZyhGGbAyQT69hVK70Zw6MIYmkZ9zLz69aypYo2vDdaa4t7hGVjtHzE9CD/s0AfT+g6smp2iyBgWAy349P0rUrw7wh4mLzlITJFdAKzgHhjjBwenavYNG1OPUICR95eOPX1oA0KQ040lACUUUUAFJS0lACUUppKACiiigB1LSUtACiobq1S7haKU/I3pxUwpGYLgHvQBw2teBrC+lJns0kYggOTzWDd/DbT/JG1Z7dtoTfE/Qj1B716LqGr21uSn3mHXHauavdaiCO7TpCF2tumk+6D+lAHmaaVcaTqCMlyy3MJH3EADoDkZ9TXqVi631gkbyvtXlm24bcOgxXl1zq1vqmpX1xLloYFwjGTaeuBg+5rsvDkjR6RCb2V5lOFDRkltwPOfz/ACoA3NWcRBjKGG5QTHjP4+1YdynnXSx7HVQoYkN79D7VvusNwWdZkkw2QQcDggj6YxWUkkNvI8pkR0eVuhzkfj0oAydU8P6fcYu3jkjukbmSNiML+B9KjOh6bdQx+TctcMCFRg+QV6EnHUjHFbsEYiU+RIkkuCV3D5W55NPNswhZYQI2ZgUKxj5QDnFAHnnjOztUsFaa3jhhtwsCJEmX4OR8x/E5PrXJWVqbe2UOsyPdfNgAnjOAcgcV2Xj4zXOnSQxW86DcHZ2GSACPn+g5/Os7TrP7bqNlFJL5qeWoKg4KAeuO9AHoHw+0aVLGM3ESLMWyAB9wYHH6Zr0b7M32QRSFeR9Mc1haDbyLCFt5DHJGUZ2ZMgqSDgH6Dr2p2s6kySY+ZYwOcn+vrQBJd2lpFMpuJ0DHoE+ZsfSqc+pW9o7fYrZHC5O6Zc7ie4FczqXiO2tVlZpFEijKh8AH8a42bVpr6ZUaZoW4bLAkZOQQfagD0mXX7t32i48rcpBRVA/IcitOy1llSIuwkGNvTkY6nNePW8sixgG7kDKdoUcEqO/Pb9atW+vzW0kaXCt5bEBS7cAEdTx/k0Ae5xXMd7au0W2QAkqB2OOM1gX6KpHAMbtjjj5vSsfRtQZAJYPmnQhihbBII+79P5V019Cl3Yi5t1ISQgmNufLbOC3+NAHEaxaLAy3KgsyNyMdRzkVjvaDzYr+J+7Bg/QAdsV2l3bRsZQQQAxjXJ+/xnP0zXFyWMlvNesbtpFkxtRx8qEDBGPQnmgCG9ja6BzJG0bfPwcbW7YPpXGXpFleq7xjbGdhVemOxJ+tbst7eC3vHult3RgFtHiOc44Ixj696858R6rGzRRW8Uu8xqrGR9298YJx6elAG+t3DKz3FoJPMYHgDK5+nHFeveAdZaaO1aZdojfDgHgZ9a+fPDtndg3EsvmKShChTgk+les/C+0upLJpSj+VLKBGGJ4I4LfiaAPfAQygqcrjg+tJTYBiFB6ACnGgBDRSmkoAKKKKAEpKXvQaAEooooAdS0lLQAoqjq8gis5HY4AHP0q8KzPECb7Fl28sCM0AeGa3431BtVuRbNbR2qttG/kuARzx3xmuR1jXpNRjh811ZACzBTtH3jjj6Yqv4nsLiyvpLeYDzY5SVG3G8Z4P69qzmsWltGmaaFXRtiRljufjn8PegCzZXYmuPIBZY0AwVGS2DkE13UHi2W2tiroUGCCdmCrHjH198V5bp4trG2uri7vZFvkmjS2t0QlZkJO8s38OMD611EeqJfW7PMAm0+buWTOGH6k9OlAHbDxhdXFmoZ7VoyFjk8r5S+CeAMDnGM47inarrpsYIbi6sWjhYeWA3Qgc7uenT61wviLVbst5+rW8CXkMKwR708t2G4MGYDgtjueSDW5omow3NvcJIFuLW3bzZFZBmNWbGdhJ6Y/DNAHdWuu2stpaGEiOAIPKBPzdzk4z2ya6WGYmySdQxReSW4465/wDrV5tpWmQRXlxcWeo+ZpmBPA4C4mb7zAnoFHFdlEJ4LKScy+daSxrKWc42MduQB6YJII9qAJ/EFib6IwjKGVCy5O3C45b3GccVw+lf6LqcU16Ha5sZdk7KxCqM/KeRyCMV6JJJEbRZIjHNESoWRn/hI9e9YmtWMV7Nb3qTtaT7OQMYfHRW9fr2zQB12l6ij2Q2BxE/RuOlc/4xu9unzL5w3nsMDPpyaw7PUGspXhaQoxbLRP8ANGcj+Fh1HH61n6zcXWoRj7QiPCZFA2gMoGf69PwoA47VLWaWeFy4I3K/LjaRzx7/AI1dhhuJ7qV0IWAbQ7K+XAII49ME9KlurSG2LuZF8tGICnGAu7oB9aZLdW2nXLiOXzEb5sxkDLZ/wA496AI9jRRs8wDq5BMh+YjnJOAeKjnuoZt6QSSlRkurjPByeB9cGqtxewzxBI1EQiYvkHG7g/Ln16VmWCzPIVeMw4+cAEjjv1+tAHpvg663TQq7q4fgOMg+vI6etep6BOr2F9GSzcgqvGVDDp+YzXjnw+hkmkaSNRsDhSjc5PP6V7Jo0BttLZ5Aglkb5tp44GMfzoAxNelVrdwc7pOCucEflXIXBlhtIxISC5ZTIpwwx0H6da6PxDtLAqrFyvVRk1xupXAMkUCSK+zhlY89Tz+ooA5PxTemCykWCR2O4pgcZHOCB2zXK6HoT3Ui3d8oxjeoD9eeCcVt3drLq+uC3nP2eKPdIWLDG0DgEjuciu48LeHre6eOW4ZRAhGyIcbiCOv5UAVPCvhQarMZi0iwIAU2tjLEe4r17RtIh01VuJS2xQojRBkkj2qbSdGjtY8iNdh5CE8H3FT6i5lmIODgAA+gz0+lAF5L6DCpuaM9RuGD9Ksq2RyevTFcfd3bRFl2INuV3BQBj1q7YXjwxoIZUK5HyOTgk0AdLSGo7W4S5j3JwRwV9KloASiiigApKWkNAC0UmaKAFpaSloAUU2WNJFIkGVx3pWICk1kXd2EdUGScHIoAwPFPgu01XEl0rMBjy3QgPGfVTXk3irwbNpkcriJHhxtDBsktk8sB9a93hu8N9/AzjpVp4YrqLLqAcYyOc0AfLx0ByBNKYpFkwD5Y+YYGOc8Vk3WhyaZd+Xfq8USxlh5RBYEcge4NfS2q+FoZ7hLyF3hmQbcKBtcehHfmuZ1bw6JoHtrpWQsw25UE49Qf1oA8E1JJ5jEXmgeQjzG2TByMr03H+IY5FdR4VdrOxubWc3CxTrtkZSGeIt/y2Hrt4BXoVJ74rS1j4dXaTGS3/eInBjkAXJ5GeOnB61z0VvqPh7UobXUIdoLFEYvgP8rY+bHzc44NAHpOmQT2enC2ENtbrau1vJsTO5hhvMA+6QVxyMDHX0rqXnLlWj2soI4BGOACORx+FcfpmmIM2URUQXEIKRyD5sAjPPbFa0VpeXy2ZaIQ4kMzxbh84KgEt68YGKANFYvLgKIWEcm0pHJjAz2qURxyI6u6qI1LCM9WXuaiBktCZrNZriKSTP2QkdMnOzPfnkH0qe72o8Vx5MUcEYxIynmM5yOPTk59KAJINNtppfNXbskQ+nT1NYF9oUaRSLAmIwQPm5aRh0O2ujtZgLd7h4Qsm7GwnlhkkHP48VNcTwyx7toBxgn0PvQB5bdaULacuwWZmKhQSAu4nknHQcDg+tc94hhiiuPlcwqFO2NzhmA6AHHr+ld1r17HHayTwRRyzu+xWPRMZPyjuxPH0rhP7LuJAW8uaeSV/lMX8PsPagDNso5iyPdbTA+HIxwckHt0yM10emaVc6i4NsC3mhmjyeVwdpye1bHh7wNqLy273A8mM8lSwZmJ457DivVNN0KG0tI5GwqEAc9eB/nigCl4O0OLS7SMZLPgF2B5J9fat7UNRWGE7+FU45Oap32rQ2kZRnUkYX3PHA/CuL1HXDeSt5ZU4JPlKemP7x/Lj3oANQv83kUhdiZG2xLnAODWMbdlWd5irRkhg4I+Uf3ecZ5xWnp+lHz4pLhZd0rZMhU4XkkZ9e3SrNx5tqnmCLCsro/AbczjB/n196APOfDsbtrGoMo3TbGDRsAcIOc4zXonhO5WZIUXZvt2JxjqMd/evL45vs3ieHHyLklGH8XoT6jiu88MSR2mrpmZHLqWYLzg5oA9j0ueOWJVkbt8hPGRSX0HzsVXvwaytPkJQxgZAAYGuhuQrOMqACoGaAOR1izkdV7DnkcVVtY5YjGi4wvPynIrp7mwdiUAJPUj+VVhp0jKDsI5oANHfZJlCw/vA963V+6MVRsrSVHLORgjgGr4OQDjrQAhopaSgAooooATFFHNFACiloFAoAbOQsZJOBXM6wv71SjqJCMqO9b2pSGO1JA71yPiS8CMVAOSPlI6Y780AcwfHNrBq82m3C+W0bhNx55zj8/Su606/H2dDEU25zjJ5H+NfMGp3Sx/Eq7nmc7BegZIyNobAOPSvofRFje1hk3pJgEl16EUAdnaz+cpy3BAwu3p+NOubSOeMF0DfzqnaNtwV49B7VqRt0HFAGHfaVyWjKlf7rCuL8feF4dV8O3QaFDcQfvoj/dcDr9MV6fcAOv+FZeo2xdGXblWyGx6UAeB6Ox1vwlEsUxeVuG3AhzyMAEHODjPHpXpdpHFK9s8J8ouiNHhD84KjPPbnI5rzrSrJrCw1SzaNC1pcSLbsoJ3HI4B65IH616LayulnYzyCM3DW4l8twSgAPynA/i7CgCTVbZJL8zQ+YhBAZ14VDnGcH2zkj1rHie9a5aPapikkO444UAn73165rS+1EwPKSJHEnmMyncigtjapx94D8s1ltPGFd5EiKRqHnkZ8SRsvJU46/hQBdvZypNx5iyrbcyCNNwT7ox789Mdqlug1wpFrwSPNZs5DBu/146Vi6lqllbxRBXBvpt2VMpAJUZI2+uM/lWlaTtC0UWptDAHycDPOTlT/u4oAwdbgtRZacgBEjzPIMA5DADAPv3xXXeF7C2tbKMrH8w6lhyD3/Cue8byGHRJ7q3VfPtR9pt1A4eTbjDEdmzjP0rl/hd4j1TX7a7kvC9vbh93kLCV8oHjBY98g4HfmgD1Qyx2zSC6uWlRpPMijVFQJ6Lwct+NYvinxU0CRlAbe1VeGbqDnB49MVh6yL22XZYRG5u2Y+WpIOBn7/8A9asJfDHiGe9F3f3EJdlZXZjuVT04Xp0x/OgC/HdXurXm6O4lESOQ7lVJOVGCB24PX/Cpn1Wy0K2D3iGe6QhTEuNxxnnj2qLSPBx3tFcS3dwQwZgDsUsOmSOTXYReHIFgdvs0HmbicKM8c4yfXGKAOFfxgHurUQ2kwd32wwZAC7uOp6ckVq3OoXzq32pOAq5hB3FGHJ3Efr+lZXiCxijt52gjWQx/vNzHluox9MVm292rWMDwynaEKO5BClcghsjr6fSgAgji1bxlE1ujCOGIsqsPunOCOOvWu00PSD/a7TBwUCDPGOvGPwxXJeGjFaa6LaJ8u6kpgEbmByVwenHrXrFgixRwBRtGBwR0NAG5ptsttArzMVB6D1qefUsuzLtCg8Z7DNc9d6qY+AxkY9FHQD0Fc/r2r21sPMvrhoISueD19qAOr1DXo4wX85gCSOBnJqCLWwWMaSsVckxuo3AgDn6fSvK9W8daZBEGsoTKOhJBAA/Gudk+IUYgEckaEI5b5CQCMfe/A0AfQdprG9xsl4VsAt/EfQVuWt2tym4kA+leBeHPHNvqJSKGWQHYJCHHBfn5c/kfxr1bwhcCa1USR7G28EHI/OgDr+5Heg1Us47kYkmuBIGUfIqYC/j3q3QAlFFFABRRRQAtG4ebsBydu7NL2J7Dk1SsFaRpZm3bmYk5bOB2/QCgCtrcuWjQNt2849TXnXiG6YyyuWgaBY2MqPkEcdQen4V1vi13tomlVgGIwmT1NeCfErX5E0C7tYPMlmJCFs42c/zNAHEXUr3mo3U5kGZJm5J+6uSRzXa+APiFfaG8lrfQG9tCvyrvwyY67T3+ledeHr9ZNhjQsA5bOdpB9T/L8a620is5EdbhjDcDlT95cAd6APpnwzr2n6/YR3mn3CTKyjIB+aM+jDsa6NZFOBmvnrwf4duoLO6u7GSSC9k2C3linOwZOSWAyGyOOa7gXvjS0V45LrTLhtv7stbumR16g4zxQB6e7qq5zmsXWtYht7dlX57j+GFGBZvw7fWuaSXX71Ujur62SSZgoS3UKd+MhVLeuDUeg6A41S5nK3NtBExBk3H7TcMpGck5yhz1HNAGNY+F73UDCtpKbO7BPmzSqN6kncxUdMknGT2rqLnRJDpCQyxR77L5IjuIV1XkZwOMmutVrezMk8kkYVPkXaMbR/d9zmqEuo6fcvLYXEo3EGMoR1yOc+3v60AcZeF7e8Nk1vD9i4l35Pll8ncM9v65rmbzUkM0rKtubdn3ERDIdCCuCOuc56113i4rHpUOUmMSNGI0kYbwwPUnqScdjXnVzebppN0rfargFGhGN6kk7FC9sEnocfMKANKAgXu24h84qzLIVHyohXqrY5bkjNbVmzXWjvJZxPKsMpXzC+8Dpu2jOM/N36VxVnbTq8ttqtq0E8KbJIiTztXcOQeG5wa6HSEm0vwxKpjcQxoLiIZ+XzWyu336j8aANyGEiWa2uAZZJH2bwmd4wCBxxn/Cuev9NlsLsXOkzXFosI+eGR98dwMn05DZ9vSunhaCwjhhRi7Sgw7c5Gc9R9ATU8m2KaONsRqvKkHhR9exPNAHPafrXny7pEjjuyhZ41YYxxnbmte21a2uJh5DEAceVIMEZxk56Hmuf8R6Q17cLckSxzr5jRKso+ZewZsc56/lUVt4ivdGJs9SgOyNMF0IJB789COaAPTbcwAHChTu6+vH/wBerRwInKnnHb+VcNb69YXkn/Etu0aX+GORsOWx2HftWwb64TT3MpHyrjK9R9fxNAHM+J9JWe7cllVfuK7ZGAR0OK4O6tJfD7WyO8H2e7lZTNJ3PIzjtXoN9ctPvS4IQFhuUcjHIzn6ivOvippV5qNnD9m8tmVjGUY4A4BDY79D+dAF6OOC4iCW8sy36/vTMchsg8tk461tWfiTWLa3iiuoobwlf9YcKyegyCc5GDniuY8LWl1aaVbqzbZtmMFgdzZxkY5A6YrsLRQtpAbmGUw7QmCwYg5x+pPagCK41rXZ7uSBIY7KBekoIfgj1BNcdrsdvZZuLm6+2StFkIwJMrA4yoHr712Xi/XTo0MEOnW1u8inaqNGRuJAG3HatfwX4LS3b7bqjvNeONxLYxGOMKvpjnmgDyaDRtb1aETwWnkojYVpiIyoI6beua3fD3w7s3jV9Uu/PcYYKikIceor2i50q2MYWNWGWzuPU1JHY29vFkHay8ZyMH2oA4jS/DUFqGksLWG3j3F18uNVIz1216D4VgCWgjVSV2kgkY47U3T7dUMkaxsFYfKqjOSfetrSbaSGLayiMAYwTQBoxjEaDbjjpS0gKqMFhS5zyOlACGilpKACiiigCDUWxYzD7ULTIx55xhPfnj8DRaiC1iijFwrM4wN7ANIR1IHf8K8S/au11v8AhHLTwvp5kMt/KLi6wvAt0yQCexL7f++TXz9oXibxfoixQWGv3NvZxYk2NibyiOMoGBwfcYoA+1PE2lPfRukbhC+QGYcL9PevJ9X+H0sjzrMSfMbd5g6Aem09/evL9K/aA8Z6UVbU4rPVrTOGdozC0h9SRxn3212TftHWTq6XPhaQkxjJivwAG+pWgDJ174W3VvLCuko7yk5ZwNvHXkdO3asjU/Dmq+Hr2zS+C3MV2CUkiYNhh95cn071pSfHrU75PsWiaFGb5lKrNLIWAU55wAPaooV13WdM0+71eWCLTrcExQpCsUCOpIbk5LEk9zg0Aem+B76O20Zkt5kM043GTgKgTggDGCw9ADyRU19rrtZSfYbnzJASf9KYxGBVUksS/BOeMD1rI0VdR1y3fT/Btokwij2XEzIIrSKRjnCuRyDknCA4IHSvRfD/AIEiitYm8UXX9q3gAzGCfIRvUA8s3+0f0oAj0jVHl0tUFvLcPPCstpJaqBnC8kk/cPPDHk+lbeiWVybWENCbfEa5d5xI7cYOSPpya3oIY7ddsKhBnPFSkk9ST9aAMiTTJl06GNpFvLiEZG8CMTMAcByMjGcc47VQ1XS4jbgy+XFLkPI4Gdy5ztJ9M/yrp1G44FYutM95byQWiKznKnepwTxn9DQB55r1pNdatPHcTXUlpJJvjkhAEceAdgwOV5zk+hGcVxotbKCHN5bySrGzsiNPsMnzEE8csCQmenQ+teg6tb3VtLcLp7LJdr+72lFXcrnL4PUjqOOvFctf6bDFcMyQj7SrMwRTnbGB82A3Tr0HGRQBm2N08OmxXElmlqIVJMoiJkffkFG55A9SMkrXSS6pfXdvZ27yypbedG8kUkO9SuOAQMbRu5yc81mCCO100zP5olVtrOzffQZIUj/gWc+1adtbvJcQQx3ED2jugkAgKPjA4BHXn+tAF63skgwVcmGFsfvE4TOcMG6kdR7Vu20UQcFmhePAO4DOc54IPWsS6WNGDtC0Txy/IoZtsmT8pbtjP9a1YrmFIZI7aSO2k3bnUHOG9efUDrQBQ1OBvOIO1tjAq5wMew9s1g6rskfKRg3Mak4A8wY78dAa2dW1SKdI4IbkSRupDyJ/CD3Poayphbw2gPnI5GUPGN2enPrxQBh2+mzadKLmzMMcUkquwdVcKpGGG08+nHFAv9Ytjc/YpoJSsiqbUKF3ZGfl3dPXvW7bRQvI7LcBXlLKY3jX5WGQCPXjFVmtbaexMNxK77CzEqMbWUAZI6UAYVzdarPHLBvW1ZCNz+UcDJPX3HNYfkma9dbi5lmLAlSCQFz2+Yda6DUYjHdSCKNZIgwcphhjDE8HHU0xNNlkKzxiO3GzfsVgWLbjxuPP1PXFAENpE4gVmjHyKyrLBtDEYHXHcAVv2zxzwpBh43Uboyq544P5mqENuIpIzp9kbO1V2J2SmUDphuRk89zV5HuEW2lmyqyjfG7rt83ruI/Q4oAREt7nxNpskjPtRHIDHOCNwBNeiWjAQIXOW6fL0z9K8t1LTWurIyR7UmPzh0IH0APX72evrXReF/Egu7dYbvbHephSD0kPqPegDucqF2MC341ZtmiV1UQR5/2uazjKg+d2KFeSc9PwqRLqPl94ABJPHJ4oAvR3MglLBwi9MJ61F/aAAZnkLNnqWzWLdK8jx7ZZFKZO1SADx1Of5is6/wBUtdIthLqEh3SLtRVG4yEnge5oA6k6lg7SgKEYBz1PWte0nD20bJllYZ5PSvE7LxXca1rENnaWsiqsb5UgZ6nn0HpXpXhm5M1ttTzAg2gB+T379+goA62kNL2zSGgAooooA434geBtM8aRKZriWzvYDtS5iwSo5O0g8EEmvCfGHwX8UabHNLo722sw+Z8hgwtwB3DBuPyNfR+r6TcXcymC4Q28iLDc20oYRsgbO9NpBVwMjOcflWnaWkFqZPs8Qj8xi7YJO5j1J9+BQB8Tap4H1eKyW9e0uJp0TZNaRwu8sRJOCygHGcHmqVt4VutQuotuiajeTbuYre0kcqcfxDbwPrX3FrE80Ng7RzxQFvlEkyF0B6jOO31IrktFvfEVtremW2qappV3bXCkM1tGySSsATnZkgKMg7vw70AeE+Dvhb4vvrnEWgx6Fbudz3d+VVwp44RSWJHYHbXtGh/CXTLa4hl8Q6le+IRAoWG3vFVLePHTMajDnvlia9JooAZEiRRrHFGkcajCqgwFHoB0FPoooAKKQkDqaiJbcwwoTHHrQBKzKFyGw3b61yXi9hpFpp1x5pSND5W0qDvY4AXcema3jL+6DAEHsMVyHxItFuPDpuYre4lks5RdYT7yhcbnGeuBnI70AcZqV07As6l9hw2WG923bsL0+XPFZ99qLTxvKIJGaIqVHyb3Bwp4GRtALZ9eKi1XUoZb9rjdARct51skL/eDDOSe3PUVR2L58TNE9sGRgpUk7i394n7oHt6UAaFnBfpE0kt2XtxvWMIgDoDxu9+4x+FdTpts0NqBI0jL1jdsKRk52kHqM/lWVY3EV7Atvaq4jCnzpAWxgejYwc5Jx9K1IJB9mMgEkpjkDztPGQSwyBwOmOCMde9AFy4juoNNjga4XyTEFP7vZkc8oexzjrWHca2beFZpmEjx7lPmhV4AGCccYHNbs1u0+nPLdQM6Z4Ern5jgHAPpknivJvHutxiSaC1iGyNVRvLUsEJO3B+ucfWgDdv/ABZDDbqLpY1SbH73OMnH3iMdulZ0/im0UeZAVkAXcpaTAbnBIyOeh/Kud8O/D/X9eliub4Gzsh92FhtkKnqQewrXv/hfLp21VuWmTB2MWI289OeKAL7a9bOzbnBlI3EbuenOPfPFTaVq1un7yPMR6MWJZXz656c5NZulfDq41K6jAvmUqN/3cAjOCAf89a34fhjqMXnkalGXONm+M9fU4PNAE9vLbxIJJvMefcS67uQAB+Hep7KSSURPAiIqS5GDnGORg9+nNYGq+F/FOlnz4kt59uAZIyecf7J7/wCFZFr4kuLa6KXkD28XCsCvQYwxB9etAHeQbiJrZ3LzSFpAhGcoSQQfUD61J5cNupklgS5xklHz0U4yvYDisK31qDynmSIXSll3BieV9sc5wOtJJrqpdRxzqklvvDFc8hM9Ow3D1/OgCe/1e3FyG4jMkgVSx+VeARx3xmp57yCW1MguYo3JKsSNpDDuPxrLuIYNSdXgghUFmkiWU7XyMkKe3UDFY8ck9xJ5EMkUEkuFSaSPIbPYA9D0BoA6h9fudPhybtZWYgjBBYE+o9MVQvviI+nJLvnWYnawMSA5ByM5J5rldRSeG4ninK208a4WJuGDZAI+nXrWppXgu0a1S5vZFnLybdkZOFHv2P4UAQaj8ULu4jKpdW0W0uQIhkgdufXvXNPri3gZ7qZpJVw+XY8AkV6xoPgm3uXkjQW1pEiAqogDsASQOT9KS/8AhaftamezjntuD5qOVYH3HcUAebaZfzWOqw3USxSRBtxaGbdtDYHOOR16GvevC2oLJ5BSRNkpGShyBxkVxGmfDCKG6S4kbzCSwEa7xgdDk55Neh+G/Dy2axrFE0Kx4DDrv4oA7iHIXBORUhqODaFIAIPvUlACUUuKKACmTSCGJ5WVmCKSQvJP0Hc0+lHHI60AQeVHciCWeFTIgLIDzs3DB/Q4p6wRK4dYo1cDAYKAcemfSpT1ooAWimsSDxTdxoAkoIwpY9BQuCDnsPyqESJcq6qHXyZCrAgjcR6eo96ACUqGyeWA6VTuLnag6ZJwB607UZYY45S0uyVBkFwQrfSub1/xLomjWS3WoXUJA+aNEcOzHB+UY6Z9aANyIPeNtQupwGUgDBz/AAj/ABr52+KHxC1fVdb1PQLe4W0061uDC0ER2yTAYyZSecZBO0YBGM1duvijrkslpdWl1a2FvBuBhlTKzAnjc2OABgYHfmtPV7Dwp8WHF5E6aB4vQBZTJgrdYAGAT97jkd/rQB5pY6jMkIWYb0OSFPRR6DsM1v22ox3avGUmWBQyOv2goyEggbSR6jtior34feINHlZLWOHVoTgBrWQAkHrlOowcZNZU96bR5LS8SaKS3kLmC5GH+4w6Y+YAnPcHAoA6pDc2sJjMck7LH5nz3GHjOcjGOSBgn3BrpYdT3LEWuypCcB8lM+5HPXOPbFcLokhlggv7b97NGFhYicZkVvlAx1XHr+Fd89i4W3uDmVNoVY0YAE4z94c8fzoAtaxrs1vo5JiKPwVbOFMYGNwrM8A+Ejf3Ueu6pHIsTMTDZMMK+B8skg/ibkkHtVGaOfXns7CMTmKW5jibdzsiGC/v14/Cva7WIRhUGAgHyhegHSgCtFaqiAHdyevpxWdrir/ZpZomYoDtPfPI4960b2WQMVGVTuw7VyHjvW202xg2gOoYb8sAMZ/OgDn9P1lrXUoo5v3fmAEKc5XtgnOM8Z/GvQNPvo5ovNBBTnDA8cE5r56vdRMt/KYnLfOcgngN3at7QPGk+lNJHcbvKUkooOAQSSc/jn+VAHtd27YXYRgYJ/pXH+IrexuYJo7mKEDDFZFGCT37dqx7nx9CEiMKkzMAMMeAR04rh9Y8UT6rdB0lCKJHCoWwQD6np1oAsaRKLHUUuDKIo1icqdoclsEDj04GfY1qMqXlzbO0OZGG99xwqPyOAO3NcrbK81vCdjSzK5QRhumQSSMdT/hW9a6hFOnlGZrebYqEOAGJH9Tgc0AWNbspVuWjtn4jXETKdrLIcDv296uWNu9pc3CE3H2xIvNt0kjBJk/uODnGf7wpZr/YE86RLgIvziXg57Zx1Heqlzr8bag6XNxC54KbBlg2OufQelAFPU7Nry8lu7hTA8rNIrqzNs4+6+Dk85A7etXPCGsS+ZBptxEwkYM0ZXjLYyQ3t7064tppIJbrT51SKQ7DEz8oOjHd7mqL6MtzbDUNOvDLMMqknICFQPlPvzjj0oA9W8I3Qad1aBUYkv8AX3/KvQLN1eMBsHgHHWvCPCXjKB9RWC/8u2u4wVAL4jmIGMA++M+2a9T03XVnjiaJI8P90CUYz6Z9qAOsym3IxgjPHU0sbIuSMg1wmp+L7GwtY5L66jijXgsrZGQeQMU208SC48q4s7hpYJPmBxn5fT60AehcdqSs+xuxI6Z5Eq5HtWgOnPWgAooooAKhN5bLefY3uYVvDEZxCW+Yxg43Y64zxmphXJDyk+Jd/JdQFp57KGOzmIYgoN29QQNoAc5IJycigDrkO5QR3FYPinxhofhZoo9ZvfLuphuhtokaWaQZwSEUE49zge9YPj3xZc6Yn9kaS/m67LC8oKBT5PZBgnAJJJzzgKTg8V5/oWk21irxTb7y9csbl5yZZ7x9pIySSep4A4HagDvJ/irpkNutw+i62toW2mcwptUf3iAxIHbpmsiP426M+iPfT6ZexyM7LaoCrLPj0foCOMg/hXIxWsl3dxJIjKkkilogm0Iqg8sOnJPOfTmsW1kt5NUvNZtLW3XTkna1sQwGJGHEk47ZPO3HTGe9AHS3/wATPF/2iGd7dNLt51LRRNEsjMMdCBls47nFc3efEDxtcGWKLWG8qRmBKwBCF9d2OBUzW7CVTCJZnY/NLIRuUE9V7nGDx3q9qas62sMcqyRK2Gbou0nv6H2oA4+9v9V1gxxalffb7xGZdsjhnUEfMGJG0Cqk1mLcyMbYq8QA/dgKi+oDAYxnNbd3C9s11FDtS1yZJXx87h8qV6HAHHNReILxo4nhVYiowYo/M3CQdAAvU9Cce9AHOuLW7hYyvIyuSr4PHPYDocGnJObTGcLIrBoipBKc8Pn1GBjvVW6uGvNQnlvF/fckqqhFH0UDHGM1o21+PLiVIwkiIYgflAcnoSCD9T9aANabVL3S7xLW8uZUnjcXkN7byh3HmANnePvZzyPzrrbbV9C8Vzw6B4wt4TqEp2WN4FC+cSOCrA/I5/LJryy7ea3vLe0S1dJkUKFX5t+e4x/StXwdBa6h4ps9E1y0dY5pA6SufLkgeM7htJ7EjBHfigDtbfwLeaXfvFoXmXbQXCl/PiKOkbc8EjbLjnoc+1dDa3TS20ENvP8Au1faS68EDOR6cZ4zXZRw239qXmoRJH9ruY1RpFk4dVyF78dTyK57xfoT3U8F3ZY8xCDJGOFlUt37ZHr3oAzPDeYfEemFyDEWmXAbOHyOfyxgfWvVbdSVUYJHTIrwyw1BVuReL/rYJxN5ca7lkI6gH/dI6ele2aJeQ3NpFNbsHjf5wQwPX196AG3cEhkYFBu6DJ7+9cT4w8H22rsm9XOMbl8zbnnPFenhlY4eMAdj61Fd2QcoVG7/AGiM0AfPerfD+7Te1m0ko3EhWYAdBg/hiuWvrDUbG4khuI9yquxmiQhTkdM++Mk+1fTF1p3DDapPQfLWNfaTDcReW6IcHpsH4j3oA+Zne3zMJJ185cDlsk47H9Tn0qOzeJ/OfzABljtaRVHTPfg+w616hqfwthOsvfWOArgkxSAbFfruHf1GOnNYUfgC9uRNI89naywOUQGIEMMc7e2cHGcUAczpV6sTQMtwylZ8My/d2jIOPwJrUvJ2iS8FtMjQSqEmKxBmCqdy4Yj5Gz6U268KahpypLPH+7wFY7cgdt2B7Zrm7M3Ml2lpJDLFJJhdp4ycd1PWgDqfBnhvVPFWorM08tnYIdkkoAJOewGeTXoH/CptMiiJL3khGfnEoBP4Y711/gq2itdGtrVUiDqiltikDdj0rtYoonBUqAxbr7+lAHz/AK94P1fSbcppd00ltH8zW8pG9sDPXGDxziqGneIUujJN9l8qRlWAHyt2SMDbs6ZOa901/T0fKsi5JJyRntXkvjPwuXMV/psWLmI7jHGNofaO/wClAGLHpkNxHM4jWWOfcY1lC+ZGWGMHPAAwRmqen+GpIr6I6aknk7A8iz7WVe2VzxjnPrVi21v+zZbu3uwLjO6N08rG5+pz6YOefetyC5trUsm9Us0BYRF8ja+3CDPpzn60AYuvQSwaaFvZkmuEQwxIyjO3oNo6Dg10fgCzaw0aGK43b1G5VLHoeSMdj/OuY8QXIu9ethIy+XGAzMsgOAVGOOwHC59q7/QbUyCGDCMq/K0kX3ZC3VvYdvwoA9T0dibGBxgZAUjHbGa1Kq6dGsVukajhQFH5CrVABRRmigBRXF/ETx1D4Wg+zWgiuNXIWQWzkquwtjGR/G2CFXqeT2rs3YRxlyM4zxXgjXptvH1zLPamZ7m6WS8mnOArbiEGCcfKo4A9aAC/stZtHk13Xntv7UuWZ/KhQDyomHKjjllAUDjselMttTtBcbITJBcxMjRPFgMcdyeoIOPY1r+NL5NRW4t0ZRL87CRhwqqoJyOoGDXiNrr0lxdu1vHZIXbKhtxTngZ/w9RQB3fiHxEBcXWk6TK0lzMxW4uNuV8t8tIF/wBvrz7mqlriy/deTKttaKdkfYcA49M8j865O0NxG6BA6iQ7Zn64x3+hzXSz2qLN5W/70e4JHJtG4rjcAcj+tAFq21KWeWGKBUkaSZXYN/DwSF+gweKuyziK9FjqFqyw5WV1jPDJgkgZPA755rAnltvsDRJKqyeWiQRxnDSEHlvTuehFSfbzGiSANczpcFVeZQGjwo53c8cdOlAE11e3FxqDywiF7mNdzvPIsaJGM5IAwTkYxiuR1bVmm1SEiMMm0KH2gEk559jzxW9f6lbrpNwf9Gkub5xtCoJNnyn+LkjB7etcNdX8nmedLGgYLuygJ3N2JoAu3V0TM3lsACgAZgNuRzwPUHmoLqYmcqYQrhmVAwwcDjH6ZrLjd57to47Y3EtrbPcv5cLSFAASzEDoAOprptP0PUypuC0NzFPH5rmQ7JBEfmLDdkEjkjFAF7T/ABbPpmJLyxubqzule0HlFRLvYqCox0GMYxXpHgP4badaG+vNRWW+QMPsc1w5EkalRuD4OC6sWXI9O1Q/DjwT/ZuqWOs3ETvcli6W0qLvEQP3lyfvEYwSPWvTjq9gNQXT3nAu8HaRGQGI5cDsSBjOPUUAT6db21jaw21nCqQwxiKMKOFAHHPep7tJPIQqA2w5GRxmq1vbGF2UyEW44jUHv1Jz1P8A9an3XmDCxoGwVJ3HGQT2PqKAPPNf0RtG1WC4sLUfZpWaRIxwqygDCnjgfe/CpfD+rSeHHKnf/YlzKTtIDPBK2MgYx8tdZrtn9ttDFJ8zJl0YfwsAcZx1+nfNcZpa7oLi3e3C2cvzoWXJBGfmJ+oOR1HFAHqthqazlFyGGBtI44POa24ZcxqY249/rXg1leavpFxLDbQNNErNtUsQCh5J9ueP0rr9P8cRCTypkaIRkqTncoIODnvQB6MJMSSi4AbccpjtUf2ONxuRuM5A9CfSuej8QQysP3iFT/F0GPSr1nqavsK9ie9AEV5ZM8ifeQnKtjjIwaoyWIX90gYkcEY4P/1zgV1EFxHcyAOV3ewNTz28O0uCwySDx0NAHD3Gj78lkAbbjaeABWHYeDLWLUvtT2sbSuwYszk85/w/lXpcqwKVE8qox67uf5etRyWTh1GxDGxyCuQcUAYen25tJfLPA79zWopkC7kPPAPNOa2mUsI4gcdBTjGxYfIcAgHbx270ASzRfa4WH/LVOvzVyOs6a/llk+becFCcBR6iuvhOy4DY56fWotStFaJjg7e3FAHhmraCJ1eG2QSSSSHcz8sW6k59DWdZ+Bb14ZFuZM7lC4bPc/p0r18aesTEPGHBOdwj7Ht/9etOw0axeMnZklAuD0GM0AeT6V4Pls53urMGPymACN8xOMA8kd89OnFeo+HtCMcXmzxIk7sGl8tvl6ZwOBXSQ2NvEsQjiXaF7DgmrSIAMYwBQAsSbVyAAp6U80DhcdhSGgAooooASf7lecePPDxvDutY7Yjd50vmHAbHQk4zxXo833K4nxpq9nZ6ZO9w8CwyBoizc54PAHc+1AHzV4w1S7Cal+93XMiJbhmyWKu2G2kdVKj61zmjxfv5baJcowLEA5GRng5rQ8ST27alcTW7kW8R8uOBkKthcEux6c9MCofC14bnQ9USOGEWouoy8rMDMG5KjGchSM846rQB0OlXEdtb3AVMTPtBZcnJBzgg8Dt0qezjvtZ1WOzhiNxqFxI0cSkDkY3Bj2AAAJPQAGsaJrmXUYIULXc87/Zbe2hzv4GQoHc5I57Y5rc15ZPCOgNpMM0U2r6rEW1XULeYMIId5VbONx3JU72H0+gBDrkdhDrkltbzxXFtHEEE0Ue2F5QRvWI5yy5B5479qqlrl4YomjQQJ87qOh5zweoyKy7KACVXkcwxRkGGJSPl+XHyj6cDNReIdZMcr2axzSRiMb5QxDu+cD2B9fpQA/UryKZZxayfZ3LBkaJcbcHgenfFcbqXnGJYWndi0g3gHjA449M1W1K5kF5NAsuWO/hc8t1x7Y7V2/w++HOu+M5rS6voWh0SQgtPuCmQDrj17mgDp/g14ft76y1HVjMfNlsZbJIIp1MskT8OWB6DGR+dekXmlWlrYWEunoIbi2mWEzkcQogw2VPUBcjpjFU/+EQl0X4teEdfgkWLw9ptrJDOjkKIQEfAH97O4Ek+nWup8WzR6mY7zw5dQYuwZVMDLIjhwOSemTQBuW1okuqJfxySRpJCuYwgw2ed+euTgcelLeSymSzh3WkN+AA5PzEKSGcRcdwMH61n6BfCAW9l5+26tozNM5fdlOhGPxGK27u2iJhuGYGSNfkk2c4PufagBsjxO0Gw43OcZPJwDxUrYLFGGZCN21ugFV+bl4niRd68PI3ZfRMd/Wrc7Sj5IwJc/wAWBwPc/wBKAKUsUSK7KMDjO3iuEjuF/tbUbSG4trvZcMivDKpWFWXhSFzg5ByT3Ar0Xy/nAeM8+uDn1H0rhF8F6NpHi2W68MQnSbR4VZ7aIkozlgSeTwMKBjpzQBQ1m78tUguZHhmVSTIM/MDkdh278Yrlb/WbOfUy0yXMMJwjSJgu3HZSQCPf39a7LUFg1Xxda6dZrLLd2i5nCEqIw/I3HHPY49ua1LLwnAmr6rby6dm3jMaWl9I277SmxS5Kj7pEhcdu31oA8kS9vLh1htzLJDHJhVDnaTnjI/KvW/B8kstpAZxKGUY29lPfFX30C2heKOKJERMqCFwc5HPuferelWSxPtSRhIM5B7HNAHTafEUu4W5wefp6VrNZW0krSyRBpHQxkkn7pOSOuKoaVE32lW/hVMZ9atak0+IYrVhEZTh5NuSigHJHucfrQBJJFbRYbai89AoOBjGeffFRSM628O9iZF+ViSMn34qG8ngSAErgqmMnqR1yaxp9YtlkRPtCbmIGFbmgDaVxGzFXOWPOGxSTShmQb5FxhvlkHP19aw0mfzneNmIAy2/0/wAaq3upR2cTNIPNZRgKB909MfWgDqHbc26IKzddrj5j9DSTTu7oqoyrtBfcSMMei/WuOj17zZMAhZl2gJ3Peuw0+/S5iVmY+Yp5jb1oAle3jJ2qQvGMbtrH6etRW8JiUjH3upzVhYMTNI8o5QJH8uShySSD+PWrCp8+843HrQARjZGqg54p1NLkSKu0kEZ3dhTqAA0lFFABRRRQAMpZMdWrxr4uWywJb+YfMidWKqRj97n5TnPr0GK9oHUD1OBXnvxP0e31XRrqK5MpKKZUEWAeOfx57UAfNviPULVbWKw1GS2iW3V2cICXLFud+f8Aa6AVNDpEF5PCs/iXT4NU1BxHDZWNp9pldgPvyHKKgAAB696l8cafAbmzilUy37IzzuGWTei8gr3HHVT6VU8N6ff2F7NZWl3aaSsjRRSz3oCyJHhmDKBliOvTrmgC9pDHwvPdWFrcXUGtz5im1BWRdsZ/gjLZ2KxwWx8xwBkVQtLZZ51tbZha24ZuI48rGyr154GTz+NbFnpUWjy3t3Z3UN21yoiiuL+1yZFY4YqAfkY/3jnirfjLUksoA9vHFZl9nmxr8xVwpVR23cLnNAHParNHZ2rLZxuz7fNLgfdIwC2e9cCl+bp5TqM4jjkWS4VWLHdIB8iNjpnpnpzQt1PfayYNPmkMzgosmP8AWOQcZx9T7V7H4E+EcU8rX/idZkmlH/HuJAfMwPvN6D2oAk+Gvwx037Ba63r6LeXMyK3lSnb5OenAPzcV67ptwkUctta2j28dqfKSKMblPA4X2wfas+80W3OnOloV+0WoVYs9mAwowO3PNcnquo3emTt9ljWPYCzSRHaAy4ByD1HHFAHV+Mdfi0vw5cXsqlsLhY1cgBs4UEY9TzWX4O1mPVdMtbiGMRCSRlZSF4OTxjrx39BiqWoJLqvguSG9jSS7MHyQeYuNxbMZI+uOaTwfbalY6BHHrUMFpdngi3Vceh5HfJ60AdF+9tLr+0IU3XwAjcIM7ohkkHt7+tXW8W20zx262k94bossWzH70LkFs9AOMdqwLhFindoRICqZMmOnf8elO0CWZ4J7uLZNYtMW8wuIzES3zdf4VI5HU5oA6+FbkT25R47axAJaKNgSzemcc8e9WrkPc20kNhN5Tr8rSnHyEeg7mqMU0UmxnKCRXZSUiIOM8EL6H1qxYxvHZImHYKQAxYFXGMlueQee9AFuJvKzvcuSMZz97n07VjQmO91m6lODGNsCIeFIUEkfhir9/cCy067n5MUMTPxwOBwM/WsDRLL+zvDEf2x5DPI7O5+9tZz8uPfnFAHTaHbR4kv4jg3B3b8YyuTjn6Cqmu+MNG0fxBZaHqU89rd30Ya3ZomEc3zY2q+Mbs8Y9xW1YW5hto4lDNGBtB/DFWL+zjlW08+3ima1bzIWeMM0b9CRkcHHpQBi3R8y4Kt90Mfk3ZB/z/OtHTrIKqswGSScdcVK1vErgkEsOmav6cg8xvXGSKALdrD5C7R0pLt0jjLfebHBPap8jHNZt9ksQD1P6UAYOvXT2qPM+C4Pc8Enpz6+1ceBNcyhnBURsWYL03dyfUV2Gp+FV1qE3rvOlxEzm2iZv3Uh2/L5i9+QCCORXFw38N3qGqaeDJBqWmukV9Afuq7KD8h/iU54NAHXaJuaRPtCAxuMbS2T+NHiS1LCZ0Uq0RDqy9TjtWbptwySnzv9UQWz/ECD0+ldK0seoR8uMgZRhxvoA8u1cr5kV3E+wu7FByFDBQBn0PJP4V0HhjX1kRYppS10h2mQfKr8Z49cVL4l0URRuFThz8yHpkjHHv71gjTmDWpdhHLDKzJhMAbuoYe4xigD07T7/eI4wv7sgY/2j3zW3Hjy029McVy2ksVij3ALuXiuntgBbIPQACgCTtSGlpKACiiigAooooAcu4OG3HZjlOxPrWXq0Cybm25Owjk4Fagqlqibo8k4VgE/yaAPmbxvocOnarcXE12zIzbFh+YSD7rja45XkYyOME1iW0M08wuGleSSVjMbmfBYt6ZwMjtzWz8eDcx+MLdpyDAkIjH93cDnB/Os/R0DSxRRNK0GwCSHPAfPBUfTqaANtFs7WGB3kW4u5iF+eT5YcqT8vB/AeteXeKbiTULuWNHk1F4j5BTy2JlwPvkA9sk1t/EPUGtbeGxima3mMm52C4LY+7tPQY+bP0FHwstZV1qe/wDsyTSRoytKDn5XHJbsCRmgDe+GfhqVLldSmtI7SG3ZERXhAaQbcll/ujJHNeuT+IoUNwTCBDHwJiQTzweOuPeqFnO0Nm8qb2jccRkA/KcfLjp0FcrrWpQ28nkxoqeah+Yp8pQHIH0z2oA6u81NTvMDeSZGXIZQQ31HUVzfiJLO5snkjyChEhdm27Oc43HryBxXOx3tzffaDAoDAKC7cB26bvxo8WX6jw/KXeMbXEe1eSSwz079KANvwhqUl6IJru3KxxRGJzJnLKCcZHfnpVq71AJbTrDJ55gk2fvI9nklgpIz/EAc8+xrJ8KXkiaZJcXNwfIwD5flEuV7fMe+aoy6nHqEdw/2uMRyyuH3MFwQAOQfw/OgDSn10C2up5ZR56JseRCFL5BGEXp3Ndb8PpI9V8PxlWt5LBTuWBlLHOScuSAPTpxkHmvLJ2+1XKqIboQRHM32WMSP5acsw5xjaOteuaVqlxOt7aW2nxrZ28cYgWMbTgqCEGeDweTnANAHSm9tbJpLiYpboB+8lc7Q5bPy7j15IpIbtrm1ad3BdQMBUIjzzzz1+tZ2pacLqZXvY47m2ixJaxTRgBZCSd3vjt+NWnuUt7SeVmkYKqgMcBi3Zfr0oAz9fin1Oa005HHlPIJrtl4DRq2Av4k/pWnqMsUjm2I2r56LkdB8wPFUNLgazglubjDX12Q1wCMBQOij2HSrLFLm7SOIea8vzpvB4x0J/EYoA6uCXiIRttO3n39/1rRyHVd7AYXJNY8AOI26Agcd/wAatvKqvtZcj370AWxbs0hI2Mu3g+nvQ8Yd1gkHlqI/MEmcbm7D8P61FM072gmhdU8hSWXBJZcdPrUyoJY4rif94FXcmVAwT2xQBefhRnrVG8A271YdSCO9V5p1imEjEs/Tk5qxaXCSBPMAbggFuozQBxvjPVr6w8Pzy2GpS6fMjKyzR2ouhHg55jxyp6cHjNc+xRomvZ0gOp6jHEbm5hiEbTOEGCygnBHoeldvrFohaRnbYhBQyRnDL2wDnjO6uK1KEWNuDGAApdjg5YuWzkE9+aAIE1IW5YlTJI77fLz2A5Knv7/WtXRdXd7aJnJIyy7O5Ge3+e1eeanqElzcq8coCMx2GR9mAODj1Oad4a1hLS6khu2KRjlZGG3B3HgD05oA9paSK9hRZH+c5Kvtzt9jSC0DctGoYHnIrFsryOG2CIWYONwJGQR6/St3T79WTy5ERyRljQBf0+33uCgChOq4rWU5UHpkVVtXWUZhwhUYI9R6/SrWCVAJ5oAWkpzHJ/Cm0AFFFBoATNFGKKAHCklQSRmMgEN/nNLSjrmgD5k+PcsMpgmOfNs5Skx7ZzjB9TwK5jw6/wBp2t5/kMAzrtHtg5r0/wCNfgnW7vUbnUtIsxd6Yy/aJgsgMkUgyWYIeoORyM9DXinhDWoL+4YLsYqSSXBIc45OO/Bz+FAG7qnhePXRBOL2SZoRyoj4WQjHA6YNdR4Y0+78PWMiW1ssabyfKC/eOc9Ae/5YrHtNWSCeeK2u1tgzjJAJ3IcjBHfnH0zWzc6lZwTxy6nO/mqUAaFQduedvse30NAHQnWJMwxXMQhZj8zoc4OOhA/nXGeIrYFJTje+SiFBgAZzyPf0q5/b9mgvQ00EESoWzKxdn5yAMfWsy412/uruWbSLUDJB86UcIcdwOi+9AFSxuItD013ulYTs4KxEESYz1A7VkzRTavfQTyRxwWrSoohK7kIA5PqT/jW+0dvFqEF/cX11Jdo6mTgFycdh35rm7m6/0hmsmHnQ8huct6knt06UAdnciXTbcWxkEypBIJSmQqBsbSy44Iyf0riNAF7qRuNNunj0tFeW6e88klrhNgEcYGO5BPHrWS3xKezsrqwa1a73yYkSZtscgHZgPmOCOORVjQ/HX9vX1hpF3aQWEGcW0unQskttKckSAgkuAcZB4wKAPSvCehx2vg6XxG6Ty6sxiIFqzi3lMh2+SQcbsDlwRwa9Fk0qFLy0uZGla6tkWOKYksF3febPc4A7cUzQ2GmaRa6ZPcLc+VJJc3F8BGkdwxI2yHGBk4OVGTgZNC66k8t1ePa6lFBC4ijDIqpMOdzqQeckDGe1AGoT50eZXEahyyljygGTnJqjaXj6jIu5AsSt5kaycOwDYEhHbPYegridd8XyXgaO1t55nLZFrHGXROwaRgMtk9hx711Oj3McU1ymtA299HEtwqBucuuFVl7c+/cUAbtrd2V/Lf8AkSJNJawtNIsbA9AeDXHaL4hM7+fdXEaur4Bdwu3IGBUmkapF4e+0lAry30TnMuA0fynKn8xXnU11aJeNbqkX2dCpVXGQCOn680AfRdhcNJEvmEI20deatDcZ/mOQec561x3hC/jutPtpt7M5jG5uvzE88fhXYxkuPkH7zHCtQBo2EwSQxt1YY+tLqV4LdPLXHmHg57CookK3KKwGc5H+frUN24kmcuQcZAOO9AGVf3pjl8tguPmOSfQdKfaXjOU/hXADe49PY1heIb1reaOEIWDMPm25IJB/wqlb+I7KC3drqbyo0cAEj+LuB60AddqEpkuEO1Sfu/XNcf4jubeGyuZJm4t1MpUj73I4B9eRUepfEDw/ZgzfbTO5AAhRMnvXlfivxhJ4kuZhCEis1XCRtnMmCuC34Dt6UAVNTvrrUb5EsIvMlTDooX15JII4P0qjd2OuxzPNeWNy2RuwsfCDH+fzr0D4b2yXEcl1Ku6aYDJC5zg8fQV6LDYg2wMGUJ64GRx6igDwvTPGF7pksURVrm2VceXLlCrY5AzyAPyr1Hwrra3axtGwRm6sXyDXNfEjQLfVWNzGqpcqNkhA2swGSMn0yRxWh4Y0QaVZWADO0rk5GMqS3IHrwMUAer6Ncu5idCcueQPT0NdOST1GD6VzHh+A7YI9hWQYH1I6munznnpQAGkpTSUAFJ3paTvQAtFFFAC0opopaAGzyeVC8mx5NgLbUGWOB2Hc+1fK3x48E3GgeNn17RrSU6RqiCe5KIQttNuCnpwAwZSB9a+qnDGNwhCuRgE9jXBfG7QotX8BXkzgm6sStxCNxAY7gGXHfIzgHvQB8xWBmWaTZ5bqXDLvZVGwdwzcY+tbN1pSTwK88XkQHIWSZRy3++mRUdxY6fHY73tbmLUSTG0Hk/uiv1z19aghllWMsWWyMKhX8qbb7A7e3UdBQBdsrRZY7uwutZmcxgRwyW67gqAjPJGcdavw6Pcfa3k0zTL+9g+aPzJ/lyuPvHnGfaubTXZ0SJna4uZDlXdTtEnPBPsMZNa97401nbELW48mJU+Zh8xkPfPtQB18miSm0B1t9M0G1jCh1Q7pioBOcnOOKfcxaX4U8If21bh7mLUZxa2yzrtLwEZZx3wSOvpWL4SYaw5vdVhvtWs7fBNqImkM7gHCk9Avqep6Ctu+8E+NfHOoSXV5DHp1iOLVLkhEgi4wqoOR6knrQB51qV/DrN6uo6polpeOpwYCuFHOAARyfpXceFrLVrjf/ZPhLQ9GiABFw9uAR7jPzE/416v4L+Guj+H7aCG+ht7+9AaV7h4/vHPRc9hnitbUtGKadNcNJMiRKziNB1Cjpjr0FAHiF94Q1ua4eW613ETMfOAGxWIBJI9uPrW2PB9zdaeLaKeSLz9qqS5b5R3PpxmpLTWLTV7+KeNvOsj80QYkbRnBUr/CQAeDzXa2N2kc8O4Lhl+8vagBdK0tNGtIY7ONAyssYbbgsoxjP86828dyT6b4x1i4iR5JhFbSjK/eQydM/hXq1xcRW9qbiZv3YJfLOAAPXJrkvirpbXmn/b4QftHlrbtu4DKTleR1waAPG9T1IoZ1AjZZJSyhusecZx75FVGumnERJBAf7oHIB4/HpVU2rRfvpQZGGYxGxO4tkYb3GT09q6LwZpk2qa/a6eJIzGq+Y6lOmBwCfWgD1rwfbXlno1l9njMsj7FJYhUjiblpD6kYwF/2s9q9L0RRJIJZFHAP5k//AF65nSbaKBUjiABCjLbjgjoOD06V11hNHtEZHzBTyTx1oAk8oC68zDHbkDFZFzGxRtwPLHIFdBE28jC98Y9ayNRmjMkgAC7W529T/wDWoA898dR3UVhKbNS9wsbCGInHzFTyTXlPhu8uzBeWl3CFUxlsTjayOOW+Xv0r2DxvfpZadK+3MexsjIzkg45+uK831eO0EFuiJJmZDA8m7YAwI/P8eKAMDT/Dd3rt1PJCiG0xlZ40JDkA4UZx34z610ukeDJoLiyXyImYXclzdTSrud08seVGg6LhmOT7D6V6Pp0cFtCLe1RUiiXADIFHvwOKvLKiyQo++SMsPmAFAGPbWjCQokEgQ8KCoTcR6D0rUsvMR4gqFlfJLfWtezex83ZcmZl6kDjH4iryQWlxITDchcn5VcYzQBxuraO17NOciPC4Xjkcc1f0TRTDKhVfNmC/e9OMYPp0611J0lUkEjy+owB/jWpawW8MWIo1Xdy23uaAK+lWX2KJndg8rnJJ/h+lWzyaU0lACGiiigApO9LSUALRRRQAUopKKAFrC8VW2pXQsItPto7i3km2XO+Qr5aEH95jo4U4+XI6+1bcm/yz5QUv23dKd3OOmeKAPOvEHw4udUgTyNYjhnA5MlruGe+MNnHtXCX/AMCdYDiW11PTbqTOG/cNAcfXLV9A01A4J3PmgDxGx+E2qX0Ri1Wazso0j8oeSod1Ge2AAfqa7LSPhj4bsBHJ9mlldBzLMScn1wOPwPFd+COo/GoVMEs6qpDSp84AJBGcjP8AOgClYRR2Ti2tY0tIYzhY0UqrADqBip7iQ/aBDDNCJm+9GyknZ3wB0PpnirbIpOSoyOhxyKjgjER3rzLtwZCPmYehoAbLblxDtl2sMLvIzle/41HCVurd2liaIq7bUPHAYjP44z+NS2duYISksz3D95G4zz6Djvj8KldQw5GcdKAPNvFPha2u9Qi1LT4XMVwV81oPkA6gOV9fX1rOnga1KLNsaSLIMgP3RkjP/wCuvTUgW3vGuQQsbgJIgJ28dDz09PxrjPEGnQ2upyO8XEmdsi9FGc4zQBw2u62smlWrafqS262kwmBeLzVZVBDJKuDuQqSDge9VtS1HVbprLSLqWGSNrqO3k+fcY9+CjKw+8AGGCB2ra1XRLCW2KtOYzJlSwADDJPAx27Y9K4/S31W01TSbTVborqVnqEb2dwsaEvCrcRSt/dUAbf8AeoA53W9OuLTxld+GtQt5hqdiqH7RGCqSqefMUdSMnGa9L8AeGV0iyWXa32yUh5dyA4yPrWjd6cut+PJvEiQyQXy2Y058NuiZVk3Ejvn0J4rZsCYERWYgnc3y/Xv9aAL8MSrIjEYP3cew9qtpLJC7/wCrCdiRnjFZ0NwrTZQNgEH5uhB5qeQm5dUZgAQQQOh/+vQBu2t2sNvGXJz1LZz+lYqwKs8zxliZGLHcev09Kb5w3pGi9vvZ44pj3SRw7pDjDY3BeDQBxPxCtlnnt7eV5XjLIjxI21nzkjB6cYz+FYet20osItNLb4EfYp6tg5X8SMYz71F4r1SO+8SRxvKVhC4WTfgYxySPxzWDceK0sba5RLeS7vSREsvOEwfvD1wRQB1Fp4ug0/y7TW22tG5iW6QllIAxhselac/izTwySJeKwDcKBgYx1wa8ZfVr+4gbZYRrCoYsuwhWLHk/XJNc7da00QlYROsgYnHJGBzjHpQB7zZ+LIGnnQ3LAAAIpbljn1FdNpmuR3NwInlQMpBOwdR/jXz74X1JbmZp7wKsxIHb5Q2NrAdBxivT9MuFs7+WWaF3kwpMoPCE/wCTzQB7joV8bsG2uMeagypDZ3rjFbUahUAGffNeVW9+UkV9Pn2uDgbT0b0+nSvRfDupDVtNF0AFbeY3XOdrrwR9PSgDSNJQaDQAlFFFABSUGigBKKKKAHUUUUAFLSUfoKAFpQfes4ai0ly0NtaySqigyS7gqqxONue5/lTpVu5oHJmhskxlnHzMoHU5PGKAARrFqVy895MyTKnlwSY2R7QclMDPOcnOag1a7VhDHaOZLtnAVY8Yx3z6VjaZYy6tMt1Ld+ZpuA0c6jabgZyD/u+/cVV1rV777VJb6eqWNnA+1pEQGWYd9noo9etAHdDftXzQA+BkDtS5VVLPwo5rzDVJ7+RFkTVL+Ntq4K3DL07ketW9H13xFYwr9qeDVrZSMmQeTcAHvx8rfTAoA765uYreAzSsVj4AwMkknAGPqRVa5v3tUmubyJILCFGeSSSQBhj2qGaS28Q6HcxWF00Xno0QlCAvA+Ou0/xLx1rn9U0DWh4istXtNazFawrDdae4DRX6KGwSCP3cmWJyuc4FAHQWdy148ZhVjEYhK0hX5MkZxz1PSr81pFKAJFJAOcev1qjbXaXOnRX12gFxMoLRBj+7fH3AOu4Hj8Ktm7S2sUm1CVItiZlkdsKD35oA5fxhpFsvh7WZ9KKxX0MDsJQofDquQCCf85rzvw34aVrXTbzULJI7wqZmQyMxJcA5YdM+1enS6/pF7aXUMjNHbTqyPNNCVjdWGCd2ORg9TXPlJIRBFLJGskSBMBc+Zj7rDPYrigDK16S+jtYP7IhtZC0y/aEncriHPzbQOrDsDT59TtbOOMFtzE7U9R15/CqmrFlSaWPKMxPzAdCO+O9eW6/dSsJnuVRRgBZBlcnuMUAezadqMMltGBKJH4BIHWrnn74VK5DHI6e//wBavAbO9u9MuI54bmE7X2GMOd2B/ER+n413a+PfLkhia0d5wBlI2B3A9PfPWgD0eXIYcAEZwR16VyviXU4WiexNwsV3n944XhARwOO5rJHiyfVYpfs1r9nZl2BpicDIzx79s1hNp8sZllvGmFwSN0m442kHB3evr9RQBga4y6jewWiqQERY4ZSmSVOchj6nI59hXY6N4XhgijcBpCQGlJbILegHbGa5ezu0i1Kd44SsMke1kJ6kMOW9vlH6V3WhTiCZo5JY9zjeMepGPzoAkTQBIABEpXlfm6gE5/nXG+KvBOnSTGVle3uZUCtFuxls8Y7D1OK9i0WK0uwsc85ScHh+3TgVieJbIZkt5Zok8xT5MhyRg8bqAPlzXvDt3o+qutvIVXzOSvUAAkH3FbWl6pfSRJjLBipKlj29R+ddxr+jTXs77lKzcb88YPY/Q1X07QrlLl4xE5liYHBwQ5H+TQB1Xg68nla2/f7XZCCoHUZHH04r27wOd+iNNsCiSeTGP4tp27vxxXlPhfw5O2oJYRyMJZBmVtvCr3IPp2r26ztorO1jt4FCxRgKoA7UATUhpaSgAooooAQ0GjvRQAlFFFAC0tJRQAtNkQyRsgLAsCAVbB/A9qdRQBn2dvd2aG3i8lFTHG0gEnk//XNQ6lDe6uk1hIhs7J0Mc8q4ZpARyqHsPetYknqc96B+H4UANjjWCFIYFVY41CIuMAKOAPyrl9YsmtJpLjAZGOA+cFSex9q6umTRRzRlZkV0PBDDINAHn9xGjW7OEVpcbvnPQnqKiRnZEVjglgMgZye1bF34baASi3vAyEjbDc/LtXuBIOo9zzUWn6LdTiRL1rezto+WaOTecemTwPrQBb8HQsZ9TmViTNIkburDhlHJ9jjANdIJP9KONxLcKo6kD+tcddeIVt2h03wrHbLalSsl6FDIjAcBQf8AWN6kmudn08XU0cmo393dSxFsqZCqsG4zgHA/CgDuNY1Wx8PWk+pypK7SzfKqYYtI3G0AdDwK5iRZb25hudbdbi+UErAR+6gJOdir0yOPmPNZdvYafa6k0kMDySoRx5mUB9QDxnmtC8nj3RqjhnzkqxwV9mHc0AaTzC6juYZ0UxsCsitggg+x4P0qt5cNnZQqZAyQrsVyn3V+g7e1ZN/qcFsoLCSUTS/N5QyE46j0FaCygMVhInTK/vAfu98/0oAbexAS7GVQW+bPVWH94exrkfFPh+HVwyvEFn/1iMuQDnO4fyrrYiWgkjid5reQMyxyD/VcDlD29ari6SeBoB5iTFDtSRNvTjdnuOP1oA8UhsVS4OnASG7EhV3KYRecAn14zWvceFtd00PPbTWznAdV/iIByNo9Tnoa6GWxt7Lx9p9xcoqPdRyI6jGxnGMYB9Rmuw1J4VCg7tj7R8uQEAJxz+QoA43QvEcV1JNHPEkItUCvC4COcjrhfvY6Vbm1NG06SG6WSMvlTBtUDaw6HPfiue19Vt/GGmX8cdvOz28u59ylchyOQP4gQRg+lNM9q1kk1yI4JXlTI4YDAyxIPVvugZ6YNAGRrSXAvXuJkiRyMyOJd6HPI68da1dF17zmaASZueMEN8vPU8dK5S81p4LKayt4rcIZDcgyKTjgjZnPPHP1rnRdzq8NxbYjlYbsBuQcZwRQB7paa65i2yq8yRjfuUYYkdSQPauoi1S3v4II5yssA+WJi2Spxnafb2rwTRdbvVm2SP5fGD22n0/rXpPhuSddQR/LJjkTeVB745wD6+tAHUalo9tOElulJLkeXIMjcegGV/Dit7RvCxaBFt4BDAHw3mj5sdz6/hW54DDy6K73CAK8u5Iz82wAAY/OulKrx8o4OeBQBQ0rSLTSonW0VyznLs7ZLc/oPar1KaSgANJRRQAUUUlABRR2pKACiiigBaKSlFAC0UlLQAUUUUAL+PNKKYqKGLAfMetOoAhvFhePEqbyOVFeaa7qRk1C5gklIsbdvIjtQPkyoAYsf4jnPX0r1CVggWRiAqtk5FeIasTFqt+JcZluJHDEcNukf/CgDRvtUFtamTasaeWADgDA7YFUr7UE/wBHc4KMQV+bkHAzk1yN3fbLMLbnar5Zlbn5icYH0HNZialJDP5aAHYdqDbjfnjd7UAegjUi03miFzbu2AxIG7j061M9zLcIvyt5jDLKSOByMVxceoq8ax3ALrKyrGqkqXbgcNjjFb1vfaTNHKpvJrNfLLH5fMAI65OATg+9AFmaWzR7cFQ8KAqSRyrY4z61Vl1oOoEUjxNlQQBnK9+/Wuc8Q3kEFuTp+ow3yRuGTy8o5Y4zlGwT17Vxtzrc7pLjZuaTdKY+Mf5OBxQB7Vb6qGsrKFVZ1kZgZBw4HYHnpxVubUhLDLMLWR3iUmJIwNzfLnaCeASRXzy2u3kEOPtMixMN5IPY9MHP9Kgi8WaqQsEclwwO47gzAkjucfWgD2rX7y1m1rT54YRJ5SvIyO4WSOQgBM9RgfNuHemwa0bS3trq71W6F1ZKwlaMLGrl3ONyj7zKvyqenTjPNePaXb61K8dyltM+9STu53MR15NdIl2pvIZJJIkuYwgeOSD73ykEk8gHJ/rQBtagTqs0949u8dt80UAJXBHLMSPUsSc+prE0/RrnXI1kml8q0zjdtG58Dkt6ckc1u6pe3urzQWjNEFcqFggj2p5agDGOhJxnNdDpkMFxueRYzcQgqsRXacYHyr+tAHnWreEIIkcRCeXPy5LYYMOuR6e9Y62CWuWWHBzyXP3s9R7V67qWlJeoTCzJtUjAQBjx0wax08NzERRu5kaRf40+YMBnaMce1AHKaTpzS3AeZGUHb/yzHzAn9egGK9K8O29yl3aiOIPe3JEEUQ4AA7ew+8fwxVjTPCN2l6TZQ3NzLgeWHAQc9Tk8cV6f4U8L2ujrLcbY2v7hQJ5FQDOP4aANXQdOj0nTYLOKRpRGuS7HJYkkk/rWhRSUAFIaDRQAUUUUAFJRRQAGkoooAKKKKACiiigBaWkFFAC0UUUAFLSUtAEV2pe3kHbHSvMfHejC1vReLH/o11IcykkhCUOVPsDz+depuAYmBHXg/Ss/VrbzLKe2Sfyw8e6I4BIPYHPagD5l1m2mS2jV5A00a7kIBweecen61i3ByQjBgmM5z3yCM16XfaQojSPY9vMqtJ5TDq+MEc9h7VxOqWBSAZOQ7EFOhGDjb+lAHPS3dwJVtpJZRGpBTklQx/8A1VVub2aMHM/zEFSCM4/wrZFvGrp+74znlzj8aqNHHNOyCMxKF52jj6UAc28jsu1sMFzkoMA981Oto2owJLKvl7ZdqjGDwOtdDo2jwS6xBHcyHT7LgyzupZhjOcLkDHTGe5rrL3QvDMEZisNdvrueP54oZLVRnjIXcG/pQB5jbaNCsjLEHl2Ngbhnk9jXRaLYRwTfNEEmzjYo5Iwcmtu1013u7FIhFA0s3ymUthGP8Rx6A1saZFZi4cwOl3IsskfmoxwSjshxx04oAhsNNSOxjmF07uFBES9EPXnHWsXV5ba6VWkt4Ptbts8wErtxkD2xzXolvplo0auYpkZEDiQggN1BUeuAa5TxTpJtZRsglktsKQAOh5JOR14oA4O01G/g1GFyQDASULjPQ4z710Oma1PLOXimZGi65OWfsw+hGPyqk2mWzzIiHar53MOoPpWvoHhtjeB4j5AD78vu+ZO5AoA9F8P3kMsumtcQRyxvIFCMcLyOvH1xXqFpoun2kwkt7eNOSc4yTnqOe/vXn/gvSVfWUkMMgtLLDg4480jAAPfA5r1cKOpwW7mgBigLgAcVLSYHpRQAUhoNFABRRRQAlFFFABSUUUAFFFFABRRRQAUUUUAFLSUooAKWkFLQAUUUUALTVUAkn5iRjJ9KUUtAGLr3h201i3IuJGjnCFI7lR88QPpXnes/DrXbyPZBdWtwiFm+f5GcnoSSOtevUvXrQB88Xfw615F3TaXvgTLeVFKGYkAcjnNYLeEtRt7hgNJ1GOIgFVWB+vqPXjj8a+pcD0pGAbGQDjpmgD5tXwrfMP8AkH6koYbQJYmBHQjPsa6LQvh9rN55k8phsFUho/N+ZvxxXt+wD7oA+lLj5cUAeX6b8MZYHVm1WTyyQWHl45A7c9Of0rqdK8E6LaRIWgaeVSx3yN1LHLHA9TXTqMDnFOoAydX0eHUdL+xqfJ8tNsTLxtHTGPTHauH1rwXrDpFFaGFljHyOJOVwenPUEEivTaKAPG4PAOqzM4fT7ePJILGQLsAwRtP6V02i+A5YpBPrd39pQDiJGwoP1HPTtXfZpKAIra1t7a3SGCFI40GFVeAKlHAAoooAKQ0UUAFFFFABRRSUAFFFJQAUUUUAFFFFABRRRQB//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A coronal section of the left cerebral hemisphere shows the rarefaction of the white matter with microcystic changes in the periventricular area. The U-fibers, corpus callosum, and internal capsule are relatively spared (anti-MBP stain).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Van der Knaap MS, Kamphorst W, Barth PG. Phenotypic variation in leukoencephalopathy with vanishing white matter. Neurology 1998; 51:540. Copyright &copy; 1998 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_1_2067=[""].join("\n");
var outline_f2_1_2067=null;
var title_f2_1_2068="Acyclovir and hydrocortisone: Patient drug information";
var content_f2_1_2068=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Acyclovir and hydrocortisone: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/35/16947?source=see_link\">",
"     see \"Acyclovir and hydrocortisone: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?38/56/39811?source=see_link\">",
"     see \"Acyclovir and hydrocortisone: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F12586583\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Xerese&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F12593059\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691791",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat cold sores.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F12593058\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3367172",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to acyclovir, hydrocortisone, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F12593063\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696817",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use coverings (bandages, dressings, make-up) unless told to do so by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3367173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not bathe, shower, or swim until 30 minutes after using.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F12593064\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696431",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad taste in your mouth.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F12593066\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F12593061\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Clean affected part before use. Make sure to dry well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696163",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a rubber glove to put on the ointment. This stops the spread of infection.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694440",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put a thin layer on the affected skin and rub in gently.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696169",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use at the first sign of a cold sore.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F12593062\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F12593067\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699159",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not freeze.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F12593068\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16478 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-58.240.65.66-BC5B390E05-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_1_2068=[""].join("\n");
var outline_f2_1_2068=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12586583\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12593059\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12593058\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12593063\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12593064\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12593066\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12593061\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12593062\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12593067\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12593068\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?16/35/16947?source=related_link\">",
"      Acyclovir and hydrocortisone: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?38/56/39811?source=related_link\">",
"      Acyclovir and hydrocortisone: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_1_2069="Seldinger technique for cricothyroidotomy";
var content_f2_1_2069=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F52511&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F52511&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Seldinger technique for cricothyroidotomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 312px; height: 525px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Kit contents. B) Cuffed tube. C) Needle insertion. D) Wire placement through needle. E) Small incision. F) Airway with dilator inserted with wire guidance. G) Airway inserted to the hub using a gentle twisting motion. H) Wire and dilator removed as one.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Walls RM. Manual of Emergency Airway Management. Lippincott Williams &amp; Wilkins, 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_1_2069=[""].join("\n");
var outline_f2_1_2069=null;
var title_f2_1_2070="Changes in appendiceal position during pregnancy";
var content_f2_1_2070=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F51960&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F51960&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Changes in appendiceal position during pregnancy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 434px; height: 452px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Harwood-Nuss A, Wolfson AB, et al. The Clinical Practice of Emergency Medicine, 3rd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2001. Copyright &copy; 2001 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_1_2070=[""].join("\n");
var outline_f2_1_2070=null;
var title_f2_1_2071="Diagnosis and classification of low-grade gliomas";
var content_f2_1_2071=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnosis and classification of low-grade gliomas",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/1/2071/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/1/2071/contributors\">",
"     Lawrence D Recht, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/1/2071/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/1/2071/contributors\">",
"     Jay S Loeffler, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/1/2071/contributors\">",
"     Patrick Y Wen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/1/2071/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/1/2071/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/1/2071/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gliomas comprise a group of primary central nervous system (CNS) neoplasms with characteristics of neuroglial cells (eg, astrocytes, oligodendrocytes) that express varying degrees of aggressiveness. The slower growing lesions are commonly referred to as low-grade gliomas (LGGs), while the more rapidly progressive tumors are referred to as high-grade gliomas (HGGs). LGGs are less common, comprising approximately one-fifth of CNS glial tumors.",
"   </p>",
"   <p>",
"    LGGs can be divided into several distinct entities based upon their histopathologic appearance. These differences correlate with important differences in biologic behavior and thus have important implications for patient management. LGGs can develop anywhere in the CNS, although studies usually are directed to a particular location (eg, cerebral hemispheres, optic pathways, brainstem).",
"   </p>",
"   <p>",
"    The classification and diagnosis of supratentorial LGGs will be reviewed here, followed by specific discussions of the more common types of LGGs. Management of patients with LGGs, as well as oligodendroglial tumors and LGGs arising elsewhere in the CNS are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/33/44568?source=see_link\">",
"     \"Management of low-grade glioma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/24/11655?source=see_link\">",
"     \"Treatment of oligodendroglial tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/40/40585?source=see_link\">",
"     \"Focal brainstem glioma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/16/39176?source=see_link\">",
"     \"Optic pathway glioma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/50/1832?source=see_link\">",
"     \"Diffuse pontine glioma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/63/7161?source=see_link\">",
"     \"Spinal cord tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classification of gliomas is usually based upon the presumed cell of origin and the degree of malignancy. Two systems are used:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bailey and Cushing originally proposed that gliomas were derived from transformation of normal glial cells during their development [",
"      <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/1\">",
"       1",
"      </a>",
"      ]. Astrocytomas were tumors with the appearance of astrocytes, while oligodendrogliomas had the appearance of oligodendrocytes. Grading based upon histologic features was not incorporated into this system. This system forms the foundation for the WHO classification schema that remains in widespread use.",
"      <br/>",
"      <br/>",
"      Each revision of the WHO classification schema, most recently published in 2007 [",
"      <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/2\">",
"       2",
"      </a>",
"      ], alters the relative incidences of astrocytomas; with each version, new types are added and old ones modified. The WHO classification schema recommends that the term \"low grade glioma\" should be avoided since it lumps together almost two dozen WHO Grade I and Grade II glial neoplasms, many of which have significantly different biological properties, prognoses, and optimal therapies.",
"      <br/>",
"      <br/>",
"      Nevertheless, because the term has become common parlance among clinicians, we will continue to use it here. The most common entities are the WHO grade I pilocytic astrocytoma (PA) (which replaces the old term \"juvenile pilocytic astrocytoma\", because it can occur in adults as well), grade I gangliogliomas, grade II diffuse astrocytomas, and the favorable risk",
"      <span class=\"nowrap\">",
"       1p/19q",
"      </span>",
"      deleted oligodendrogliomas.",
"     </li>",
"     <li>",
"      Kernohan estimated the prognosis of glial tumors based upon the extent of observed anaplastic features (ie, mitoses, endothelial proliferation, cellular atypia, necrosis) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/3\">",
"       3",
"      </a>",
"      ]. Such a classification proved to be of prognostic value, especially for astrocytomas. The Kernohan system continues to be used in modified form [",
"      <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/4,5\">",
"       4,5",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Although the term LGG is widely used, it is not explicitly defined in either system. LGG describes a spectrum of primary brain tumors composed of cells that histologically resemble one or more differentiated types of macroglial cells (diffuse and fibrillary astrocytes, oligodendrocytes, ependymal cells) without evidence of anaplasia. In the Kernohan scheme, LGGs encompass grade I and II tumors (",
"      <a class=\"graphic graphic_table graphicRef55759 \" href=\"UTD.htm?16/42/17067\">",
"       table 1",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      LGGs have been referred to as \"benign\" gliomas, but this is a misnomer. Although these tumors have a more favorable natural history than HGGs, LGGs are only occasionally associated with prolonged (&gt;10 years) survival and frequently develop characteristics similar to more aggressive brain tumors.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27250679\">",
"    <span class=\"h1\">",
"     MOLECULAR PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;LGGs constitute a heterogeneous group of tumors and represent the most common brain tumors in children [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/6\">",
"     6",
"    </a>",
"    ]. Advances in understanding the molecular pathogenesis of these tumors may provide important information that facilitates accurate diagnosis and eventually leads to improved therapies.",
"   </p>",
"   <p>",
"    Recent results have implicated activation of the",
"    <span class=\"nowrap\">",
"     RAS/RAF/MEK/ERK",
"    </span>",
"    kinase pathway based upon alterations in BRAF in specific subsets of these patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A tandem duplication of chromosome 7q34 results in a fusion of the BRAF and KIAA1549 genes, which has been observed in 60 to 80 percent of sporadic pilocytic astrocytomas [",
"      <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/7\">",
"       7",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Pilocytic astrocytomas'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Alternatively, a characteristic V600E mutation in BRAF may provide an alternative mechanism for the activation of this pathway [",
"      <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/6,8\">",
"       6,8",
"      </a>",
"      ]. This was illustrated by an analysis of 1320 nervous system tumors, in which such mutations were identified in approximately two-thirds of the 87 cases of pleomorphic xanthoastrocytomas or anaplastic pleomorphic xanthoastrocytomas [",
"      <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/8\">",
"       8",
"      </a>",
"      ]. The V600E mutation was also present in approximately 20 percent of gangliogliomas and 10 percent of pilocytic astrocytomas.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A tentative diagnosis of LGG often can be made based upon the clinical presentation and imaging findings. An LGG is highly likely when a patient presents with a transient neurologic disturbance consistent with seizure and imaging studies (MRI",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    CT) reveal a nonenhancing hemispheric lesion that produces little mass effect [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/9\">",
"     9",
"    </a>",
"    ]. By MRI, these tumors are best seen on T2-weighted MRI sequences. They are frequently nonenhancing on T1-gadolinium sequences. Calcifications are sometimes present, most commonly in oligodendrogliomas.",
"   </p>",
"   <p>",
"    Persistent symptoms in this setting may reflect either the location of the tumor (eg, hemiparesis, ataxia) or are the result of increased intracranial pressure (eg, headache, change in mental status).",
"   </p>",
"   <p>",
"    The role of clinical and imaging findings in suggesting the diagnosis of an LGG is illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 1028 patients with brain tumor, the prevalence of seizures was higher in patients with LGGs (85 versus 69 and 49 percent, in patients with anaplastic glioma and glioblastoma, respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a series of 831 consecutive patients, tumor contrast enhancement was present on CT in 21 percent of cases with LGG, compared with 57 to 96 percent of those with HGGs [",
"      <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/11\">",
"       11",
"      </a>",
"      ]. However, pilocytic astrocytomas are different from other LGGs since they typically show contrast enhancement [",
"      <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/12,13\">",
"       12,13",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Pilocytic astrocytomas'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Positron-emission tomography (PET) can provide additional evidence to support a diagnosis of LGG. These tumors are characterized by glucose hypometabolism [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/14\">",
"     14",
"    </a>",
"    ]. The presence of hypermetabolic areas may indicate the presence of foci of high-grade tumors, and signal the need for biopsy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    active treatment.",
"   </p>",
"   <p>",
"    Since there may be a prolonged period of clinical stability in patients with an LGG, physicians may delay making a histologic diagnosis and initiating specific antitumor treatment until symptoms worsen or there is evidence of tumor progression by imaging. Whether such a delay in diagnosis and treatment significantly affects outcome is controversial and is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/33/44568?source=see_link\">",
"     \"Management of low-grade glioma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ASTROCYTIC AND OLIGODENDROGLIAL TUMORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diffuse astrocytomas, oligodendrogliomas, and mixed oligoastrocytomas constitute about 25 percent of supratentorial gliomas. Results from the Surveillance, Epidemiology and End Results (SEER) database have provided important epidemiologic and prognostic information about these tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/15\">",
"     15",
"    </a>",
"    ]. In the 1970s, diffuse astrocytomas were reported to constitute about 80 percent of these lesions. The percentage of oligodendrogliomas and mixed tumors has progressively risen since then, and these histologies comprised 65 percent of LGGs in the 1994 to 2001 period, based upon an increased awareness of the histologic criteria for oligodendroglial tumors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Diffuse astrocytomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diffuse astrocytomas generally occur in adults with a peak age incidence in their late 30s, approximately 20 years younger than in those with HGGs. Diffuse astrocytomas most commonly arise in the cerebral hemispheres.",
"   </p>",
"   <p>",
"    Diffuse astrocytomas widely infiltrate surrounding neural tissues. They can be subdivided based upon their histopathologic appearance into the following variants:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fibrillary &mdash; Fibrillary tumors typically arise from deeper white matter. They are firm and rubbery due to the neuroglial fibrils that they produce. Microscopically, fine and coarse neuroglial fibrils form a matrix between the cells (",
"      <a class=\"graphic graphic_picture graphicRef70133 \" href=\"UTD.htm?34/20/35144\">",
"       picture 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Gemistocytic &mdash; Gemistocytic astrocytomas are composed of gemistocytes, which are cells that appear exceptionally large and are densely packed. In many cases, distention of their cell bodies results in a globoid appearance (",
"      <a class=\"graphic graphic_picture graphicRef77661 \" href=\"UTD.htm?2/31/2550\">",
"       picture 2",
"      </a>",
"      ). Although it has been suggested that these tumors are better classified as anaplastic astrocytomas, the reported survival figures and prognostic determinants generally mirror those for diffuse fibrillary astrocytomas [",
"      <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Protoplasmic &mdash; Astrocytoma cells can resemble protoplasmic astrocytes. Protoplasmic tumors are the least common variant of diffuse astrocytomas and tend to arise in the cerebral cortex [",
"      <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/17\">",
"       17",
"      </a>",
"      ]. They may have a better prognosis than other diffuse astrocytomas.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These distinctions are not absolute. Among gemistocytic tumors, for example, both \"pure\" and \"mixed\" subtypes have been noted [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/16\">",
"     16",
"    </a>",
"    ]. The former has been defined as a glial tumor with more than 60 percent gemistocytes and a background of fibrillary astrocytes; the latter has been defined as containing 20 to 60 percent gemistocytes and a background of anaplastic astrocytes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Oligodendroglial tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Until approximately 15 years ago, oligodendrogliomas (ODs) and mixed oligoastrocytomas (OAs) were considered pathologic variants of glial tumors, whose only significance was the better prognosis compared to astrocytic tumors of similar grade.",
"   </p>",
"   <p>",
"    However, advances in our knowledge of oligodendroglial tumors have highlighted important differences with implications for patient management. These include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oligodendroglial tumors are markedly more sensitive to systemic chemotherapy than astrocytomas of a comparable grade. The responsiveness to treatment may contribute to a longer survival, which could also reflect a different natural history for these tumors.",
"     </li>",
"     <li>",
"      Subsequent observations showed that most ODs and some OAs contain a characteristic chromosomal abnormality, namely the codeletion of the short arm of chromosome 1 (1p) and the long arm of chromosome 19 (19q). The presence of this",
"      <span class=\"nowrap\">",
"       1p/19q",
"      </span>",
"      codeletion correlates with a more prolonged natural history and an increased responsiveness to therapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clinical manifestations, pathology, characteristic molecular abnormalities, and treatment of oligodendroglial tumors are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/4/44103?source=see_link\">",
"     \"Clinical features, pathology, and prognostic factors for oligodendroglial tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/24/11655?source=see_link\">",
"     \"Treatment of oligodendroglial tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PILOCYTIC ASTROCYTOMAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pilocytic astrocytomas are slow growing, generally well demarcated, tumors that are frequently cystic. Pilocytic astrocytomas occur predominantly in children and young adults although they are occasionally seen in older individuals as well. Pilocytic astrocytomas most frequently arise in the cerebellar hemispheres and around the third ventricle [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/18-20\">",
"     18-20",
"    </a>",
"    ], but also are encountered in the cerebral hemispheres [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/21-24\">",
"     21-24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pilocytic astrocytomas differ microscopically from fibrillary astrocytomas in that there is scant intercellular fibrillary matrix, even though glial fibrillary acidic protein (GFAP)-positive fibrils are demonstrable in the cell cytoplasm (",
"    <a class=\"graphic graphic_picture graphicRef73961 \" href=\"UTD.htm?36/63/37878\">",
"     picture 3",
"    </a>",
"    ). Tumor cells remote from blood vessels have a rarefied and sparsely cellular appearance and tend to undergo microcystic degeneration. Rosenthal fibers are frequently encountered and are a useful pathologic hallmark in differentiating these tumors from other LGGs.",
"   </p>",
"   <p>",
"    Pilocytic astrocytomas are associated with a molecular profile that may be helpful in distinguishing these tumors from other LGGs and which may eventually provide an opportunity for targeted therapy. Pilocytic astrocytomas often have a tandem duplication of chromosome 7q34, which is associated with a BRAF-KIAA fusion gene [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/7\">",
"     7",
"    </a>",
"    ]. In large series of patients with sporadic pilocytic astrocytomas, this fusion gene is present in 60 to 80 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/25-28\">",
"     25-28",
"    </a>",
"    ]. Pilocytic astrocytomas seen in conjunction with neurofibromatosis type 1 lack this fusion gene, and it is absent from other LGGs as well.",
"   </p>",
"   <p>",
"    Although almost always circumscribed on imaging studies, pilocytic astrocytomas enhance on CT and MRI scanning because their blood vessels undergo chronic glomeruloid degenerative hyalinization (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef78521 \" href=\"UTD.htm?30/20/31041\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/12,13,21\">",
"     12,13,21",
"    </a>",
"    ]. A different mechanism, endothelial proliferation, is responsible for enhancement in anaplastic astrocytomas and GBMs.",
"   </p>",
"   <p>",
"    The natural history of pilocytic astrocytomas is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/33/44568?source=see_link&amp;anchor=H19#H19\">",
"     \"Management of low-grade glioma\", section on 'Pilocytic astrocytomas'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     GANGLIOGLIOMAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gangliogliomas are composed of both neoplastic neurons and astrocytes (",
"    <a class=\"graphic graphic_picture graphicRef59644 \" href=\"UTD.htm?43/20/44355\">",
"     picture 4",
"    </a>",
"    ). They most commonly arise in the temporal lobe and frequently are a fortuitous finding when temporal lobectomies are performed to treat epilepsy. The course is generally benign with a natural history similar to that of PA. Transformation to a malignant glial tumor is rare, occurring in just 3 of 184 patients in one series [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     OTHER LGGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of other rare variants are also included with the LGGs, including pleomorphic xanthoastrocytomas [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/30\">",
"     30",
"    </a>",
"    ], subependymomas [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/31\">",
"     31",
"    </a>",
"    ], and desmoplastic gangliogliomas [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2071/abstract/32\">",
"     32",
"    </a>",
"    ]. These variants are important to recognize because of their generally long natural history. Even when surgical resection is incomplete, additional treatment is usually not necessary.",
"   </p>",
"   <p>",
"    Ependymomas tend to occur in young patients and arise in the area of the fourth ventricle. However, they are generally not grouped with other LGGs even though they are composed of cells that have the appearance of ependymal cells, which are glial cells that line the ventricular cavity. Ependymomas are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/51/15161?source=see_link\">",
"     \"Ependymoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Subependymal giant cell astrocytomas are slow-growing grade I tumors that occur in about 10 percent of individuals with tuberous sclerosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/38/34410?source=see_link&amp;anchor=H17#H17\">",
"     \"Tuberous sclerosis complex: Genetics, clinical features, and diagnosis\", section on 'Brain lesions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/34/6690?source=see_link\">",
"       \"Patient information: Astrocytoma (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?35/42/36515?source=see_link\">",
"       \"Patient information: Primary low-grade glioma in adults (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Low-grade glioma (LGG) describes a spectrum of primary brain tumors that are composed of cells which histologically resemble one or more differentiated types of macroglial cells and that have no evidence of anaplasia (ie, grade I or grade II). In general, patients with LGGs have a longer duration of survival than seen with HGGs, independent of the approach to treatment. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Classification'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A tentative diagnosis of LGG can often be made based upon a patient's clinical presentation with transient neurologic disturbance consistent with seizure and imaging findings of a nonenhancing hemispheric mass that produces little mass effect. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Specific features of the most common types of LGGs have important prognostic and therapeutic implications:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diffuse astrocytomas are the most common LGGs. For many patients there will a period of relative radiographic and clinical stability; however, tumor growth eventually accelerates and the clinical course is then indistinguishable from a high-grade glioma. The average survival is about seven years. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diffuse astrocytomas'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pilocytic astrocytomas (JPAs) occur predominantly before 25 years of age. They are associated with a substantially better prognosis than other LGGs and may be cured by surgery. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Pilocytic astrocytomas'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gangliogliomas are rare LGGs that are most frequently diagnosed as an incidental finding in the temporal lobe following epilepsy surgery. The prognosis following resection is similar to that for JPAs. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Gangliogliomas'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Bailey P, Cushing H. A Classification of Tumors of the Glioma Group, Lippincott, Philadelphia 1926.",
"    </li>",
"    <li>",
"     WHO Classification of Tumours of the Central Nervous System, Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (Eds), IARC Press, Lyon 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/3\">",
"      KERNOHAN JW, MABON RF. A simplified classification of the gliomas. Proc Staff Meet Mayo Clin 1949; 24:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/4\">",
"      Daumas-Duport C, Scheithauer BW, Kelly PJ. A histologic and cytologic method for the spatial definition of gliomas. Mayo Clin Proc 1987; 62:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/5\">",
"      Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas. A simple and reproducible method. Cancer 1988; 62:2152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/6\">",
"      Dougherty MJ, Santi M, Brose MS, et al. Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. Neuro Oncol 2010; 12:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/7\">",
"      Jones DT, Kocialkowski S, Liu L, et al. Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 2008; 68:8673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/8\">",
"      Schindler G, Capper D, Meyer J, et al. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 2011; 121:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/9\">",
"      Ricci PE, Dungan DH. Imaging of low- and intermediate-grade gliomas. Semin Radiat Oncol 2001; 11:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/10\">",
"      Lote K, Stenwig AE, Skullerud K, Hirschberg H. Prevalence and prognostic significance of epilepsy in patients with gliomas. Eur J Cancer 1998; 34:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/11\">",
"      Lote K, Egeland T, Hager B, et al. Prognostic significance of CT contrast enhancement within histological subgroups of intracranial glioma. J Neurooncol 1998; 40:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/12\">",
"      Lee YY, Van Tassel P, Bruner JM, et al. Juvenile pilocytic astrocytomas: CT and MR characteristics. AJR Am J Roentgenol 1989; 152:1263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/13\">",
"      Coakley KJ, Huston J 3rd, Scheithauer BW, et al. Pilocytic astrocytomas: well-demarcated magnetic resonance appearance despite frequent infiltration histologically. Mayo Clin Proc 1995; 70:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/14\">",
"      Sasaki M, Kuwabara Y, Yoshida T, et al. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours. Eur J Nucl Med 1998; 25:1261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/15\">",
"      Claus EB, Black PM. Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001. Cancer 2006; 106:1358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/16\">",
"      Krouwer HG, Davis RL, Silver P, Prados M. Gemistocytic astrocytomas: a reappraisal. J Neurosurg 1991; 74:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/17\">",
"      Prayson RA, Estes ML. Protoplasmic astrocytoma. A clinicopathologic study of 16 tumors. Am J Clin Pathol 1995; 103:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/18\">",
"      Schneider JH Jr, Raffel C, McComb JG. Benign cerebellar astrocytomas of childhood. Neurosurgery 1992; 30:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/19\">",
"      Morreale VM, Ebersold MJ, Quast LM, Parisi JE. Cerebellar astrocytoma: experience with 54 cases surgically treated at the Mayo Clinic, Rochester, Minnesota, from 1978 to 1990. J Neurosurg 1997; 87:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/20\">",
"      Casotto A, Buoncristiani P, Signorini E, Giordana MT. Third ventricle gliomas. Report of 7 cases with benign clinical behaviour. Acta Neurochir (Wien) 1985; 74:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/21\">",
"      Palma L, Guidetti B. Cystic pilocytic astrocytomas of the cerebral hemispheres. Surgical experience with 51 cases and long-term results. J Neurosurg 1985; 62:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/22\">",
"      Garcia DM, Fulling KH. Juvenile pilocytic astrocytoma of the cerebrum in adults. A distinctive neoplasm with favorable prognosis. J Neurosurg 1985; 63:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/23\">",
"      Forsyth PA, Shaw EG, Scheithauer BW, et al. Supratentorial pilocytic astrocytomas. A clinicopathologic, prognostic, and flow cytometric study of 51 patients. Cancer 1993; 72:1335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/24\">",
"      Burkhard C, Di Patre PL, Sch&uuml;ler D, et al. A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma. J Neurosurg 2003; 98:1170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/25\">",
"      Horbinski C, Hamilton RL, Nikiforov Y, Pollack IF. Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas. Acta Neuropathol 2010; 119:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/26\">",
"      Yu J, Deshmukh H, Gutmann RJ, et al. Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma. Neurology 2009; 73:1526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/27\">",
"      Jacob K, Albrecht S, Sollier C, et al. Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours. Br J Cancer 2009; 101:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/28\">",
"      Korshunov A, Meyer J, Capper D, et al. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma. Acta Neuropathol 2009; 118:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/29\">",
"      Luyken C, Bl&uuml;mcke I, Fimmers R, et al. Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer 2004; 101:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/30\">",
"      Tonn JC, Paulus W, Warmuth-Metz M, et al. Pleomorphic xanthoastrocytoma: report of six cases with special consideration of diagnostic and therapeutic pitfalls. Surg Neurol 1997; 47:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/31\">",
"      Lombardi D, Scheithauer BW, Meyer FB, et al. Symptomatic subependymoma: a clinicopathological and flow cytometric study. J Neurosurg 1991; 75:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2071/abstract/32\">",
"      Kuchelmeister K, Bergmann M, von Wild K, et al. Desmoplastic ganglioglioma: report of two non-infantile cases. Acta Neuropathol 1993; 85:199.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5211 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-201.211.0.116-250F3CF535-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_1_2071=[""].join("\n");
var outline_f2_1_2071=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27250679\">",
"      MOLECULAR PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ASTROCYTIC AND OLIGODENDROGLIAL TUMORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Diffuse astrocytomas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Oligodendroglial tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PILOCYTIC ASTROCYTOMAS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      GANGLIOGLIOMAS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      OTHER LGGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/5211\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/5211|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?30/20/31041\" title=\"diagnostic image 1\">",
"      Pilocytic astrocytoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/5211|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/20/35144\" title=\"picture 1\">",
"      Fibrillary astrocytoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/31/2550\" title=\"picture 2\">",
"      Gemistocytic astrocytoma Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/63/37878\" title=\"picture 3\">",
"      Pilocytic astrocytoma Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/20/44355\" title=\"picture 4\">",
"      Ganglioglioma Light",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/5211|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17067\" title=\"table 1\">",
"      Types of low grade glioma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/4/44103?source=related_link\">",
"      Clinical features, pathology, and prognostic factors for oligodendroglial tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/50/1832?source=related_link\">",
"      Diffuse pontine glioma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/51/15161?source=related_link\">",
"      Ependymoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/40/40585?source=related_link\">",
"      Focal brainstem glioma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/33/44568?source=related_link\">",
"      Management of low-grade glioma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/16/39176?source=related_link\">",
"      Optic pathway glioma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/34/6690?source=related_link\">",
"      Patient information: Astrocytoma (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/42/36515?source=related_link\">",
"      Patient information: Primary low-grade glioma in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/63/7161?source=related_link\">",
"      Spinal cord tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/24/11655?source=related_link\">",
"      Treatment of oligodendroglial tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/38/34410?source=related_link\">",
"      Tuberous sclerosis complex: Genetics, clinical features, and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_1_2072="Differential diagnosis of renal allograft dysfunction";
var content_f2_1_2072=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Differential diagnosis of renal allograft dysfunction",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/1/2072/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/1/2072/contributors\">",
"     Pradeep V Kadambi, MD, MBA",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/1/2072/contributors\">",
"     Daniel C Brennan, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/1/2072/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/1/2072/contributors\">",
"     Barbara Murphy, MB, BAO, BCh, FRCPI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/1/2072/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/1/2072/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/1/2072/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common complication of renal transplantation is allograft dysfunction, which in some cases leads to graft loss. Although there is a wide intercenter variability, data from the United States indicate that overall one-year unadjusted survival of a renal allograft is approximately 89 percent for a deceased donor kidney and approximately 95 percent for a living donor kidney [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of risk factors have been identified for lower one-year deceased donor renal allograft survival. These include prior sensitization with more than 50 percent panel reactivity, the presence of delayed graft function (defined as the requirement for dialysis during the first week after transplantation), the number and severity of rejection episodes, second or third transplant, donor age less than five or greater than 60 years, greater degrees of HLA mismatching, and allograft dysfunction at discharge (plasma creatinine concentration above 2",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [176",
"    <span class=\"nowrap\">",
"     &micro;mol/L]).",
"    </span>",
"   </p>",
"   <p>",
"    The causes of renal allograft dysfunction vary with the time (usually classified as immediate, early, and late period) after transplantation. The best approach is to consider prerenal, postrenal, and intrinsic renal causes of dysfunction during each time period. This topic review will serve as an overview in those areas; the major issues are discussed in detail elsewhere.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     IMMEDIATE POSTTRANSPLANTATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal failure persisting after transplantation necessitating dialysis within the first week is called delayed graft function (DGF). The incidence is markedly higher among extended criteria donor (ECD) kidneys and non-heart beating donor kidneys, compared with standard kidneys [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/2\">",
"     2",
"    </a>",
"    ]. This most likely reflects inherent donor disease with a predisposition to atherosclerosis and acute tubular necrosis.",
"   </p>",
"   <p>",
"    The definition of DGF varies in different studies but generally refers to oliguria or the requirement for dialysis in the first week posttransplantation. Less than 5 percent of kidneys with DGF never function (primary nonfunction).",
"   </p>",
"   <p>",
"    Immediately after transplant surgery, the principal underlying causes of kidney allograft dysfunction can be categorized as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Prerenal",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two major prerenal causes immediately after transplantation are hypotension and volume depletion. Vasodilatation from anesthesia with or without cytokine release from induction agents such as OKT3 or anti-lymphocyte agents such as Thymoglobulin or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/25/26008?source=see_link\">",
"     alemtuzumab",
"    </a>",
"    (Campath) predispose to fluid extravasation and intravascular volume depletion. These should be identified and corrected as soon as possible. It is not uncommon to require volume resuscitation with 5 to 10 percent of the total body weight to counteract these effects and prevent delayed DGF. A common mistake is to limit fluid resuscitation. Another cause of early graft dysfunction is thrombosis of the renal artery or vein, which may be technical or related to a hypercoagulable state or early acute rejection, which may be considered as a prerenal or intrinsic renal problem.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Postrenal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary bladder dysfunction (especially in diabetics), undiagnosed benign prostatic hyperplasia (BPH) in elderly males, or ureteral obstruction due to ureteral necrosis with a urinary leak or to a hematoma may all result in postrenal causes of kidney dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Intrinsic renal disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common cause of intrinsic renal disease in this time period is postischemic acute tubular necrosis (ATN) or reperfusion injury. Hyperacute and antibody mediated rejection (AMR) and thrombosis must also be considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Postischemic acute tubular necrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postischemic ATN or reperfusion injury is the most common cause of DGF (",
"    <a class=\"graphic graphic_picture graphicRef80709 \" href=\"UTD.htm?19/35/20020\">",
"     picture 1",
"    </a>",
"    ). The reason for the distinction between ATN and reperfusion injury is that classic signs of ATN, such as denuded tubules with mitotic figures, are often absent on early posttransplant biopsies. The incidence of this complication increases with:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cold ischemia time exceeding 24 hours, with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      induction therapy, especially at doses above 10",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day [",
"      <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/5\">",
"       5",
"      </a>",
"      ]&nbsp;(see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/53/14170?source=see_link\">",
"       \"Risk factors for graft failure in kidney transplantation\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Prior sensitization in retransplanted patients, indicating that, in some cases, DGF may be mediated by immunologic injury",
"     </li>",
"     <li>",
"      The type of dialysis performed immediately prior to transplantation (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11224?source=see_link\">",
"       \"Dialysis issues prior to and after renal transplantation\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      The quality of the donor (ie, whether the donor was older or had a history of hypertension suggesting that a higher perfusion pressure may be needed) may also contribute to early or late renal allograft dysfunction",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional factors that may enhance the risk of ATN include preservation of the allograft in Eurocollins solution, severe vascular disease in the donor and recipient, administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    , and possibly laparoscopic donor nephrectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/6-11\">",
"     6-11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/56/16262?source=see_link\">",
"     \"Benefits and complications of laparoscopic donor nephrectomy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/9/17562?source=see_link\">",
"     \"Mammalian target of rapamycin (mTOR) inhibitors in renal transplantation\"",
"    </a>",
"    .) Use of dopamine or pump perfusion in donor management may also reduce the incidence of early allograft dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Hyperacute and acute antibody mediated rejection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperacute antibody mediated reaction is caused by preformed donor-specific antibodies, such as ABO isoagglutinins, anti-endothelial antibodies, and anti-HLA antibodies, and frequently results in allograft loss within the first 24 hours. Acute antibody mediated reaction (AMR) is used to describe an antibody mediated rejection that occurs after the first 24 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of hyperacute rejection is usually made by the surgeon in the operating room, as the pink kidney becomes mottled and cyanotic. There is little or no urine output and no renal blood flow as detected by renal scan or duplex doppler studies. Renal biopsy shows intrarenal coagulopathy with thrombi occluding the small arteries and glomeruli and renal cortical necrosis (",
"    <a class=\"graphic graphic_picture graphicRef78954 graphicRef79378 graphicRef59928 graphicRef66537 \" href=\"UTD.htm?18/52/19274\">",
"     picture 2A-D",
"    </a>",
"    ). It can be largely prevented by testing recipients for the presence of preformed, cytotoxic antibodies that react with donor cells (crossmatch test) prior to transplantation.",
"   </p>",
"   <p>",
"    The diagnosis of AMR, which relies upon C4d staining in the allograft, characteristic histologic changes,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    presence of donor-specific antibodies (DSA) occurring in the proper clinical setting, is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12505?source=see_link\">",
"     \"Clinical manifestations and diagnosis of acute renal allograft rejection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/21/25946?source=see_link\">",
"     \"C4d staining in renal allografts and treatment of antibody mediated rejection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Atheroemboli",
"    </span>",
"    &nbsp;&mdash;&nbsp;The source of atheroemboli could be either the recipient's native vascular tree or donor's aorta [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. A donor source may result in a greater atheromatous load and little likelihood of recovering a significant degree of renal function [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thrombosis may arise with or without rejection (secondary and primary thrombosis, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/17-20\">",
"     17-20",
"    </a>",
"    ]. Primary thrombosis of the allograft is an uncommon event, occurring in 0.5 to 6 percent in most series, which usually leads to loss of the graft [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/21\">",
"     21",
"    </a>",
"    ]. One series of 558 consecutive deceased donor renal transplants found that primary thrombosis occurred in 34 patients and was responsible for nearly 45 percent of early graft loss (defined as less than 90 days posttransplant) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Causes of thrombosis may result from technical problems, including intimal dissection or kinking of the artery, or angulation or kinking of the vein [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/20\">",
"     20",
"    </a>",
"    ]. Additional risk factors or causes for thrombosis may vary with the vessel involved [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Arterial thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypotension, hyperacute or unresponsive acute rejection, a hypercoagulable state, multiple renal arteries, and unidentified intimal flaps.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Venous thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypercoagulable state, hematomas or lymphoceles causing compression, anastomotic stenosis, and extension of a deep venous thrombosis.",
"   </p>",
"   <p>",
"    As observed in children with congenital nephrotic syndrome, adults with massive proteinuria may also be at increased risk for thrombosis. In this setting, prophylactic nephrectomy reduces the risk of posttransplant vascular thrombosis.",
"   </p>",
"   <p>",
"    Another specific risk factor for thrombosis is the presence of antibodies directed against either phospholipids or plasma proteins bound to anionic phospholipids [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/17\">",
"     17",
"    </a>",
"    ]. Thus, patients with lupus nephritis, antiphospholipid antibodies, and a history of thromboembolic events, as well as those with the antiphospholipid syndrome, may benefit from continued anticoagulation after kidney transplantation. If untreated, these patients appear to be at risk for both intrarenal and systemic clotting events. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35287?source=see_link\">",
"     \"Antiphospholipid syndrome and the kidney\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Whether inherited thrombophilias predispose to renal allograft thrombosis has not been well studied [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/22\">",
"     22",
"    </a>",
"    ]. At least two inherited thrombophilias, a prothrombin gene mutation and heterozygosity for the factor V Leiden mutation, may increase the risk of this complication [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/17,23,24\">",
"     17,23,24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/16/20743?source=see_link\">",
"     \"Prothrombin gene mutation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Very limited evidence suggests that the prophylactic administration of low dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    (75",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    for one month posttransplant) may help prevent renal vein thrombosis. In a retrospective single-center study, the use of such a regimen decreased the incidence of renal thrombosis from 5.6 to 1.2 percent in all transplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/25\">",
"     25",
"    </a>",
"    ]. Whether such therapy has a role in this setting requires further study.",
"   </p>",
"   <p>",
"    Thrombosis of the renal artery and vein are both associated with a sudden decrease in urine output [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/20\">",
"     20",
"    </a>",
"    ]. Renal vein thrombosis, but not usually renal artery thrombosis, is associated with a tender, swollen allograft.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7820564\">",
"    <span class=\"h2\">",
"     Multiple renal arteries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sometimes, when the donor kidney has multiple renal arteries, reconstruction using conjoined anastomotic technique is performed on equal sized arteries and end-to-side anastomosis of smaller arteries to larger arteries. The small polar vessels are simply ligated [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/26\">",
"     26",
"    </a>",
"    ]. This may lead to infarction of the polar region of the kidney. In rare instances, ligation of the lower polar artery might cause necrosis of the transplanted ureter and resulting in obstruction or urine leak.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Calcium oxalate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Calcium oxalate deposits can occur with oxalosis and cause acute irreversible renal failure. Crystalline deposition and acute tubular necrosis may occur in patients with uncontrolled secondary hyperparathyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Evaluation and diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of hyperacute rejection is usually made by the surgeon in the operating room, as the pink kidney becomes mottled and cyanotic. There is little or no urine output, and no renal blood flow by renal scan or duplex Doppler. Renal biopsy shows intrarenal coagulopathy with thrombi occluding the small arteries and glomeruli and renal cortical necrosis.",
"   </p>",
"   <p>",
"    Postsurgery, we first perform a history and physical to assess fluid balance and whether there was intraoperative hypotension. It is customary that the patient receives 3 to 5 liters intraoperatively to maintain sufficient intravascular volume repletion given the obligate \"third-spacing\" associated with anesthesia. A common mistake is not to recognize this phenomenon and limit fluid resuscitation. The central venous pressure (if measured) should therefore be maintained at the higher levels of normal (7 to 11 mmHg) with adequate oxygenation-oxygen saturation above 90 percent. Transient (less than 10 minutes) hypotension with systolic blood pressures of 90 mmHg is common and should only contribute to ATN if the kidney is accustomed to seeing higher blood pressures or the patient has atherosclerosis requiring higher perfusion pressures.",
"   </p>",
"   <p>",
"    We next determine that the Foley catheter is not obstructed by visual inspection and irrigation or replacement. We obtain a bedside ultrasound with Dopplers to rule out obstruction and ensure adequate perfusion of the kidney. Lack of cortical flow on bedside evaluation requires a formal ultrasound to rule out arterial or venous thrombosis. A formal ultrasound is obtained if there is any question regarding the bedside findings. A reversal of flow with diastolic velocities higher than systolic velocities on Doppler examination suggests venous thrombosis or elevated iliac pressures from a thigh graft, pulmonary hypertension, or right-sided heart failure, which may cause venous congestion and prevent adequate arterial perfusion of the kidney. Evidence of arterial or venous thrombosis requires immediate surgical reexploration.",
"   </p>",
"   <p>",
"    In the absence of concerns for the above, a renal scan should be obtained to assess renal graft perfusion and rule out urine leak. Particular attention should be paid to this issue if the donor kidney had multiple renal arteries as mentioned above. (See",
"    <a class=\"local\" href=\"#H7820564\">",
"     'Multiple renal arteries'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     EARLY (1 TO 12 WEEKS) POSTTRANSPLANTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis is substantially different in patients with initial graft function who then develop renal insufficiency. The major causes in this setting are:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Prerenal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypotension and volume depletion can occur, especially if patients are unable to keep up with fluid intake.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Postrenal",
"    </span>",
"    &nbsp;&mdash;&nbsp;This could be a result of urinary bladder dysfunction or undiagnosed benign prostatic hyperplasia in elderly males. Sometimes lymphoceles (collections of lymph fluid leakage from severed lymphatics that overlie the iliac vessels) may compress the allograft and cause dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Intrinsic renal",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important intrinsic renal causes include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute rejection, which is most common (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12505?source=see_link\">",
"       \"Clinical manifestations and diagnosis of acute renal allograft rejection\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       Cyclosporine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      nephrotoxicity (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/61/41945?source=see_link\">",
"       \"Cyclosporine and tacrolimus nephrotoxicity\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Infection, possibly reflecting renal disease induced by cytomegalovirus or polyoma (BK) virus (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/7/6266?source=see_link\">",
"       \"Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/45/42712?source=see_link\">",
"       \"Management of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/2/29738?source=see_link\">",
"       \"Cytomegalovirus infection in renal transplant recipients\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Recurrence of the primary disease, such as focal segmental glomerulosclerosis, hemolytic-uremic syndrome or thrombotic thrombocytopenic purpura, and recurrent anti-GBM antibody disease, which may also be associated with prior allograft loss to anti-GBM antibodies in the setting of hereditary nephritis [",
"      <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/28\">",
"       28",
"      </a>",
"      ] (see appropriate topic reviews)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Limited data also suggest that drug-induced acute interstitial nephritis may be an infrequent cause of renal allograft dysfunction in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early allograft dysfunction is characterized by a plasma creatinine concentration that is stable at an elevated level above the previous baseline or is increasing. Unless there is suggestive evidence of infection, recurrent disease (such as heavy proteinuria or a nephritic urine sediment with red cells and red cell casts), or strong clinical concern for rejection, we begin the evaluation of such patients by measuring the plasma calcineurin inhibitor concentration. If the drug level is significantly elevated and the likely etiology of graft dysfunction, we reduce the dose. A renal biopsy is performed if no improvement is noted within one to two days after decreasing the dose.",
"   </p>",
"   <p>",
"    If the plasma calcineurin inhibitor concentration is normal or low, we immediately perform an ultrasound and, if unremarkable for obstruction or other causality, a biopsy is done. This is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/52/4938?source=see_link\">",
"     \"Acute renal allograft rejection: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Renal ultrasonography or other appropriate imaging studies should be performed prior to renal biopsy to exclude a urinary leak or obstruction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     LATE ACUTE DYSFUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following conditions should be considered when acute allograft dysfunction develops more than three months after transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/30\">",
"     30",
"    </a>",
"    ]:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Prerenal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Volume depletion remains an important cause in this time period. Also, renal artery stenosis should be considered, especially if it is associated with hypertension. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/23/16761?source=see_link\">",
"     \"Hypertension after renal transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Postrenal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary tract obstruction and lymphocele should be considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/38/25190?source=see_link\">",
"     \"Diagnosis of urinary tract obstruction and hydronephrosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Intrinsic renal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Causes of intrinsic renal disease that occur in the late acute period include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       Cyclosporine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      nephrotoxicity, which may result acutely at any time as a result of pharmacologic interaction with agents prescribed by other caregivers. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/61/41945?source=see_link\">",
"       \"Cyclosporine and tacrolimus nephrotoxicity\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acute rejection, possibly due to reduced dose of immunosuppressive medications or nonadherence. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12505?source=see_link\">",
"       \"Clinical manifestations and diagnosis of acute renal allograft rejection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Recurrence of the primary diseases noted above. (See appropriate topic reviews).",
"     </li>",
"     <li>",
"      De novo renal disease, such as acute tubular necrosis due to sepsis or nephrotoxins, or drug- or infection-induced interstitial nephritis. Human polyomavirus type BK-associated interstitial nephritis is an increasingly recognized cause of graft dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/31-33\">",
"       31-33",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/7/6266?source=see_link\">",
"       \"Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/45/42712?source=see_link\">",
"       \"Management of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/7/44151?source=see_link\">",
"       \"Clinical manifestations and diagnosis of JC, BK, and other polyomavirus infections\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depending upon the degree of worsening renal function and the clinical scenario, our initial approach in this setting is to repeat the plasma creatinine concentration after ensuring adequate hydration and measure the plasma calcineurin inhibitor level and adjust the dose, if indicated.",
"   </p>",
"   <p>",
"    Renal ultrasonography is obtained, with evaluation for renal artery stenosis, if indicated, and, if negative, a renal biopsy is performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     LATE CHRONIC ALLOGRAFT DYSFUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many patients have slowly progressive renal disease over a period of years after renal transplantation, often associated with persistent proteinuria [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/34\">",
"     34",
"    </a>",
"    ]. Most causes of late renal allograft dysfunction are disorders of the renal parenchyma, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chronic allograft nephropathy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/61/34778?source=see_link\">",
"       \"Chronic renal allograft nephropathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Calcineurin inhibitor nephrotoxicity. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/61/41945?source=see_link\">",
"       \"Cyclosporine and tacrolimus nephrotoxicity\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypertensive nephrosclerosis from poorly controlled hypertension or renal artery stenosis.",
"     </li>",
"     <li>",
"      Viral infections, particularly cytomegalovirus or polyomavirus (as above).",
"     </li>",
"     <li>",
"      Recurrent or de novo renal disease. Late recurrence may be seen in many diseases, including focal segmental glomerulosclerosis, membranoproliferative glomerulonephritis, IgA nephropathy, and diabetic nephropathy [",
"      <a class=\"abstract\" href=\"UTD.htm?2/1/2072/abstract/35,36\">",
"       35,36",
"      </a>",
"      ]. (See appropriate topic reviews).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most recurrent or new renal diseases in the allograft are diagnosed by renal biopsy. Even in this setting, it is often difficult to determine whether the allograft dysfunction is caused by these disorders or by concurrent chronic allograft nephropathy. Sometimes, it is essential to do a complete evaluation (especially for urinary tract obstruction).",
"   </p>",
"   <p>",
"    The evaluation, diagnosis, and therapy for chronic allograft nephropathy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/61/34778?source=see_link\">",
"     \"Chronic renal allograft nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The causes of renal allograft dysfunction vary with the time after transplantation. These periods are usually classified as immediate (zero to one week postsurgery), early (1 to 12 weeks postsurgery), late acute (after three months), and late chronic (years). The best approach is to consider prerenal, postrenal, and intrinsic renal causes of dysfunction during each time period. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Renal failure persisting after transplantation necessitating dialysis within the first week is called delayed graft function (DGF). The principal underlying causes of kidney allograft dysfunction immediately after transplantation include postischemic acute tubular necrosis (ATN), volume depletion, thrombosis of the renal artery or vein, and postrenal causes. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Immediate posttransplantation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Among patients with initial graft function who then develop renal insufficiency (1 to 12 weeks posttransplantation), the major causes in this setting are calcineurin inhibitor toxicity, acute allograft rejection, urinary obstruction, infection, hypovolemia, and recurrent disease. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Early (1 to 12 weeks) posttransplantation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute allograft dysfunction that develops more than three months after transplantation is most commonly due to calcineurin inhibitor toxicity, acute allograft rejection, urinary obstruction, volume depletion, recurrent disease, and de novo renal disease. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Late acute dysfunction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Slowly progressive renal disease that occurs over a period of years after renal transplantation (often associated with persistent proteinuria) most commonly results from chronic allograft nephropathy, calcineurin inhibitor nephrotoxicity, hypertensive nephrosclerosis, viral infections, and recurrent or de novo renal disease. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Late chronic allograft dysfunction'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     optn.transplant.hrsa.gov, accessed 6/10.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/2\">",
"      Saidi RF, Elias N, Kawai T, et al. Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: realities and costs. Am J Transplant 2007; 7:2769.",
"     </a>",
"    </li>",
"    <li>",
"     Lim, EC, Terasaki, PI. Early graft function. In: Clinical Transplants, Terasaki, PI (Ed), UCLA Tissue Typing Laboratory, Los Angeles, 1991, p. 401.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/4\">",
"      Irish WD, McCollum DA, Tesi RJ, et al. Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol 2003; 14:2967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/5\">",
"      Cravedi P, Codreanu I, Satta A, et al. Cyclosporine prolongs delayed graft function in kidney transplantation: are rabbit anti-human thymocyte globulins the answer? Nephron Clin Pract 2005; 101:c65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/6\">",
"      Lechevallier E, Dussol B, Luccioni A, et al. Posttransplantation acute tubular necrosis: risk factors and implications for graft survival. Am J Kidney Dis 1998; 32:984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/7\">",
"      Bleyer AJ, Burkart JM, Russell GB, Adams PL. Dialysis modality and delayed graft function after cadaveric renal transplantation. J Am Soc Nephrol 1999; 10:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/8\">",
"      Nogueira JM, Cangro CB, Fink JC, et al. A comparison of recipient renal outcomes with laparoscopic versus open live donor nephrectomy. Transplantation 1999; 67:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/9\">",
"      Van Biesen W, Vanholder R, Van Loo A, et al. Peritoneal dialysis favorably influences early graft function after renal transplantation compared to hemodialysis. Transplantation 2000; 69:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/10\">",
"      Torregrosa JV, Campistol JM, Fenollosa B, et al. Role of secondary hyperparathyroidism in the development of post-transplant acute tubular necrosis. Nephron 1996; 73:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/11\">",
"      Lind MY, Zur Borg IM, Hazebroek EJ, et al. The effect of laparoscopic and open donor nephrectomy on the long-term renal function in donor and recipient: a retrospective study. Transplantation 2005; 80:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/12\">",
"      Moers C, Smits JM, Maathuis MH, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009; 360:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/13\">",
"      Schnuelle P, Gottmann U, Hoeger S, et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA 2009; 302:1067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/14\">",
"      Montgomery RA, Hardy MA, Jordan SC, et al. Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols. Transplantation 2004; 78:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/15\">",
"      Bolander, JE II, Carter, CB. Cholesterol embolization in renal allografts. J Am Soc Nephrol 1996; 7:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/16\">",
"      Ripple MG, Charney D, Nadasdy T. Cholesterol embolization in renal allografts. Transplantation 2000; 69:2221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/17\">",
"      Kujovich JL. Thrombophilia and thrombotic problems in renal transplant patients. Transplantation 2004; 77:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/18\">",
"      P&eacute;rez Font&aacute;n M, Rodr&iacute;guez-Carmona A, Garc&iacute;a Falc&oacute;n T, et al. Peritoneal dialysis is not a risk factor for primary vascular graft thrombosis after renal transplantation. Perit Dial Int 1998; 18:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/19\">",
"      Ojo AO, Hanson JA, Wolfe RA, et al. Dialysis modality and the risk of allograft thrombosis in adult renal transplant recipients. Kidney Int 1999; 55:1952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/20\">",
"      Humar A, Matas AJ. Surgical complications after kidney transplantation. Semin Dial 2005; 18:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/21\">",
"      Bakir N, Sluiter WJ, Ploeg RJ, et al. Primary renal graft thrombosis. Nephrol Dial Transplant 1996; 11:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/22\">",
"      Irish A. Renal allograft thrombosis: can thrombophilia explain the inexplicable? Nephrol Dial Transplant 1999; 14:2297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/23\">",
"      Oh J, Schaefer F, Veldmann A, et al. Heterozygous prothrombin gene mutation: a new risk factor for early renal allograft thrombosis. Transplantation 1999; 68:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/24\">",
"      W&uuml;thrich RP, Cicvara-Muzar S, Booy C, Maly FE. Heterozygosity for the factor V Leiden (G1691A) mutation predisposes renal transplant recipients to thrombotic complications and graft loss. Transplantation 2001; 72:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/25\">",
"      Robertson AJ, Nargund V, Gray DW, Morris PJ. Low dose aspirin as prophylaxis against renal-vein thrombosis in renal-transplant recipients. Nephrol Dial Transplant 2000; 15:1865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/26\">",
"      Makiyama K, Tanabe K, Ishida H, et al. Successful renovascular reconstruction for renal allografts with multiple renal arteries. Transplantation 2003; 75:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/27\">",
"      Sewpaul A, Sayer JA, Mohamed MA, et al. Rapid onset intratubular calcification following renal transplantation requiring urgent parathyroidectomy. Clin Nephrol 2007; 68:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/28\">",
"      Braun, WE. The immunobiology of different types of renal allograft rejection. In: Renal Transplantation: Contemporary Issues in Nephrology, Milford, EL (Ed), Churchill Livingstone, New York, 1989; 19:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/29\">",
"      Josephson MA, Chiu MY, Woodle ES, et al. Drug-induced acute interstitial nephritis in renal allografts: histopathologic features and clinical course in six patients. Am J Kidney Dis 1999; 34:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/30\">",
"      Frem GJ, Rennke HG, Sayegh MH. Late renal allograft failure secondary to thrombotic microangiopathy-human immunodeficiency virus nephropathy. J Am Soc Nephrol 1994; 4:1643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/31\">",
"      Randhawa PS, Finkelstein S, Scantlebury V, et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/32\">",
"      Nickeleit V, Hirsch HH, Binet IF, et al. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol 1999; 10:1080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/33\">",
"      Nickeleit V, Hirsch HH, Zeiler M, et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 2000; 15:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/34\">",
"      EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.1 Differential diagnosis of chronic graft dysfunction. Nephrol Dial Transplant 2002; 17 Suppl 4:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/35\">",
"      Ramos EL. Recurrent diseases in the renal allograft. J Am Soc Nephrol 1991; 2:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2072/abstract/36\">",
"      Chadban S. Glomerulonephritis recurrence in the renal graft. J Am Soc Nephrol 2001; 12:394.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7301 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-6F4C19BDB0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_1_2072=[""].join("\n");
var outline_f2_1_2072=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      IMMEDIATE POSTTRANSPLANTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Prerenal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Postrenal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Intrinsic renal disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Postischemic acute tubular necrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Hyperacute and acute antibody mediated rejection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Atheroemboli",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Thrombosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Arterial thrombosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7820564\">",
"      Multiple renal arteries",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Calcium oxalate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Evaluation and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      EARLY (1 TO 12 WEEKS) POSTTRANSPLANTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Prerenal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Postrenal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Intrinsic renal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      LATE ACUTE DYSFUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Prerenal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Postrenal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Intrinsic renal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      LATE CHRONIC ALLOGRAFT DYSFUNCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7301\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7301|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/35/20020\" title=\"picture 1\">",
"      Renal allograft biopsy showing ATN light microscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/54/43874\" title=\"picture 2A\">",
"      Hyperacute rejection Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/5/29778\" title=\"picture 2B\">",
"      Hyperacute rejection Fibrin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/63/24561\" title=\"picture 2C\">",
"      Hyperacute rejection IF Fibrin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/2/18479\" title=\"picture 2D\">",
"      Hyperacute rejection IF IgM",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/52/4938?source=related_link\">",
"      Acute renal allograft rejection: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35287?source=related_link\">",
"      Antiphospholipid syndrome and the kidney",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/56/16262?source=related_link\">",
"      Benefits and complications of laparoscopic donor nephrectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/21/25946?source=related_link\">",
"      C4d staining in renal allografts and treatment of antibody mediated rejection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/61/34778?source=related_link\">",
"      Chronic renal allograft nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/7/6266?source=related_link\">",
"      Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/7/44151?source=related_link\">",
"      Clinical manifestations and diagnosis of JC, BK, and other polyomavirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12505?source=related_link\">",
"      Clinical manifestations and diagnosis of acute renal allograft rejection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/61/41945?source=related_link\">",
"      Cyclosporine and tacrolimus nephrotoxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/2/29738?source=related_link\">",
"      Cytomegalovirus infection in renal transplant recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/38/25190?source=related_link\">",
"      Diagnosis of urinary tract obstruction and hydronephrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11224?source=related_link\">",
"      Dialysis issues prior to and after renal transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/23/16761?source=related_link\">",
"      Hypertension after renal transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/9/17562?source=related_link\">",
"      Mammalian target of rapamycin (mTOR) inhibitors in renal transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/45/42712?source=related_link\">",
"      Management of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/16/20743?source=related_link\">",
"      Prothrombin gene mutation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/53/14170?source=related_link\">",
"      Risk factors for graft failure in kidney transplantation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_1_2073="Chromosomal abnormalities AML";
var content_f2_1_2073=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F53821&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F53821&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Chromosomal abnormalities in acute myeloid leukemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 728px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_1_2073=[""].join("\n");
var outline_f2_1_2073=null;
var title_f2_1_2074="Musculoskeletal changes and pain during pregnancy and postpartum";
var content_f2_1_2074=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Musculoskeletal changes and pain during pregnancy and postpartum",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/1/2074/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/1/2074/contributors\">",
"     Bonnie L Bermas, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/1/2074/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/1/2074/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/1/2074/contributors\">",
"     Peter H Schur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/1/2074/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/1/2074/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/1/2074/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 28, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy is a time of many physical and physiological changes. The gravida must nurture and host the fetus, but also adapt to a new body habitus and alterations in the hormonal milieu. Not surprisingly, these changes impact the musculoskeletal system, which can develop a variety of problems, such as back pain, separation of the pelvic bones, transient osteoporosis, and tendonitis.",
"   </p>",
"   <p>",
"    Pain related to the musculoskeletal system in pregnant women will be reviewed here. Neurological disorders, myopathies, and inflammatory muscle diseases are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/9/20634?source=see_link\">",
"     \"Neurologic disorders complicating pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NORMAL PREGNANCY CHANGES",
"    </span>",
"    &nbsp;&mdash;&nbsp;During pregnancy, women gain 25 to 35 pounds, on average, and undergo multiple hormonal changes and biomechanical alterations that strain the axial skeleton and pelvis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/61/13274?source=see_link\">",
"     \"Maternal endocrine and metabolic adaptation to pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Musculoskeletal consequences that ensue as a result of weight gain and hormonal changes include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Force across some joints is increased up to two-fold [",
"      <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Exaggerated lordosis of the lower back, forward flexion of the neck, and downward movement of the shoulders typically occur to compensate for the enlarged uterus and change in center of gravity. Stretching, weakness, and separation of abdominal muscles further impede neutral posture and place even more strain on paraspinal muscles.",
"     </li>",
"     <li>",
"      Joint laxity in the anterior and posterior longitudinal ligaments of the lumbar spine creates more instability in the lumbar spine and can predispose to muscle strain.",
"     </li>",
"     <li>",
"      There is widening and increased mobility of the sacroiliac joints and pubic symphysis in preparation for the fetus' passage through the birth canal.",
"     </li>",
"     <li>",
"      A significant increase in the anterior tilt of the pelvis occurs, with increased use of hip extensor, abductor, and ankle plantar flexor muscles [",
"      <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/2\">",
"       2",
"      </a>",
"      ]. Stance is widened to maintain trunk movement [",
"      <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Fluid retention can cause compression of certain vulnerable structures such as the median nerve.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Relaxin is a hormone produced by the corpus luteum, decidua, and placenta. The concentration peaks during the first trimester, when relaxin is thought to be involved with placental implantation and growth. Later in pregnancy, relaxin contributes to relaxation of the myometrium, separation of the symphysis pubis and softening of the cervix [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/4\">",
"     4",
"    </a>",
"    ]. Laxity in the joints of the extremities, however, appears to be due to other factors. This was illustrated in a study of joint laxity during pregnancy in which 19 of 35 women (54 percent) demonstrated a &ge;10 percent increase in wrist laxity from the first to the third trimester, but the increase did not correlate with relaxin levels [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/5\">",
"     5",
"    </a>",
"    ]. Subjective joint pain was associated with increased estradiol and progesterone levels, but not with elevated relaxin concentrations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     LOW BACK PAIN AND DISC DISEASE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Incidence and epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;One to two thirds of all pregnant women will experience back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/6-9\">",
"     6-9",
"    </a>",
"    ]. In one survey of almost 1000 pregnant women, 41 percent reported first occurrence of back pain during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/9\">",
"     9",
"    </a>",
"    ]. It is more common in women with preexisting back pain, back pain in a previous pregnancy, advanced maternal age, and multiparity [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/6-10\">",
"     6-10",
"    </a>",
"    ]. Height, weight, race, fetal weight, and socioeconomic status do not appear to be risk factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most cases, back pain is due to mechanical factors resulting from altered posture, muscle weakness, joint laxity,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    vertebral facet joint irritation. Fluid retention within connective tissue can also contribute [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/6\">",
"     6",
"    </a>",
"    ]. Degenerative spondylolisthesis (ie, the slipping forward of the body of one lumbar vertebrae on the vertebrae below) is aggravated by pregnancy. The L4 to L5 level is particularly vulnerable in women who have been pregnant [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Disc herniation is rarely the cause of back pain during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/12\">",
"     12",
"    </a>",
"    ]. About 10 percent of nonpregnant women of childbearing age without back pain have asymptomatic lumbar disc herniation visible on magnetic resonance (MR) imaging of the lumbosacral spine, and 40 percent have disc bulges [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/13\">",
"     13",
"    </a>",
"    ]. The incidence of these abnormalities appears to be the same in nulliparous nonpregnant, multiparous nonpregnant, and pregnant women [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neuraxial anesthesia for labor",
"    <span class=\"nowrap\">",
"     nad/or",
"    </span>",
"    delivery does not cause long-term back pain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/40/39562?source=see_link&amp;anchor=H16#H16\">",
"     \"Adverse effects of neuraxial analgesia and anesthesia for obstetrics\", section on 'Backache'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     History and physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Back pain may occur at any time during the gestation, but is most prevalent in the second half of pregnancy. The woman usually describes pain that is aggravated by activity and relieved by rest. It occurs in the lower back, but may radiate down the back of the thighs, or, less often, over the lower part of the abdomen and anterior thighs [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/15\">",
"     15",
"    </a>",
"    ]. The pain is often worse at night, especially with turning, and may interfere with sleep.",
"   </p>",
"   <p>",
"    On physical examination, palpation of the lower spine, paraspinal muscles, sciatic notches, and sciatic nerve may reveal tenderness, muscle spasms, or radiating pain. Nerve root irritation may be associated with muscle tenderness: S1 irritation affects calf muscles, L5 irritation affects the extensor hallucis muscle (which affects the toe walking test) and the anterior tibial muscles, and L4 irritation affects the quadriceps and the anterior tibialis (which affects heel walking with foot dorsiflexion) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/16\">",
"     16",
"    </a>",
"    ]. Physical examination should also evaluate for the presence of significant muscle weakness, sensory impairment, or deep tendon reflex changes suggesting radiculopathy.",
"   </p>",
"   <p>",
"    Low back pain is characterized by lumbar pain above the sacrum, which is made worse by pregnancy-associated forward flexion of the waist, and decreased range of motion of the lumbar spine. In contrast, sacroiliac pain is made worse by extension and hip rotation to the affected side. With the patient supine, manual separation of the sacroiliac joint or compression of the iliac crests also may reproduce pain related to sacroiliac joint dysfunction (see",
"    <a class=\"local\" href=\"#H12\">",
"     'Pregnancy related pelvic joint pain'",
"    </a>",
"    below). By comparison, discogenic pain is worse on flexion of the back, such as when touching the toes from a standing position. Chronic discogenic pain worsens with flexion, but with an acute herniation, the individual can rarely even stand up straight, as the herniation protrudes posteriorly and is compressed by extension. In facet pain, the pain is worse when the spine is extended and is localized to the level of the irritated facet.",
"   </p>",
"   <p>",
"    A detailed description of the physical examination in patients with back pain can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=see_link&amp;anchor=H12#H12\">",
"     \"Approach to the diagnosis and evaluation of low back pain in adults\", section on 'Physical examination'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Diagnostic evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most cases, the definitive physiologic cause of back pain symptoms cannot be established. Laboratory tests are not useful and imaging studies are not generally indicated. Magnetic resonance imaging (MRI) is usually performed if an invasive intervention, such as epidural steroid injection or surgery, is contemplated and in complicated cases. The indications for MRI of the lumbosacral spine in pregnant women with low back pain are the same as in nonpregnant women. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=see_link&amp;anchor=H16#H16\">",
"     \"Approach to the diagnosis and evaluation of low back pain in adults\", section on 'Approach to imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various interventions have been tried; a multimodal approach is probably best [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Periods of rest with hip flexion can reverse the lordosis and temporarily decrease pain. The woman should lie in the lateral recumbent position, with her knees and hips bent. A pillow can be used to support the weight of the uterus or placed between the knees to reduce the mechanical burden on the back [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A meta-analysis of four trials (n = 566 subjects) found that exercise, support belts, and acupuncture may be helpful [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/19\">",
"     19",
"    </a>",
"    ]. The purpose of back exercises is to strengthen the trunk muscles to stabilize the spine. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?8/47/8950?source=see_link\">",
"     \"Patient information: Low back pain in adults (Beyond the Basics)\"",
"    </a>",
"    .) Back flexion exercises strengthen the abdominal muscles and also reduce the lumbar lordosis, while extension exercises strengthen the paraspinal muscles. Walking is generally prescribed to relieve some of the hamstring tightness and to lessen chronic discogenic symptoms.",
"   </p>",
"   <p>",
"    Water therapy has shown some benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Acupuncture appears to be more beneficial than physiotherapy, but both can be effective [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/22-25\">",
"     22-25",
"    </a>",
"    ]. If a short course of an analgesic is indicated,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    has the best safety profile in pregnancy. (See",
"    <a class=\"local\" href=\"#H17496530\">",
"     'Pharmacologic treatment of pain during pregnancy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The American College of Obstetricians and Gynecologists (ACOG) suggests the following interventions to ease back pain during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/26\">",
"     26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Wear low-heeled (but not flat) shoes with good arch support.",
"     </li>",
"     <li>",
"      Get help when lifting heavy objects.",
"     </li>",
"     <li>",
"      Place a board between the mattress and box spring if your bed is too soft.",
"     </li>",
"     <li>",
"      Squat down, bend knees and keep the back straight when lifting.",
"     </li>",
"     <li>",
"      Sit in chairs with good back support, or use a small pillow to provide support.",
"     </li>",
"     <li>",
"      Sleep on the side with pillows between the knees for support.",
"     </li>",
"     <li>",
"      Apply heat, cold, or massage to the painful area.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, if it is necessary to stand or sit for a prolonged period, taking breaks, and placing one foot on a low stool relieves pressure on the lower back. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/21/13658?source=see_link\">",
"     \"Treatment of acute low back pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Osteopathic manipulation has shown promise in a pilot randomized trial [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/16/41222?source=see_link&amp;anchor=H5#H5\">",
"     \"Spinal manipulation in the treatment of musculoskeletal pain\", section on 'Low back pain'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Management of disc herniation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In women with symptomatic disc disease, indications for disc surgery during pregnancy are incapacitating pain, progressive neurologic deficits, and bladder or bowel dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/28\">",
"     28",
"    </a>",
"    ]. There is no contraindication to epidural or spinal anesthesia; antenatal consultation with an anesthesiologist may be helpful in allaying patient concerns. Cesarean delivery is required only for the usual obstetric indications, but instrumental vaginal delivery may be useful to avoid increased intrathecal pressures associated with the Valsalva maneuver.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 80 to 95 percent of cases, back pain resolves postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. At two to three years after delivery, about 20 percent of patients continue to experience back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. In a study that followed 303 women with back pain during pregnancy, the prevalence of back pain six years postpartum was 16 percent, comparable to the prepregnancy prevalence of 18 percent in the same group [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/29\">",
"     29",
"    </a>",
"    ]. Another long-term follow-up study of 62 women with severe low back pain during pregnancy noted both recurrent episodes in a subsequent pregnancy and back pain requiring sick leave when not pregnant were very common [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Screening for depression may be helpful in women with persistent pain [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SCOLIOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy does not appear to affect curve progression, nor does scoliosis appear to affect pregnancy outcome when scoliosis has been treated or is mild. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/12/37065?source=see_link&amp;anchor=H27#H27\">",
"     \"Treatment and prognosis of adolescent idiopathic scoliosis\", section on 'Pregnancy'",
"    </a>",
"    .) Respiratory failure and an increase in pulmonary hypertension during the second and third trimesters have been reported in rare cases of pregnancy in women with severe curvature, particularly when there is a coexisting muscular disorder (eg, muscular dystrophy, spinal muscular atrophy) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]. Most patients can receive neuraxial anesthesia successfully during labor [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     PREGNANCY RELATED PELVIC JOINT PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased mobility",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    asymmetry of pelvic joints make the pelvic area vulnerable to pain during pregnancy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    postpartum. As noted, the symphysis pubis widens at the 10th to 12th week of gestation in response to high relaxin concentrations. This widening allows increased mobility of the pubic symphysis, which can be painful. Mechanical strain may also play a role [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/38\">",
"     38",
"    </a>",
"    ]. In observational studies, magnetic resonance (MR) imaging of postpartum women at high risk of pubic injury (eg, second-stage labor",
"    <em>",
"     &gt;",
"    </em>",
"    150 minutes, third- or fourth-degree lacerations, instrument assisted delivery, infant birth weight",
"    <em>",
"     &gt;",
"    </em>",
"    4000 g) commonly showed bone marrow edema, pubic bone fractures, levator ani tears and abnormal widening or capsular distension of the pubic symphysis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/39,40\">",
"     39,40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other pregnancy related painful pelvic joint conditions include pelvic girdle syndrome (pain in all three pelvic joints) and unilateral or bilateral sacroiliac joint pain [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/41,42\">",
"     41,42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Pubic symphysis separation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peripartum pubic symphysis separation (pubic diastasis, symphysiolysis, osteitis pubis) is uncommon, but not rare; inconsistent definitions and sporadic reporting prevent an accurate estimate of incidence. Purported risk factors include fetal macrosomia, precipitous labor or rapid second stage of labor, intense uterine contractions, previous pelvic pathology or trauma to the pelvic ring, multiparity, and forceps delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical manifestations of pubic symphysis separation include suprapubic pain, tenderness, swelling, and edema with pain radiating to the legs, hips, or back [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/43\">",
"     43",
"    </a>",
"    ]. The pain is often potentiated by weight-bearing, especially with walking and climbing stairs. Turning in bed, lifting, or getting up from a chair may also cause pain. Some women report waking up during the night because of pain [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/44\">",
"     44",
"    </a>",
"    ]. Pain can also be evoked by bilateral pressure on the trochanters or by hip flexion with the legs in extension. Rarely, a palpable groove at the level of the symphysis may be detected by internal or external examination.",
"   </p>",
"   <p>",
"    In a nonpregnant woman, the normal symphysis gap is 4 to 5 mm; with pregnancy, the gap increases by at least 2 to 3 mm [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/45\">",
"     45",
"    </a>",
"    ]. The diagnosis of diastasis is based on the persistence of symptoms and a separation of more than 10 to 13 mm on imaging; however, radiographic imaging is not necessary, as the diagnosis can be made clinically on the basis of symptoms and response to therapy. Furthermore, the amount of symphyseal separation does not necessarily correlate with severity of symptoms or the degree of disability. One study that performed X-rays of the pelvis and lower spine, magnetic resonance imaging, urine dipstick, and blood tests (erythrocyte sedimentation rate, C-reactive protein, complete blood count, creatinine, rheumatoid factor, antinuclear antibodies) in women with transient or persistent pelvic joint pain and controls did not find any of these tests to be useful diagnostically [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Standard treatment of pubic symphysis separation is conservative: bedrest in the lateral decubitus position, pelvic support with a brace or girdle, ambulation with a walker or crutches, and a graded exercise protocol [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/47\">",
"     47",
"    </a>",
"    ]. It is unclear whether combination therapy speeds recovery. Safe options for analgesia antepartum are more limited than after delivery (see",
"    <a class=\"local\" href=\"#H17496530\">",
"     'Pharmacologic treatment of pain during pregnancy'",
"    </a>",
"    below). Nonsteroidal antiinflammatory medications are helpful for controlling pain postpartum. Opiates and intrasymphyseal injections with various medications have also been effective [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/43\">",
"     43",
"    </a>",
"    ]. Open reduction and internal fixation has been performed in women with separation of &ge;4 cm and those with persistent pain, but this is rarely necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/14/39142?source=see_link\">",
"     \"Osteitis pubis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The pelvis usually returns to normal by 4 to 12 weeks postpartum. Pain resolves in the majority of patients within a month [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/41,50\">",
"     41,50",
"    </a>",
"    ], but can take much longer. In a group of nine women with atypical pubic pain after childbirth, a large interpubic gap (greater than 21 millimeters) measured sonographically was associated with a delayed recovery; two of the nine patients were still disabled 36 weeks postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/14\">",
"     14",
"    </a>",
"    ]. Severe diastasis (&gt;25 mm) may require surgery. Symptoms may recur in subsequent pregnancies and may be worse, but this does not preclude vaginal birth [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/43,51\">",
"     43,51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Pelvic girdle pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Posterior pelvic pain related to the sacroiliac joint is common and often included under the broad classification of low back pain. Risk factors include increased parity, previous low back pain, emotional stress, obesity, young maternal age, low educational level, early menarche, physically demanding work, and cesarean delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/52-55\">",
"     52-55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pregnancy related posterior pelvic pain is characterized by pain related to the sacroiliac joints. It has been described as a stabbing pain in the buttocks distal and lateral to L5-S1; radiation as far down as the knee may occur. The pain may worsen with weight-bearing and there may be pain-free intervals.",
"   </p>",
"   <p>",
"    Posterior pelvic joint pain is assessed by the posterior pelvic pain provocation test [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/56\">",
"     56",
"    </a>",
"    ]. With the patient supine and her hip flexed 90 degrees, the examiner exerts pressure on the knee and along the femur to the hip, while stabilizing the pelvis with a hand on the opposite anterior iliac spine. A positive test elicits pain in the ipsilateral buttock. In addition, palpation of the SI joints (dimples of venus) may demonstrate nodules or tenderness to palpation. The Faber test (forward bending and hip rotation) may aggravate SI joint pain on the affected side. There is normal range of motion at the hips and spine.",
"   </p>",
"   <p>",
"    A brace or girdle provides compression and stability to the sacroiliac joints and improves disbursement of weight-bearing forces in the pelvis, back, hips, and legs. It appears to be useful for management of posterior pelvic pain [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/57\">",
"     57",
"    </a>",
"    ]. The nonelastic device should be placed to lie over the greater trochanters.",
"   </p>",
"   <p>",
"    Pregnancy related pelvic joint pain has been treated with acupuncture, with inconsistent results [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/50,58,59\">",
"     50,58,59",
"    </a>",
"    ]. One trial randomly assigned 386 pregnant women with pelvic girdle pain to standard treatment or standard treatment plus stabilizing exercises or acupuncture [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/59\">",
"     59",
"    </a>",
"    ]. The addition of acupuncture to standard treatment resulted in significantly lower pain scores at six weeks; stabilizing exercises [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/60,61\">",
"     60,61",
"    </a>",
"    ] also improved the efficacy of standard therapy. However, another randomized trial that compared standardized therapy alone to standardized treatment plus stabilizing exercises or standardized treatment plus acupuncture found no differences in recovery among the three treatment groups [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/50\">",
"     50",
"    </a>",
"    ]. Stabilizing exercises are targeted to the muscles supporting the pelvic girdle (eg, hip adductors and abductors, gluteus maximus, transverse abdominal muscles) and are supervised by a physical therapist [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    About 80 percent of women fully recover within six months of delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/54\">",
"     54",
"    </a>",
"    ]; however, recovery from pelvic girdle syndrome can be prolonged (over two years) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/63\">",
"     63",
"    </a>",
"    ]. A variety of treatments are available for women with chronic pain after delivery. As an example, slow-release corticosteroid injection to the insertion of the sacrospinous ligament on the ischial spine was effective in a randomized trial [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/64\">",
"     64",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39753?source=see_link\">",
"     \"Subacute and chronic low back pain: Nonsurgical interventional treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Appropriate options for antepartum analgesia are discussed below (see",
"    <a class=\"local\" href=\"#H17496530\">",
"     'Pharmacologic treatment of pain during pregnancy'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     HIP PAIN",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Osteonecrosis of the femoral head",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteonecrosis of the femoral head during pregnancy is rare. The etiology is unclear, but may be secondary to weight gain, endogenous production of glucocorticoids by the adrenal gland [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/65\">",
"     65",
"    </a>",
"    ], or a hypercoagulable state [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/66\">",
"     66",
"    </a>",
"    ]. Patients usually present with hip pain radiating to the groin or lateral thigh, particularly with weight-bearing, but not necessarily related to activity [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/66\">",
"     66",
"    </a>",
"    ]. Limitation of motion is a late event. In one series, 13 of 13 patients had involvement of the left hip and 4 had bilateral involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Physical findings are largely nonspecific. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/36/22088?source=see_link\">",
"     \"Evaluation of the adult with hip pain\"",
"    </a>",
"    .) The diagnosis is made by imaging studies. The plain radiograph can remain normal for months after symptoms of osteonecrosis begin; the earliest findings are mild density changes, followed by sclerosis and cysts as the disease progresses. The pathognomonic crescent sign (subchondral radiolucency) is evidence of subchondral collapse. Later stages reveal loss of sphericity or collapse of the femoral head. Ultimately, joint-space narrowing and degenerative changes in the acetabulum are visible. MRI is the most sensitive imaging method for making this diagnosis.",
"   </p>",
"   <p>",
"    Osteonecrosis can be a progressive disease leading to collapse of the articular surface and degenerative joint disease. Restricted weight-bearing has generally been ineffective at halting the progression of disease, thus justifying aggressive therapy. Treatment options include osteotomy, core decompression, and grafts [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/66\">",
"     66",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/43/28346?source=see_link&amp;anchor=H18#H18\">",
"     \"Osteonecrosis (avascular necrosis of bone)\", section on 'Clinical manifestations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/43/28346?source=see_link&amp;anchor=H34#H34\">",
"     \"Osteonecrosis (avascular necrosis of bone)\", section on 'Treatment options'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Safe options for analgesia antepartum are more limited than after delivery (see",
"    <a class=\"local\" href=\"#H17496530\">",
"     'Pharmacologic treatment of pain during pregnancy'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Transient osteoporosis of the hip",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transient osteoporosis of the hip also presents with pain with activity and limitation of motion of the hip. The diagnosis can be made by plain radiographs, which show generalized osteopenia [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/67\">",
"     67",
"    </a>",
"    ], or MRI, which shows a diffuse bone-marrow-edema-pattern signal with an increased signal intensity on T2-weighted images and a decreased intensity on T1-weighted images [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/66\">",
"     66",
"    </a>",
"    ]. MRI is useful for distinguishing between transient osteoporosis and osteonecrosis.",
"   </p>",
"   <p>",
"    The treatment is generally conservative with prevention of weight-bearing (use of crutches) in order to circumvent femoral fracture. There have also been case reports of treating patients with bisphosphonates [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/68\">",
"     68",
"    </a>",
"    ]; however, human data on the safety of bisphosphonates in pregnancy are anecdotal and sparse. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/35/42553?source=see_link&amp;anchor=H11#H11\">",
"     \"Evaluation and treatment of premenopausal osteoporosis\", section on 'Bisphosphonates'",
"    </a>",
"    .) Safe options for analgesia antepartum are more limited than after delivery (see",
"    <a class=\"local\" href=\"#H17496530\">",
"     'Pharmacologic treatment of pain during pregnancy'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    In contrast to osteonecrosis, transient idiopathic osteoporosis resolves by six to eight months postpartum with conservative therapy; fractures or other serious sequelae are rare [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21859517\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of other orthopedic conditions can cause hip pain in pregnant and postpartum women. Some, such as acetabular labral tear, may be related to maternal position during delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/69\">",
"     69",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/36/22088?source=see_link\">",
"     \"Evaluation of the adult with hip pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/39/25210?source=see_link&amp;anchor=H12#H12\">",
"     \"Radiologic evaluation of the painful hip in adults\", section on 'Imaging studies for specific clinical settings'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     KNEE PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Knee pain is not uncommon in pregnant women. Postural changes, increase in weight, and increased laxity of ligaments can all contribute to pain in the knee. Ligamentous laxity in the knee occurs during the second half of pregnancy, and is not exacerbated by exercise programs with minimal to moderate weight-bearing [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/70\">",
"     70",
"    </a>",
"    ]. Significant improvement occurs by four months postpartum. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6618?source=see_link\">",
"     \"Evaluation of the active adult patient with knee pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Patellofemoral disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patellofemoral disorder usually manifests itself as pain behind or around the patella, especially when going up and down stairs or with prolonged sitting. Quadriceps strengthening exercises can help the patella track correctly, and patella sleeves can also be helpful [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/71\">",
"     71",
"    </a>",
"    ]. The diagnosis and treatment of patellofemoral pain are discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43993?source=see_link\">",
"     \"Patellofemoral pain syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     LEG CRAMPS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leg cramps are common, usually occurring during the latter half of pregnancy. The cramps are due to painful muscle contractions and are generally experienced in the calves at night. They are thought to be secondary to a buildup of lactic and pyruvic acids leading to involuntary contraction of the affected muscles, but the exact etiology is unknown [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A Cochrane review found that the only placebo-controlled trial of calcium treatment showed no evidence of benefit in the treatment of leg cramps, but placebo controlled trials of magnesium supplementation suggested a possible benefit (odds ratio 0.18, 95 percent CI 0.05 to 0.60) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/72\">",
"     72",
"    </a>",
"    ]. This was a small trial of 69 pregnant women with persistent leg cramps. The preparation used was magnesium lactate or citrate 5 mmol in the morning and 10 mmol in the evening [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Stretching exercises may be an effective preventive measure. These can be performed in the weight-bearing position; they are held for 20 seconds and repeated three times in succession, four times daily for one week, then twice daily thereafter (",
"    <a class=\"graphic graphic_picture graphicRef70744 \" href=\"UTD.htm?33/20/34126\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    If a cramp occurs, calf stretches (toe raises), walking, or leg jiggling followed by leg elevation may be helpful. Other nonpharmacologic remedies include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A hot shower or warm tub bath",
"     </li>",
"     <li>",
"      Ice massage",
"     </li>",
"     <li>",
"      Regular exercise for conditioning, calf strengthening and stretching",
"     </li>",
"     <li>",
"      Increased hydration",
"     </li>",
"     <li>",
"      Use of long-countered shoes and other proper foot gear. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32407?source=see_link\">",
"       \"Joint protection program for the lower limb\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     HAND AND WRIST PAIN",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     De Quervain's tenosynovitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;De Quervain's tenosynovitis refers to tenosynovitis of the abductor pollicis longus and extensor pollicis brevis tendons. It is most often a cumulative movement disorder due to chronic overuse of the wrist and hand. Bilateral or unilateral tenosynovitis may accompany pregnancy, or can be related to direct trauma or systemic diseases such as rheumatoid arthritis. Although this disorder can occur antenatally, it is more common in the postpartum period where lifting the infant can cause the initial irritation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients have pain at the radial side of the wrist during pinch grasping or thumb and wrist movement. The pain may radiate to the thumb or up to the volar aspect of the wrist. The patient may complain of difficulty gripping, and often rubs over the radial styloid when describing the condition. Lifting can also provoke symptoms.",
"   </p>",
"   <p>",
"    The diagnosis is based upon the characteristic history of wrist pain on the radial side and specific findings on physical examination (",
"    <a class=\"graphic graphic_picture graphicRef67845 graphicRef56635 graphicRef58422 \" href=\"UTD.htm?7/8/7303\">",
"     picture 2A-C",
"    </a>",
"    ). Treatment consists of rest and immobilization; nonsteroidal antiinflammatory drugs can be helpful acutely in nonpregnant women, but should be avoided in pregnancy after about 30 weeks of gestation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/59/38842?source=see_link\">",
"     \"Use of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation\"",
"    </a>",
"    .) A local intralesional corticosteroid injection is indicated if pain or swelling is persistent for four to six weeks despite these measures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/40/27270?source=see_link\">",
"     \"de Quervain's tenosynovitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Carpal tunnel syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;(see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/9/20634?source=see_link&amp;anchor=H9#H9\">",
"     \"Neurologic disorders complicating pregnancy\", section on 'Carpal tunnel syndrome'",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     FOOT PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant women appear to have significantly more foot pain than nonpregnant nulliparous women. In one study, foot pain tended to be self-limited; in most patients, it resolved in less than four months [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/75\">",
"     75",
"    </a>",
"    ]. Potential causes of foot pain include weight gain, peripheral ligamentous laxity, and changes in posture and pedal pressure points [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/75,76\">",
"     75,76",
"    </a>",
"    ]. These changes can lead to over-pronation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/77\">",
"     77",
"    </a>",
"    ]. Peripheral edema also contributes to foot discomfort in pregnancy. Treatment of foot pain is supportive.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2338603\">",
"    <span class=\"h1\">",
"     CHEST WALL PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest wall changes that occur during pregnancy include increases in the subcostal angle, the anterior-posterior and transverse diameters of the chest wall, and the chest wall circumference. These changes compensate for the elevation of the diaphragm during pregnancy and preserve total lung capacity, and are not associated with pain. There are no causes of musculoskeletal chest pain specific to pregnancy other than fractures of the ribs that may occur with the rare disorder &lsquo;pregnancy associated osteoporosis&rsquo; [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/78-82\">",
"     78-82",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/25/6553?source=see_link&amp;anchor=H18#H18\">",
"     \"Epidemiology and etiology of premenopausal osteoporosis\", section on 'Pregnancy and lactation associated osteoporosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Anecdotally, pregnant women, especially those who have a short torso or a very large uterus, near term may complain of discomfort (soreness, tenderness) in lower rib area, often on the right. This is presumed to be due to pressure from the uterus in this area and may be relieved by wearing loose clothing and changes in position to provide more room.",
"   </p>",
"   <p>",
"    The painful rib syndrome is characterized by discomfort in the lower chest or upper abdomen, tenderness over the costal margins, and reproduction of the pain by pressure on the ribs [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/83\">",
"     83",
"    </a>",
"    ]. This syndrome accounts for as many as 3 percent of new referrals to surgeons for the evaluation of upper abdominal pain. It is most common in women, usually unrelated to pregnancy. The syndrome has a benign outcome and is important to recognize and diagnose to avoid unnecessary testing and treatment and to provide reassurance to the patient. In one review, 8 of 76 patients underwent noncurative cholecystectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/1/2074/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10872442\">",
"    <span class=\"h1\">",
"     ARTHRITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy related changes in circulating hormones may contribute to alterations in the immune system that may impact the activity of autoimmune diseases associated with arthritis. Patients with rheumatoid arthritis are particularly at risk of flaring in the postpartum period. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/53/40791?source=see_link\">",
"     \"Rheumatoid arthritis and pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/45/39641?source=see_link\">",
"     \"Pregnancy in women with systemic lupus erythematosus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/4/41030?source=see_link\">",
"     \"Management of psoriasis in pregnant women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other less common causes of postpartum arthritis include septic arthritis caused by mycoplasma (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/28/31177?source=see_link&amp;anchor=H14#H14\">",
"     \"Mycoplasma hominis, Mycoplasma genitalium, and Ureaplasma urealyticum infections\", section on 'Arthritis'",
"    </a>",
"    ) and rubella vaccine associated arthropathy (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23354?source=see_link&amp;anchor=H6#H6\">",
"     \"Specific viruses that cause arthritis\", section on 'Rubella and rubella vaccine virus'",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17496530\">",
"    <span class=\"h1\">",
"     PHARMACOLOGIC TREATMENT OF PAIN DURING PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;If drugs are needed to relieve pain during pregnancy,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    is probably the safest choice. The use of nonsteroidal drugs and opioids are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/59/38842?source=see_link\">",
"     \"Use of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42010?source=see_link&amp;anchor=H1702574#H1702574\">",
"     \"Initial prenatal assessment and patient education\", section on 'Treatment of pain and fever'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?15/9/15506?source=see_link\">",
"       \"Patient information: Nocturnal (nighttime) leg cramps (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pregnancy-related changes in body weight, shape, and hormones are associated with musculoskeletal consequences, including lordosis and joint laxity. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Normal pregnancy changes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       Acetaminophen",
"      </a>",
"      may be used throughout pregnancy. Nonsteroidal antiinflammatory drugs may be used after a confirmed pregnancy test until the 24th week of gestation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/59/38842?source=see_link\">",
"       \"Use of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Low back pain is a common complaint during pregnancy. It usually is caused by mechanical factors, rather than disc herniation. We suggest nonpharmacologic interventions for management of low back pain in pregnancy, rather than surgery or medication. If medication is needed,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      appears to be a safe and effective initial choice. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Low back pain and disc disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For pain related to the pubic symphysis, we suggest conservative interventions (bedrest in the lateral decubitus position, pelvic support with a brace or girdle, ambulation with a walker, and a graded exercise protocol). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Pregnancy related pelvic joint pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pregnancy does not appear to affect curve progression, nor does scoliosis appear to affect pregnancy outcome when scoliosis has been treated or is mild. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Scoliosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hip pain may be related to osteonecrosis, which is a chronic progressive disease potentially requiring aggressive therapy, or transient idiopathic osteoporosis, which typically resolves in 8 to 12 months and should be treated conservatively. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Hip pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Leg cramps are common in pregnant women. We suggest nonpharmacologic interventions such as calf stretching. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Leg cramps'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      De Quervain's tenosynovitis is frequent and most commonly occurs in the postpartum period when lifting the infant causes the initial irritation. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'De Quervain's tenosynovitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Carpal tunnel syndrome is a common complication in pregnancy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/9/20634?source=see_link&amp;anchor=H9#H9\">",
"       \"Neurologic disorders complicating pregnancy\", section on 'Carpal tunnel syndrome'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Karzel, RP, Freedman, MJ. Orthopedic injuries in pregnancy. In: Exercise in Pregnancy, 2nd ed, Artal, R, Wiswell, RA, Drinkwater, BL (Eds), Lippincott, Williams and Wilkins, Baltimore 1991.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/2\">",
"      Foti T, Davids JR, Bagley A. A biomechanical analysis of gait during pregnancy. J Bone Joint Surg Am 2000; 82:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/3\">",
"      Gilleard W, Crosbie J, Smith R. Effect of pregnancy on trunk range of motion when sitting and standing. Acta Obstet Gynecol Scand 2002; 81:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/4\">",
"      Ivell R. Endocrinology. This hormone has been relaxin' too long! Science 2002; 295:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/5\">",
"      Marnach ML, Ramin KD, Ramsey PS, et al. Characterization of the relationship between joint laxity and maternal hormones in pregnancy. Obstet Gynecol 2003; 101:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/6\">",
"      MacEvilly M, Buggy D. Back pain and pregnancy: a review. Pain 1996; 64:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/7\">",
"      Colliton J. Managing Back Pain During Pregnancy. Medscape Womens Health 1997; 2:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/8\">",
"      Fast A, Shapiro D, Ducommun EJ, et al. Low-back pain in pregnancy. Spine (Phila Pa 1976) 1987; 12:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/9\">",
"      Wang SM, Dezinno P, Maranets I, et al. Low back pain during pregnancy: prevalence, risk factors, and outcomes. Obstet Gynecol 2004; 104:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/10\">",
"      Ostgaard HC, Andersson GB. Previous back pain and risk of developing back pain in a future pregnancy. Spine (Phila Pa 1976) 1991; 16:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/11\">",
"      Sanderson PL, Fraser RD. The influence of pregnancy on the development of degenerative spondylolisthesis. J Bone Joint Surg Br 1996; 78:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/12\">",
"      Chan YL, Lam WW, Lau TK, et al. Back pain in pregnancy--magnetic resonance imaging correlation. Clin Radiol 2002; 57:1109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/13\">",
"      Weinreb JC, Wolbarsht LB, Cohen JM, et al. Prevalence of lumbosacral intervertebral disk abnormalities on MR images in pregnant and asymptomatic nonpregnant women. Radiology 1989; 170:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/14\">",
"      Scriven MW, Jones DA, McKnight L. Current concepts review. Musculoskeletal considerations in pregnancy. J Bone Joint Surg Am 1995; 77:1465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/15\">",
"      Heckman JD, Sassard R. Musculoskeletal considerations in pregnancy. J Bone Joint Surg Am 1994; 76:1720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/16\">",
"      Gregory DS, Seto CK, Wortley GC, Shugart CM. Acute lumbar disk pain: navigating evaluation and treatment choices. Am Fam Physician 2008; 78:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/17\">",
"      George JW, Skaggs CD, Thompson PA, et al. A randomized controlled trial comparing a multimodal intervention and standard obstetrics care for low back and pelvic pain in pregnancy. Am J Obstet Gynecol 2013; 208:295.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/18\">",
"      Thomas IL, Nicklin J, Pollock H, Faulkner K. Evaluation of a maternity cushion (Ozzlo pillow) for backache and insomnia in late pregnancy. Aust N Z J Obstet Gynaecol 1989; 29:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/19\">",
"      Richards E, van Kessel G, Virgara R, Harris P. Does antenatal physical therapy for pregnant women with low back pain or pelvic pain improve functional outcomes? A systematic review. Acta Obstet Gynecol Scand 2012; 91:1038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/20\">",
"      Kihlstrand M, Stenman B, Nilsson S, Axelsson O. Water-gymnastics reduced the intensity of back/low back pain in pregnant women. Acta Obstet Gynecol Scand 1999; 78:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/21\">",
"      Granath AB, Hellgren MS, Gunnarsson RK. Water aerobics reduces sick leave due to low back pain during pregnancy. J Obstet Gynecol Neonatal Nurs 2006; 35:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/22\">",
"      Kvorning N, Holmberg C, Grennert L, et al. Acupuncture relieves pelvic and low-back pain in late pregnancy. Acta Obstet Gynecol Scand 2004; 83:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/23\">",
"      Wedenberg K, Moen B, Norling A. A prospective randomized study comparing acupuncture with physiotherapy for low-back and pelvic pain in pregnancy. Acta Obstet Gynecol Scand 2000; 79:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/24\">",
"      Ee CC, Manheimer E, Pirotta MV, White AR. Acupuncture for pelvic and back pain in pregnancy: a systematic review. Am J Obstet Gynecol 2008; 198:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/25\">",
"      Pennick VE, Young G. Interventions for preventing and treating pelvic and back pain in pregnancy. Cochrane Database Syst Rev 2007; :CD001139.",
"     </a>",
"    </li>",
"    <li>",
"     Easing back pain during pregnancy. American College of Obstetricians and Gynecologists, Washington, DC, 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/27\">",
"      Licciardone JC, Buchanan S, Hensel KL, et al. Osteopathic manipulative treatment of back pain and related symptoms during pregnancy: a randomized controlled trial. Am J Obstet Gynecol 2010; 202:43.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/28\">",
"      Garmel SH, Guzelian GA, D'Alton JG, D'Alton ME. Lumbar disk disease in pregnancy. Obstet Gynecol 1997; 89:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/29\">",
"      Ostgaard HC, Zetherstr&ouml;m G, Roos-Hansson E. Back pain in relation to pregnancy: a 6-year follow-up. Spine (Phila Pa 1976) 1997; 22:2945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/30\">",
"      Brynhildsen J, Hansson A, Persson A, Hammar M. Follow-up of patients with low back pain during pregnancy. Obstet Gynecol 1998; 91:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/31\">",
"      Nor&eacute;n L, Ostgaard S, Johansson G, Ostgaard HC. Lumbar back and posterior pelvic pain during pregnancy: a 3-year follow-up. Eur Spine J 2002; 11:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/32\">",
"      To WW, Wong MW. Persistence of back pain symptoms after pregnancy and bone mineral density changes as measured by quantitative ultrasound--a two year longitudinal follow up study. BMC Musculoskelet Disord 2011; 12:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/33\">",
"      Gutke A, Josefsson A, Oberg B. Pelvic girdle pain and lumbar pain in relation to postpartum depressive symptoms. Spine (Phila Pa 1976) 2007; 32:1430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/34\">",
"      K&auml;hler CM, H&ouml;gl B, Habeler R, et al. Management of respiratory deterioration in a pregnant patient with severe kyphoscoliosis by non-invasive positive pressure ventilation. Wien Klin Wochenschr 2002; 114:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/35\">",
"      Gamzu R, Shenhav M, Fainaru O, et al. Impact of pregnancy on respiratory capacity in women with muscular dystrophy and kyphoscoliosis. A case report. J Reprod Med 2002; 47:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/36\">",
"      Yim R, Kirschner K, Murphy E, et al. Successful pregnancy in a patient with spinal muscular atrophy and severe kyphoscoliosis. Am J Phys Med Rehabil 2003; 82:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/37\">",
"      Ko JY, Leffert LR. Clinical implications of neuraxial anesthesia in the parturient with scoliosis. Anesth Analg 2009; 109:1930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/38\">",
"      Mens JM, Pool-Goudzwaard A, Stam HJ. Mobility of the pelvic joints in pregnancy-related lumbopelvic pain: a systematic review. Obstet Gynecol Surv 2009; 64:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/39\">",
"      Brandon C, Jacobson JA, Low LK, et al. Pubic bone injuries in primiparous women: magnetic resonance imaging in detection and differential diagnosis of structural injury. Ultrasound Obstet Gynecol 2012; 39:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/40\">",
"      Miller JM, Brandon C, Jacobson JA, et al. MRI findings in patients considered high risk for pelvic floor injury studied serially after vaginal childbirth. AJR Am J Roentgenol 2010; 195:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/41\">",
"      Albert HB, Godskesen M, Westergaard JG. Incidence of four syndromes of pregnancy-related pelvic joint pain. Spine (Phila Pa 1976) 2002; 27:2831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/42\">",
"      Smith MW, Marcus PS, Wurtz LD. Orthopedic issues in pregnancy. Obstet Gynecol Surv 2008; 63:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/43\">",
"      Snow RE, Neubert AG. Peripartum pubic symphysis separation: a case series and review of the literature. Obstet Gynecol Surv 1997; 52:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/44\">",
"      Robinson HS, Eskild A, Heiberg E, Eberhard-Gran M. Pelvic girdle pain in pregnancy: the impact on function. Acta Obstet Gynecol Scand 2006; 85:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/45\">",
"      Parker JM, Bhattacharjee M. Images in clinical medicine. Peripartum diastasis of the symphysis pubis. N Engl J Med 2009; 361:1886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/46\">",
"      Hansen A, Jensen DV, Larsen EC, et al. Postpartum pelvic pain--the \"pelvic joint syndrome\": a follow-up study with special reference to diagnostic methods. Acta Obstet Gynecol Scand 2005; 84:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/47\">",
"      Jain N, Sternberg LB. Symphyseal separation. Obstet Gynecol 2005; 105:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/48\">",
"      Kharrazi FD, Rodgers WB, Kennedy JG, Lhowe DW. Parturition-induced pelvic dislocation: a report of four cases. J Orthop Trauma 1997; 11:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/49\">",
"      Rommens PM. Internal fixation in postpartum symphysis pubis rupture: report of three cases. J Orthop Trauma 1997; 11:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/50\">",
"      Elden H, Hagberg H, Olsen MF, et al. Regression of pelvic girdle pain after delivery: follow-up of a randomised single blind controlled trial with different treatment modalities. Acta Obstet Gynecol Scand 2008; 87:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/51\">",
"      Culligan P, Hill S, Heit M. Rupture of the symphysis pubis during vaginal delivery followed by two subsequent uneventful pregnancies. Obstet Gynecol 2002; 100:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/52\">",
"      Bjelland EK, Eskild A, Johansen R, Eberhard-Gran M. Pelvic girdle pain in pregnancy: the impact of parity. Am J Obstet Gynecol 2010; 203:146.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/53\">",
"      Bjelland EK, Eberhard-Gran M, Nielsen CS, Eskild A. Age at menarche and pelvic girdle syndrome in pregnancy: a population study of 74 973 women. BJOG 2011; 118:1646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/54\">",
"      Bjelland EK, Stuge B, Engdahl B, Eberhard-Gran M. The effect of emotional distress on persistent pelvic girdle pain after delivery: a longitudinal population study. BJOG 2013; 120:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/55\">",
"      Bjelland EK, Stuge B, Vangen S, et al. Mode of delivery and persistence of pelvic girdle syndrome 6 months postpartum. Am J Obstet Gynecol 2013; 208:298.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/56\">",
"      Ostgaard HC, Zetherstr&ouml;m G, Roos-Hansson E. The posterior pelvic pain provocation test in pregnant women. Eur Spine J 1994; 3:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/57\">",
"      Ostgaard HC, Zetherstr&ouml;m G, Roos-Hansson E, Svanberg B. Reduction of back and posterior pelvic pain in pregnancy. Spine (Phila Pa 1976) 1994; 19:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/58\">",
"      Wang SM, Dezinno P, Lin EC, et al. Auricular acupuncture as a treatment for pregnant women who have low back and posterior pelvic pain: a pilot study. Am J Obstet Gynecol 2009; 201:271.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/59\">",
"      Elden H, Ladfors L, Olsen MF, et al. Effects of acupuncture and stabilising exercises as adjunct to standard treatment in pregnant women with pelvic girdle pain: randomised single blind controlled trial. BMJ 2005; 330:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/60\">",
"      Richardson CA, Snijders CJ, Hides JA, et al. The relation between the transversus abdominis muscles, sacroiliac joint mechanics, and low back pain. Spine (Phila Pa 1976) 2002; 27:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/61\">",
"      Richardson CA, Jull GA. Muscle control-pain control. What exercises would you prescribe? Man Ther 1995; 1:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/62\">",
"      Stuge B, Laerum E, Kirkesola G, V&oslash;llestad N. The efficacy of a treatment program focusing on specific stabilizing exercises for pelvic girdle pain after pregnancy: a randomized controlled trial. Spine (Phila Pa 1976) 2004; 29:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/63\">",
"      V&oslash;llestad NK, Stuge B. Prognostic factors for recovery from postpartum pelvic girdle pain. Eur Spine J 2009; 18:718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/64\">",
"      Torstensson T, Lindgren A, Kristiansson P. Corticosteroid injection treatment to the ischiadic spine reduced pain in women with long-lasting sacral low back pain with onset during pregnancy: a randomized, double blind, controlled trial. Spine (Phila Pa 1976) 2009; 34:2254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/65\">",
"      Pellicci PM, Zolla-Pazner S, Rabhan WN, Wilson PD Jr. Osteonecrosis of the femoral head associated with pregnancy. Report of three cases. Clin Orthop Relat Res 1984; :59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/66\">",
"      Montella BJ, Nunley JA, Urbaniak JR. Osteonecrosis of the femoral head associated with pregnancy. A preliminary report. J Bone Joint Surg Am 1999; 81:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/67\">",
"      Lose G, Lindholm P. Transient painful osteoporosis of the hip in pregnancy. Int J Gynaecol Obstet 1986; 24:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/68\">",
"      Schapira D, Braun Moscovici Y, Gutierrez G, Nahir AM. Severe transient osteoporosis of the hip during pregnancy. Successful treatment with intravenous biphosphonates. Clin Exp Rheumatol 2003; 21:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/69\">",
"      Brooks AG, Domb BG. Acetabular labral tear and postpartum hip pain. Obstet Gynecol 2012; 120:1093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/70\">",
"      Dumas GA, Reid JG. Laxity of knee cruciate ligaments during pregnancy. J Orthop Sports Phys Ther 1997; 26:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/71\">",
"      Ritchie JR. Orthopedic considerations during pregnancy. Clin Obstet Gynecol 2003; 46:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/72\">",
"      Young GL, Jewell D. Interventions for leg cramps in pregnancy. Cochrane Database Syst Rev 2002; :CD000121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/73\">",
"      Dahle LO, Berg G, Hammar M, et al. The effect of oral magnesium substitution on pregnancy-induced leg cramps. Am J Obstet Gynecol 1995; 173:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/74\">",
"      Schned ES. DeQuervain tenosynovitis in pregnant and postpartum women. Obstet Gynecol 1986; 68:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/75\">",
"      Vullo VJ, Richardson JK, Hurvitz EA. Hip, knee, and foot pain during pregnancy and the postpartum period. J Fam Pract 1996; 43:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/76\">",
"      Nyska M, Sofer D, Porat A, et al. Planter foot pressures in pregnant women. Isr J Med Sci 1997; 33:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/77\">",
"      Bohemen EK, Gendi NS. Flatfeet in pregnancy. Br J Rheumatol 1996; 35:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/78\">",
"      Lidder S, Lang KJ, Lee HJ, et al. Bilateral hip fractures associated with transient osteoporosis of pregnancy. J R Army Med Corps 2011; 157:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/79\">",
"      Maliha G, Morgan J, Vrahas M. Transient osteoporosis of pregnancy. Injury 2012; 43:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/80\">",
"      Kovacs CS. Calcium and bone metabolism disorders during pregnancy and lactation. Endocrinol Metab Clin North Am 2011; 40:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/81\">",
"      Baitner AC, Bernstein AD, Jazrawi AJ, et al. Spontaneous rib fracture during pregnancy. A case report and review of the literature. Bull Hosp Jt Dis 2000; 59:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/82\">",
"      Even-Tov I, Yedwab GA, Persitz E, David MP. Stress fracture of ribs in late pregnancy. Int Surg 1979; 64:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/1/2074/abstract/83\">",
"      Scott EM, Scott BB. Painful rib syndrome--a review of 76 cases. Gut 1993; 34:1006.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 427 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-7727F3B860-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_1_2074=[""].join("\n");
var outline_f2_1_2074=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NORMAL PREGNANCY CHANGES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      LOW BACK PAIN AND DISC DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Incidence and epidemiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Etiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      History and physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Diagnostic evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Management of disc herniation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SCOLIOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PREGNANCY RELATED PELVIC JOINT PAIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Pubic symphysis separation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Pelvic girdle pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      HIP PAIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Osteonecrosis of the femoral head",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Transient osteoporosis of the hip",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21859517\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      KNEE PAIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Patellofemoral disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      LEG CRAMPS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      HAND AND WRIST PAIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      De Quervain's tenosynovitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Carpal tunnel syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      FOOT PAIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2338603\">",
"      CHEST WALL PAIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10872442\">",
"      ARTHRITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17496530\">",
"      PHARMACOLOGIC TREATMENT OF PAIN DURING PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/427\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/427|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/20/34126\" title=\"picture 1\">",
"      Posterior leg stretch wall",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/28/21967\" title=\"picture 2A\">",
"      Palpation radial styloid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/54/27503\" title=\"picture 2B\">",
"      Resisting thumb extension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/14/22752\" title=\"picture 2C\">",
"      Finkelstein test deQuervains",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/40/39562?source=related_link\">",
"      Adverse effects of neuraxial analgesia and anesthesia for obstetrics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=related_link\">",
"      Approach to the diagnosis and evaluation of low back pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/25/6553?source=related_link\">",
"      Epidemiology and etiology of premenopausal osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/35/42553?source=related_link\">",
"      Evaluation and treatment of premenopausal osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6618?source=related_link\">",
"      Evaluation of the active adult patient with knee pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/36/22088?source=related_link\">",
"      Evaluation of the adult with hip pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42010?source=related_link\">",
"      Initial prenatal assessment and patient education",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32407?source=related_link\">",
"      Joint protection program for the lower limb",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/4/41030?source=related_link\">",
"      Management of psoriasis in pregnant women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/61/13274?source=related_link\">",
"      Maternal endocrine and metabolic adaptation to pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/28/31177?source=related_link\">",
"      Mycoplasma hominis, Mycoplasma genitalium, and Ureaplasma urealyticum infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/9/20634?source=related_link\">",
"      Neurologic disorders complicating pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/14/39142?source=related_link\">",
"      Osteitis pubis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/43/28346?source=related_link\">",
"      Osteonecrosis (avascular necrosis of bone)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43993?source=related_link\">",
"      Patellofemoral pain syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/47/8950?source=related_link\">",
"      Patient information: Low back pain in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?15/9/15506?source=related_link\">",
"      Patient information: Nocturnal (nighttime) leg cramps (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/45/39641?source=related_link\">",
"      Pregnancy in women with systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/39/25210?source=related_link\">",
"      Radiologic evaluation of the painful hip in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/53/40791?source=related_link\">",
"      Rheumatoid arthritis and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23354?source=related_link\">",
"      Specific viruses that cause arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/16/41222?source=related_link\">",
"      Spinal manipulation in the treatment of musculoskeletal pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39753?source=related_link\">",
"      Subacute and chronic low back pain: Nonsurgical interventional treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/12/37065?source=related_link\">",
"      Treatment and prognosis of adolescent idiopathic scoliosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/21/13658?source=related_link\">",
"      Treatment of acute low back pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/59/38842?source=related_link\">",
"      Use of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/40/27270?source=related_link\">",
"      de Quervain's tenosynovitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_1_2075="Postcardiac surgery pl effusion";
var content_f2_1_2075=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F55729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F55729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of pleural effusion after cardiac surgery",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Nonspecific pleural effusions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Heart failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Postpericardiotomy syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pneumonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pulmonary embolism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Central line erosion through central venous structures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chylothorax",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemothorax",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_1_2075=[""].join("\n");
var outline_f2_1_2075=null;
var title_f2_1_2076="Burn class depth";
var content_f2_1_2076=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F61540&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F61540&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Classification of burns by depth of injury",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Depth",
"      </td>",
"      <td class=\"subtitle1\">",
"       Appearance",
"      </td>",
"      <td class=\"subtitle1\">",
"       Sensation",
"      </td>",
"      <td class=\"subtitle1\">",
"       Healing time",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Superficial",
"      </td>",
"      <td>",
"       <p>",
"        Dry, red",
"       </p>",
"       <p>",
"        Blanches with pressure",
"       </p>",
"      </td>",
"      <td>",
"       Painful",
"      </td>",
"      <td>",
"       3 to 6 days",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Superficial partial-thickness",
"      </td>",
"      <td>",
"       <p>",
"        Blisters",
"       </p>",
"       <p>",
"        Moist, red, weeping",
"       </p>",
"       <p>",
"        Blanches with pressure",
"       </p>",
"      </td>",
"      <td>",
"       Painful to temperature and air",
"      </td>",
"      <td>",
"       7 to 21 days",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Deep partial-thickness",
"      </td>",
"      <td>",
"       <p>",
"        Blisters (easily unroofed)",
"       </p>",
"       <p>",
"        Wet or waxy dry",
"       </p>",
"       <p>",
"        Variable color (patchy to cheesy white to red)",
"       </p>",
"       <p>",
"        Does not blanch with pressure",
"       </p>",
"      </td>",
"      <td>",
"       Perceptive of pressure only",
"      </td>",
"      <td>",
"       &gt;21 days, usually requires surgical treatment",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Full-thickness",
"      </td>",
"      <td>",
"       <p>",
"        Waxy white to leathery gray to charred and black",
"       </p>",
"       <p>",
"        Dry and inelastic",
"       </p>",
"       <p>",
"        No blanching with pressure",
"       </p>",
"      </td>",
"      <td>",
"       Deep pressure only",
"      </td>",
"      <td>",
"       Rare, unless surgically treated",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Fourth degree",
"      </td>",
"      <td>",
"       Extends into fascia and/or muscle",
"      </td>",
"      <td>",
"       Deep pressure",
"      </td>",
"      <td>",
"       Never, unless surgically treated",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Mertens DM, Jenkins ME, Warden GD, Med Clin North Am 1997; 32:343; and Peate, WF, Am Fam Physician 1992; 45:1321; and Clayton MC, Solem LD, Postgrad Med 1995; 97:151.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_1_2076=[""].join("\n");
var outline_f2_1_2076=null;
var title_f2_1_2077="Etiology sore throat";
var content_f2_1_2077=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F60174&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F60174&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Etiology of sore throat by age",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Cause",
"       </td>",
"       <td class=\"subtitle1\">",
"        Infants &amp; young children",
"       </td>",
"       <td class=\"subtitle1\">",
"        Older children and adolescents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"green\">",
"         Viral pharyngitis",
"        </span>",
"       </td>",
"       <td>",
"        <p>",
"         Respiratory viruses",
"        </p>",
"        <p>",
"         <span class=\"green\">",
"          Herpangina (enterovirus)",
"         </span>",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         <span class=\"green\">",
"          Epstein-Barr virus (infectious mononucleosis)",
"         </span>",
"        </p>",
"        <p>",
"         <span class=\"green\">",
"          Respiratory viruses",
"         </span>",
"        </p>",
"        <p>",
"         Human immunodeficiency virus (HIV)",
"        </p>",
"        <p>",
"         Herpangina (enterovirus)",
"        </p>",
"        <p>",
"         Herpes simplex virus",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Bacterial pharyngitis",
"       </td>",
"       <td>",
"        <p>",
"         Group A streptococcus",
"        </p>",
"        <p>",
"         Fusobacterium necrophorum and other anaerobic bacteria",
"         <span class=\"red\">",
"          (&plusmn; Lemierre's syndrome)",
"         </span>",
"        </p>",
"        <p>",
"         Other bacteria*",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         <span class=\"green\">",
"          Group A streptococcus",
"         </span>",
"        </p>",
"        <p>",
"         Neisseria gonorrhoeae",
"        </p>",
"        <p>",
"         Fusobacterium necrophorum and other anaerobic bacteria",
"         <span class=\"red\">",
"          (&plusmn; Lemierre's syndrome)",
"         </span>",
"        </p>",
"        <p>",
"         Other bacteria*",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Other infections",
"       </td>",
"       <td>",
"        <p>",
"         <span class=\"red\">",
"          Retropharyngeal abscess",
"         </span>",
"        </p>",
"        <p>",
"         <span class=\"red\">",
"          Lateral pharyngeal abscess",
"         </span>",
"        </p>",
"        <p>",
"         <span class=\"red\">",
"          Epiglottitis",
"         </span>",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         <span class=\"red\">",
"          Peritonsillar abscess",
"         </span>",
"        </p>",
"        <p>",
"         <span class=\"red\">",
"          Retropharyngeal abscess",
"         </span>",
"        </p>",
"        <p>",
"         <span class=\"red\">",
"          Lateral pharyngeal abscess",
"         </span>",
"        </p>",
"        <p>",
"         <span class=\"red\">",
"          Epiglottitis",
"         </span>",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Miscellaneous conditions",
"       </td>",
"       <td>",
"        <p>",
"         Steven-Johnson syndrome",
"        </p>",
"        <p>",
"         Kawasaki disease",
"        </p>",
"        <p>",
"         Beh&ccedil;et syndrome",
"        </p>",
"        <p>",
"         PFAPA syndrome",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Psychogenic pharyngitis",
"        </p>",
"        <p>",
"         Referred pain",
"        </p>",
"        <p>",
"         Steven-Johnson syndrome",
"        </p>",
"        <p>",
"         Kawasaki disease",
"        </p>",
"        <p>",
"         Beh&ccedil;et syndrome",
"        </p>",
"        <p>",
"         PFAPA syndrome",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Traumatic injury",
"       </td>",
"       <td>",
"        <p>",
"         Foreign body",
"        </p>",
"        <p>",
"         Chemical exposure",
"        </p>",
"       </td>",
"       <td>",
"        <span class=\"green\">",
"         Irritation of the mucosa",
"        </span>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <font color=\"#ff0000\">",
"     <font color=\"black\">",
"      PFAPA:&nbsp;&nbsp;",
"     </font>",
"     <font color=\"black\">",
"      Periodic fever with aphthous stomatitis, pharyngitis, and adenitis",
"      <br/>",
"     </font>",
"     Red",
"    </font>",
"    : life-threatening.",
"    <br>",
"     <font color=\"#008000\">",
"      Green",
"     </font>",
"     : common cause.",
"     <div class=\"footnotes\">",
"      * Other bacteria that can cause acute pharyngitis include group C and G Streptococcus, Arcanobacterium hemolyticum, Mycoplasma pneumoniae, Chlamydia pneumoniae, Francisella tularensis, Corynebacterium diphtheriae, and Neisseria gonorrhoeae.",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_1_2077=[""].join("\n");
var outline_f2_1_2077=null;
var title_f2_1_2078="Stroke rates AF risk category";
var content_f2_1_2078=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F82291&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F82291&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 486px\">",
"   <div class=\"ttl\">",
"    Rate of ischemic stroke is related to risk category",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 466px; height: 274px; background-image: url(data:image/gif;base64,R0lGODlh0gESAdUAAP////8AAAAz/4CAgH8AAAAZfwAAAH9/f0BAQMDAwNDQ0HBwcBAQEDAwMKCgoPDw8CAgIFBQULCwsJCQkGBgYP8/P/9/f+Dg4D9m/3+Z//+/v7/M/z8AAAAMP/9PT19///8fHw8///+vr8/Y/6+//2+M//+fn5+y/9/l//8vLy9Z//8PD//Pz7+/v/9fXx9M///f3/9vbz8/P/+Pj+/y/09y/4+l///v7wAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAADSARIBAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6ytrq+wsbKztLW2t7i5uAkKRQoJF7rCw5UKAwYIRAoMBgPEz9CMCAbIRA3UzkIJA9zd3glE297j5OXm5+jp6uvs7efg0fF0CdVCAwwLzUPi5QjZ9jIOCBxIsKDBgwgTKlzIsKHDhwJl/JNXhh85eNDoJQOgwICEYxOTcCMy4ICuAyEpirE4DuMzjfaoyUxpZOSQkidpqiSTwGU0/wUTDDRI8OBCTwoGKARbYtOeyVwod6ppGm+aTIwgm1DFCVWn1DBUv0rZ+hRXVLFmwqJ9Qjbn2jJq3zJp21XumLh2RU7katZrXix4/9bcW1ZJC4gHW1A6K7hL4MY3CTc5wIGA5cuYM2vmUBgSY8haHoOmu+QAgQCoU6tezZpA50efQQP2O1oyE9Osc+t2TQSGht8axlSIYSa2bCuiIZNWglu389S8h1hQjWR68CsWTADQEMCCkAoBoHD3zpz2cbbmGy9P0vy58+hDuFcQYsKCCA8eWMAA70L7DQsVeCDCdhawYIIGMNjnQgUsiDCcENkB4EIAFVigAQjdBaeBB8PdAP9AffflJyGF5CFh3HlTJKeebaWd5t57ncn3XQAgpEAjCximQFwKK1hgIwvTrZAhauCtAAKG2lEIgI0gVGCCkE6KEIAHMUwJAHg10rgkjfOxlx6KTH3513omuvhibvAJIeOV4W0JgHUAsEDihBZMN+B23bGJp3dKjjejEB50ZwGGerrpZ3lgXqGiYGQe0d6Zq6WJZ5fg/QmnfHVaCOeeevrZZ56Fgpepd5V2CqqXiSInZl6NGvEopNAVBsMMAaQQXKmVTmchACuscOAM9QVwnZ+VejofdwKyKQILtHqggQguhBoesneauGqqRSw6JovMmQlrrERMl5q0AMCAoQdxBkr/owibEjttnkqyuQIAIgg5w5sYWolrm0Uiim2K18rVahGvfispbAH/C4C2nTgAjwQSrDEwEQXDerAjJyocJiv+CLHARmlMPARlmpVsMmeLJfwvw5rQIxM1EUjMbRKHIVaQYpNkrLFeqiiAAAMQIIBABL1MNXMtOu98BMubOPyGyK8krXS2KmPywATdOCAzSa/RIvXUkXH8MshoQO3K12AvXPUlQvXEy9Y3dT0L2mAzrUkDa2tTNAAXYD3BA1od7XXeYNqdyQIQZC2FMfUAYJVQgXPdRM02D4SzJHRPbTgmjzf+hFUgS/DAAxAYAA9L3nQc92QdFOD667DHLnsHcjOS/7nSm1/yi9t7QwFTEaUvhXo3qjs1WQECJK/88sw3X0Dti9y+c+6WPPCxAhFELMXvQwS1QOSr34Z88+ST/7wRJGSQAQlalIDBFBiUkIX0GlNfSQTUJEBBzNt7ng8FTjDbAcZXvgIm73xDoIEKBICBBWbACRgQQBJO8EApMHB+hEOR/ShhgAkgYBtkcwJQ2gY4/CVuAD5ZmuBcRUADlg+BQsiAAOQHgBGQAAUZ2AAAcKjDEXwAAzU4wQZeIIAcouCH8aMBACgIgA2s74fs2+EPPzCCGGLgAxfEAv0UtsFJeOSDQ5NC58DxMn1sLHylaaELnVeYEyQPAxmo4gaK2MQiov9AACrIwAeCGAIGChGOWPwAACIIABmGIIICQAEKQpDHEIQAACUQQA1k+D4tZvA8XZQEBRgANANozWiSE98aCwjDGPYxeUKk4xzjKIAXlMAGSiSkEE7wwwsSUoY6jOQGbCCAD2QgghsIwQuEkMUrbHFll5TEA/CHDzYIUI2jVF4plVjDSGJglXV8IAkw0EcVDFKCkJzhHN93SwHoEJcy9KX67ljJYlrhmNjKZCSMAoAHEAVuxhNlNNlIhF8KEYusDMEvi7iBD5AgmI+MIAlGoFA3klOCuCykOUeAx4OWgKECIIFDMZi2uSQzEg2IGekACEo0Mgea+yzlBhD5ggpG8gX/AEXBAvFYRRL00QYj6GMEHyrRc5oTACSYqQpQMAIi7pSjHVWCPCFhOnuEMC0rJBhKo1lKz3y0NqxgwASEEAH+hSyqFJvqKKuKsKQq9aqPQEoDrvHJr4ayNK2TnVzlSruUmZVnq3gAUpqJz4VBbwiUq9wBLhcJeKZqqeF4ByAU0Lu+8uUWhk0UYveROn9wI4V6ENrTwAqLyBYOrUiYbBkk0IDNvhWyoGVUagdDiM49FS6cjdpqWTVbktQ2DB8TGgK+V9J89uWuob2tPYQLBnsa17F/lS1wVQhVQjggfw3grVtNagvPapC4oiUDBBoAARAi1y3LpVpzB2G6D37su3UJ/69txysICFAAb3ydrm9Rq971wpYQEpAJA5Yi34UFRLAADrCAB7wQidQ3bPclhDEmwN/+Ds8dEI6whCdM4YsceLjsFcRHGOxM4l64E9kV7yDyQQ0GNDbDH35GiO0rCANEIAESYIBXo/A2ITzAAQNwAOA8muJ4rBjBghiKUxd3DJBdYxql5XGPofFjDI/YskLLMRRAJ4T8xgx/2jvrkpmMXQ93oXPUeK0SfpeVrADgwQMo3paF0WS1KdhtvKNxPcpsRjSrec25aHOb7/A77wEgH1s9I551oWcv02GEQymKAbobPCUPOs9d5sQYAeCA0kGgrVp+NKRRDIs9a1oShT6E/v8wSwZPfxoSoTZER5Bx4rsY+tSOSLWopVy2V8OaEbLW8AAuMIBWl9rWt1ZErgFB4gREgKT9DXanIz0IBrzXu71V9rI57Yfy6k/Mrpa2LIb9BwRwF3+BTra2WcFtPyyDGg3YsbjHrYpy/6HGfWX3KtzNB9UtYMZnMLW8C0HvPPA6aNxoALbFoO99D6LfeHDZy2xdcIMHAuF3sGcDKNATX//a4fMOGJrREeUIkzoTDce4H5g2gLjO9eQoP3kHgE0EBzAjzPEWOSlILtZ9UpXlQ4BA6X6G7FrLHBU0t7nQmVcAnAvBIwb4c8/zbfSf4yHoQ4960eFgOrxFYOBgabrT7QD/9agLfepvmPgxDCBdn2995gEbQM29/kKtC2EC4V732UGc9rWz3XlNX0DZYz53uo/F7ndfHtjdQAGsS+HGA/gb+PoOiq4Hfo2Db8MEGKC4KzzgyAZggLrxyvhPOP7xBow8G1yLBXqUdhofB3Ln/R4FtYN+rE3fXcWxcHmhuJey5rjz6jXx+debz+1c0Gsn062Nc+h+95jove+JDvwtBMUZ+DNPyJHPhY0b37LuQADgQS/6RDx3KGx1NPX5XRmTmf/85+fA9h/f/TUY955YWAAzErf48RNiAN76lv4DQID1B779afBcVbd31GZ/f4B/+5eA/Od/dweAaLBd3ZVmfGeA/yOXfwp4Jv23fKHXdNZ2XtFGgYCAgBdoMAzIdg54Bu4FXwSYYCD4cBY4gs+RgRrYdnCQXyXWYEzXgoIggjCIgSXodSd4BguGgzmogyH4gj2IJj8odU3XVgqwghdnhAeIhEkYKUs4dEFYBkNzNQxgeF8wfVLYelRYhdBxhV/XhJmXeVlmdmHIBzxIhrthhjaXhWWgAEGzeWzYhnrwhnDYGnKYUjinW96GDFCYbXq4B3zYh6ohgzOId25QRjD3gYfIdWMIh4zYiILXfG0AhpPIFJVIhpeIiQekdR6UPR12V2iWeqGQiIqIGqEoinQ4BiRGDWtYhEllER2HQvP2iVX4iv+YGItioA/L5IVewInDYIwV2IpKKIrMR3Xa44Fy11HI2Aes2Iq+2IjAGAb4M4hxZ4vLNY1uyItJeI0zmI3FxUyFaIjhBY6IKI49SI4aaI5fwFimpV7suIfuCIPwuHzy6AWa5Qb3aAsB+XT5OIL76Hv92AWkVY/rqIn4qIx+yIyZCAeklwWIlx4DSQsZSYkQaYUSKU15J4jp+ATnhgAQUH/AtZF1UI2KeJCvl5BcoABLIZNZUDoWx1r26JB5wJJ96JLc13SqI4FX0BE652K41w86WQsqSQc8aYl/eHNu4DNAIzRdWHptE35nZnxJqZFbyZEdWYYfOYpuoHAlVotT0BH/yWBmmdaQr9CUoPiUsAcHC4BpNekR16CKbpaTbVmQF+iT7NeEOnZsWqAA18AAdBlc9bWUc+CWvQiXkNd0EDABSNFBEyiNXbmSfKmAfvl/HJgAAgeNeZiSl8mUmZmAm9mATUd5zSCU0Zg2iikHjDmOjulCMLkFxTZxlemao7mYpbl/p2mCTXc1otNruVk3uwmbval/vwmEx6mO39iccBCb7zibG7iK0Elu1wmQyUmCYSkAtbkIr+kK4Rmd22kx1ElK2fmF6ZkK4/k05Qkpy8mEbiCIujWSYNCeGbeXXwmWYfmdVwCJnuONoqmf+7mA3emfWNBdQkABDLeeQOegU/Ge/z54oBwYaKApoHeFn5sooS8Sn1gIlMhwDUtXgJZJoPvpoWcIB8sEM3hIorppol+JonOode/Xoiz4nDDakTIKiHAggJ5pn+qZmBAaMhzqHjsKlW8AgdDWmsaZoxB5pHH5Bh1IjI4xpKWgoc5UpDF4njSYpO91D0BajFaKdk6qjFD6mDWoX0R4owMqnlr6Hlz6e3EwhKeol25aoAban02oPQlwmGyaoWOaFm8ahxRKkZ60MFTKBVj6oGVqjXHqiG/wM6uZqEvwC2uKk2x5pwV6prQJlNyQeZSaBOeGkYEqCosaoXjKqdUZqc7wXKGKBNdgRoKGo5p6oo/ajG/gNAAgAf9+Ohb4IKt2VqrW2agteasT2Qgd8RHAqpVCSqw9aawg+YgJUJHIUUbSJ6yMYH25h33ugJePIJ36CK1i2QYI8IQiiQVGoT9JcaksdhwDUH7oF6/yygHYGkCDuox6GglquZbueq+tUa9a4a8ema+bSA696pyyAa4GCbBzIbCLKK7eiXMA+qqzUTgOCx0M64mpCrEIWgVwFmeSqBwX64rpkYoHN7J5+pEdawVXU3lMahcK25clW1nd4K1eaauF+gb4IxMUqygZewgxq5lpN6RBa5ocy4H5MK0NarGpOrRAi7Kqip5UlwD7xZqhORpQ67SGULS+ebRwYJgRAAFVGbLqkbX/Y0G0UOu1ueoAy2BixQmzZtt6aLuxOet5P7u1cQsFp7owaVu3bZBbQhOmVcq0m6q1/Na3BDufY/O2ApO36PG0dJu4cQABZvmnItu0Zwu5m6q2ciBwjPsWXKuchnt/iKuyITmI+OairOK4ATS3m+u3oycTEHCTWUe4Jzq6Jxu5pjusGsS6KLmDpSuRK1sF2FOfn+uxisWevit+ufu6kssGpcOzx0sFuIh9NssJoWswuAu8uiu8HJi6L6uod7sF2Wsx2+uC3cuMw0sFESC49+lle5tvUMut7JCL3cqb6QuLTbdJxku271urMWpyKTfAA7xy+Ou8uxupi+u/QdoK5Quf/5xLnvn7iwDbN4lno5hquafwwBP6vNo5wdgYnFjDDQc7ZTKRZLMaheQWvOoLfBzcoREcu9KLBaJDOk2VwgirvCBcji7MwvpLdUMxe1vQaFmZe/A7vqHhwxR8wDjrwWqAN1/gZ8VnxFcLdEocwkwcozG8BojjslfwP61bxRt8xTycxTq6xWpArVZgQpfFvDm8BSaLvgjsvWb8pGicBrIHb1ZgrW5McKtVvTXLvXPcwnVspne8BhewACOqwf/LyNRIxvHYwzscySrqAFTGwGKquu04yfwoyYP8w22gAJskE0QzvRXryOHIyQjpyU2cwM6UeRSQX9c7uBjayKSryi/Jyv9aDLshA8uyXKeaHBoQ+sJGesio+slL3AY39jgUQLu2jMrkO8yQ3MmF7Ki8jMgDsHOm7LPBvJPTvMrVXKzX3AYS0I3dLMznfAfEvKXjLDHfnMu8m86qgre4/JPh/KztnHxHLM+YWc9/ec9Omc+X4GlMo639QL/sMMsE9872jJz+zJnxDM01IcAEXNF05XbrDKcCXTYM/c+NpzIGTQ72W7/GzNEPjZoA/ZYbXQmG867y+tLop34rDRcdDdEOjcxY/NFUkNGE6sTufNLAmdKNOdOT0NI1jdJxwNP46soSjNNlrNMpctRBndRSzZxCLZtEDWoqo9QR6dPH3Mp0fNNgTcj/UD0WVS2fVA3UVi3Wu+zV+rzTZ/2hbH3GWX0XcZ2iZS2Gao3WTT3WoJzWTk3Jea23dz2jc23Hdb3Qey3XjoB4Ova79rrYeN3Xbc3U7inZhu0ImIfC/ErYmM2jgO3XyRzalR3WjGBlAIBlfRywn42klE3Xbk2krR2luKYPZmZnCF2/8ArTvI0ZHEDRFh3crtMBuV1hFIYAu93bvf3bwt3cr0Pcxh3dqZPcyg3TzO3czW3AjUBn2RDS0v3d4B3e4j3e5F3e5n3e6G3eCt0HfgZonfjeQnABi5YARAzfnVhpi1bC9r3f/N3f/v3fAB7gAj7gBF7gZ7beTGDJrbZbi9AT/ztmqZWKAPrdBRcqBD4z4XzQE/ENDI4DhQruBB/uCxKeKtTgBduwpgFqCNSwVfItq0hADwkD41KAY0cg44dQ4gtj2716DDZ74kZg42CC4zb2Mc2clb1A4w9Aa5SlAA7j46I8NFpTDcZQuYBADSdJYtlQitqjV0MjjGlmirwGY1qTW0WOFB2T5ENjljjWNxdA47t6dRQn4x/hzHiA42X2SRKAAAzqDMcgmQhgltvA5D2xa2+u5z2hD3N+HkIOAA1AeY1+AR3xPTaZX914DMzwqcAgFAOwPwCADA/AAMSn4qUTY6XjDPlwbx7B6GSHFM7Q6ANwDb+QhsmQOPJ3ktcQNP+M7ugG0FjTwAzTmnTPFQEDIOwwTg+LXG2Tqg/VkF94Uzo53oXUgIOWvpqmE+zDjkLNYOwoIuSRvquUuV0dgTf5wGtXcQzaw+NEuQCKhww/Q+d7gAwRwElZAer15GIdAUAwjpabnu1ktw8fwwxnpg/6zuqP4zgGsGPTAABBgTdaQw/yF+rkxcfVMA3BkPA8/memM3YZn+o5ngALL2UOD+oY/BdCLuMyjhQLEF1rVVrpShQX3/G7KqmlZeU3rOJ/TnZZUQ/IYPL8br02bmWklXQ8b72yZ/BDkPCISg0LQA+cpHmFYOfKngxIb/FNxeMtn+Q3fPFppvRMz0kjnxfYMBL/QGNsu+7tHeQyBPjyPK4/EkC1DNDpDUCUX98H1eDy+oBlff7p3ZUPzsBJDjMBDmNGICEBzk4Ppuj3Hk+XSG/0E7D0we7wQQG+yB4TzlANfE/4Saf1NR8T8MDjjd+nLgb5RqnoL8MRt95WzNALqV8TWW86FxCrcd/paTn6Tw8yWbGifOVyyCDwO0u5Nl57RSkEvc4RvV+Li5/wmO9i9qQP02DOk5/jlZ8MDzANwa/5PqH2ppP8EbD8ztD8Bv5obd6n9P799ndu9k7+6J/+6r/+7N/+7v/+8B//8j//9F//9n//+J//+r///A8EAOGQWDQekUnlktl0PqFR6ZRatV6xNlntltv1fsFh8ZhcNp/RafWa3Xa/4XH5nF633/F5/Z7f9/8BAwUHCQsNDxETFRcZGx0fIQuDAAA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The incidence of a stroke in patients with either intermittent or sustained atrial fibrillation (AF) is related to risk category; the patients were treated with aspirin and followed for a mean of two years. Among those with intermittent AF, 24 percent were high risk, 32 percent are moderate risk and 43 percent are low risk; among those with sustaind AF, the respective values were 30, 34, and 36 percent. The stroke risk was similar in patients with intermittent and sustained AF.",
"    <div class=\"footnotes\">",
"     High risk: any of the following - age &gt;75 and hypertension, age &gt;75 and female, systolic BP &gt;160 mm Hg, prior stroke or transient ischemic attack; Moderate risk: either of - hypertension and age &le;75 or diabetes and no high risk features; Low risk: no moderate or high risk features.",
"    </div>",
"    <div class=\"reference\">",
"     Data from Hart RG, Pearce LA, Rothbart RM, et al. J Am Coll Cardiol 2000; 35:183.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_1_2078=[""].join("\n");
var outline_f2_1_2078=null;
var title_f2_1_2079="Agents responsible for RADS-I";
var content_f2_1_2079=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F55545%7EPULM%2F68367&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=15\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F55545%7EPULM%2F68367&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=15\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Agents responsible for reactive airways dysfunction syndrome",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Agent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Study",
"       </td>",
"       <td class=\"subtitle1\">",
"        Evidence",
"       </td>",
"       <td class=\"subtitle1\">",
"        References",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Acetic acid",
"       </td>",
"       <td>",
"        epidemiologic",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Am Rev Respir Dis 1991; 144:1058",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, P",
"       </td>",
"       <td>",
"        Br J Ind Med 1989; 4 6:67",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Sulfuric acid",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Chest 1988; 94:476",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        Hydrochloridic acid",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S",
"       </td>",
"       <td>",
"        Chest 1988; 94:476",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        case report",
"       </td>",
"       <td rowspan=\"2\">",
"        H, S, BR",
"       </td>",
"       <td>",
"        Chest 1985; 88:376",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chest 1990; 98:928",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Various acids",
"       </td>",
"       <td rowspan=\"2\">",
"        case report",
"       </td>",
"       <td rowspan=\"2\">",
"        H, S, BR, P",
"       </td>",
"       <td>",
"        Chest 1985; 88:376",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        JOM 1994; 36:623",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Heated acid",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR, P",
"       </td>",
"       <td>",
"        Chest 1985; 88:376",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Ammonia",
"       </td>",
"       <td rowspan=\"2\">",
"        case report",
"       </td>",
"       <td rowspan=\"2\">",
"        H, S",
"       </td>",
"       <td>",
"        Mayo Clin Proc 1983; 58:389",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thorax 1992; 47:755",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Bleaching agent",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Chest 1988; 94:476",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        epidemiologic",
"       </td>",
"       <td>",
"        H",
"       </td>",
"       <td>",
"        Am J Ind Med 2003; 43:532",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Bromochlorodifluoro- methane",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Occup Env Med 2004; 61:712",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Bromotrifluoromethane",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S",
"       </td>",
"       <td>",
"        Eur Respir J 1999; 13:1192",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        Chlorine",
"       </td>",
"       <td>",
"        epidemiologic",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Occup Env Med 1994; 61:712",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        epidemiologic",
"       </td>",
"       <td>",
"        H",
"       </td>",
"       <td>",
"        Env Res 2002; 88:89",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        clinical",
"       </td>",
"       <td>",
"        H, S, BR, P",
"       </td>",
"       <td>",
"        Toxicol Industrial Health 1993; 9:439",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Chloropicrin",
"       </td>",
"       <td>",
"        experimental",
"       </td>",
"       <td>",
"        P",
"       </td>",
"       <td>",
"        Toxicol Appl Pharm 1984; 74:417",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Cleaning agents",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S",
"       </td>",
"       <td>",
"        Chest 1976; 69:372",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Diesel exhaust",
"       </td>",
"       <td rowspan=\"2\">",
"        case report",
"       </td>",
"       <td rowspan=\"2\">",
"        H, S, BR",
"       </td>",
"       <td>",
"        Chest 1985; 88:376",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        J Occup Med 1993; 35:149",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Diethylaminoethanol",
"       </td>",
"       <td>",
"        epidemiologic",
"       </td>",
"       <td>",
"        H, S",
"       </td>",
"       <td>",
"        J Occup Med 1994; 36:623",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Epichlorohydrin",
"       </td>",
"       <td>",
"        experimental",
"       </td>",
"       <td>",
"        P",
"       </td>",
"       <td>",
"        Toxicol Appl Pharm 1984; 74:417",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Ethylene oxide",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR, P",
"       </td>",
"       <td>",
"        Br J Ind Med 1992; 49:523",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"5\">",
"        Fire/smoke",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Chest 1988; 94:476",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        epidemiologic, case report",
"       </td>",
"       <td>",
"        H, S, BR, P",
"       </td>",
"       <td>",
"        Occup Med 1993; 8:431",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        case report",
"       </td>",
"       <td rowspan=\"2\">",
"        H, S",
"       </td>",
"       <td>",
"        Chest 1985; 88:376",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        J Occup Med 1991; 33:458",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        epidemiologic",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Am J Respir Crit Care Med 2003; 168:54",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Formaldehyde",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Allergy 2004; 59:15",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     H: clinical history; S: spirometry; BR: bronchial responsiveness; P: pathology.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Agents responsible for reactive airways dysfunction syndrome, continued",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Agent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Study",
"       </td>",
"       <td class=\"subtitle1\">",
"        Evidence",
"       </td>",
"       <td class=\"subtitle1\">",
"        References",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Floor sealer",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Chest 1988; 94:476",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Floor polish",
"       </td>",
"       <td>",
"        epidemiologic",
"       </td>",
"       <td>",
"        H",
"       </td>",
"       <td>",
"        Int Arch Ocup Environ Health 2000; 73:498",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Fluorocarbon",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Eur Respir J 1999; 13:1192",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Formol",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S",
"       </td>",
"       <td>",
"        Lancet 1975; 2:603",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Freon (degradation)",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, Br, P",
"       </td>",
"       <td>",
"        Scand J Work Environ Health 2003; 29:71",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Cleaning mist (perchloroethylene)",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Chest 1988; 94:476",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Hydrazine",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Chest 1988; 94:476",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Iodine compounds",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR, P",
"       </td>",
"       <td>",
"        Ind Health 2009; 47:681",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"7\">",
"        Isocyanates",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Scand J Work Environ Health 1981; 7:310",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR, P",
"       </td>",
"       <td>",
"        Allergy 1996; 51:262",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        experimental",
"       </td>",
"       <td>",
"        S",
"       </td>",
"       <td>",
"        Toxicol App Pharmacol 1987; 89:332",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S",
"       </td>",
"       <td>",
"        Br J Ind Med 1990; 47:239",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Am J Ind Med 2003; 44:325",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Chest 1989; 96:297",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Am J Ind Med 2003; 44:325",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Metal remover",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Chest 1988; 94:476",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Oxyde (calcium)",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Chest 1989; 96:297",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Paints (heated)",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Chest 1989; 96:297",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Pesticides",
"       </td>",
"       <td>",
"        epidemiologic",
"       </td>",
"       <td>",
"        H, S",
"       </td>",
"       <td>",
"        Am J Ind Med 2003; 43:447",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Phthalic anhyride",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Rev Pneumol Clin 1993; 49:247",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Spray paint",
"       </td>",
"       <td rowspan=\"2\">",
"        case report",
"       </td>",
"       <td rowspan=\"2\">",
"        H, S, BR, P",
"       </td>",
"       <td>",
"        Chest 1989; 96:297",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chest 1985; 88:376",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"5\">",
"        Sulfur dioxide",
"       </td>",
"       <td rowspan=\"2\">",
"        case report",
"       </td>",
"       <td rowspan=\"2\">",
"        H, S, BR, P",
"       </td>",
"       <td>",
"        Am Rev Respir Dis 1979; 119:555",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chest 1990; 98:928",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        case report",
"       </td>",
"       <td rowspan=\"2\">",
"        H, S, BR",
"       </td>",
"       <td>",
"        Am Rev Respir Dis 1983; 128:890",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thorax 1992; 47:755",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, P",
"       </td>",
"       <td>",
"        Arch Int Med 1919; 24:678",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Gas (chlorine, mustard, phosgene, etc)",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, P",
"       </td>",
"       <td>",
"        Br Med J 1915; 165",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Teargas",
"       </td>",
"       <td>",
"        case report",
"       </td>",
"       <td>",
"        H, S, BR",
"       </td>",
"       <td>",
"        Rev Mal Respir 1999; 16:558",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     H: clinical history; S: spirometry; BR: bronchial responsiveness; P: pathology.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_1_2079=[""].join("\n");
var outline_f2_1_2079=null;
